0001144204-11-062508.txt : 20111109 0001144204-11-062508.hdr.sgml : 20111109 20111109155047 ACCESSION NUMBER: 0001144204-11-062508 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20110925 FILED AS OF DATE: 20111109 DATE AS OF CHANGE: 20111109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GlenRose Instruments Inc. CENTRAL INDEX KEY: 0001340095 STANDARD INDUSTRIAL CLASSIFICATION: HAZARDOUS WASTE MANAGEMENT [4955] IRS NUMBER: 203521719 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51645 FILM NUMBER: 111191573 BUSINESS ADDRESS: BUSINESS PHONE: 781.622.1120 MAIL ADDRESS: STREET 1: 45 FIRST AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Glenrose Instruments Inc. DATE OF NAME CHANGE: 20050928 10-Q 1 v238568_10q.htm FORM 10-Q


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 10-Q
 
R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 25, 2011

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Commission file number 000-51645

GLENROSE INSTRUMENTS INC.
(Exact name of Registrant as specified in its charter)
 
Delaware
20-3521719
(State of incorporation or organization)
(IRS Employer Identification No.)

45 First Avenue
 
Waltham, Massachusetts
02451
(Address of Principal Executive Offices)
(Zip Code)

Registrant’s Telephone Number, Including Area Code: (781) 622-1120
 


Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x    No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x        No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):
Large accelerated filer ¨
Accelerated filer ¨
   
Non –accelerated filer ¨
Smaller reporting company x
(Do not check if a smaller reporting company)
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
           Yes ¨ No x
 
Title of each class
 
Outstanding at September 25, 2011
Common Stock, $0.01 par value
 
3,112,647
 


 
 

 

GLENROSE INSTRUMENTS INC.

QUARTERLY REPORT ON FORM 10-Q
FOR THE PERIOD ENDING SEPTEMBER 25, 2011

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION

Item 1:
Financial Statements
3
     
 
Condensed Consolidated Balance Sheets – September 25, 2011 (unaudited) and December 26, 2010
3
     
 
Condensed Consolidated Statement of Operations – Three Months Ended September 25, 2011 and September 26, 2010 (unaudited)
5
     
 
Condensed Consolidated Statement of Operations – Nine Months Ended September 25, 2011 and September 26, 2010 (unaudited)
6
     
 
Condensed Consolidated Statement of Cash Flows – Nine Months Ended September 25, 2011 and September 26, 2010 (unaudited)
7
     
 
Notes to Condensed Consolidated Financial Statements
8
     
Item 2:
Management’s Discussion and Analysis of Financial Condition and Results of Operations
16
     
Item 3:
Quantitative and Qualitative Disclosures about Market Risk
21
     
Item 4T:
Controls and Procedures
21
     
  PART II - OTHER INFORMATION
     
Item 1A:
Risk Factors
22
     
Item 6:
Exhibits
22
     
Signatures
 
23

References in this Form 10-Q to “we”, “us”, “our”, the “company” “GlenRose Instruments” and “GlenRose” refers to GlenRose Instruments Inc. and its consolidated subsidiaries, unless otherwise noted.

 
2

 

PART I – FINANCIAL INFORMATION
 
Item 1 – Financial Statements
 
GLENROSE INSTRUMENTS INC.
CONSOLIDATED BALANCE SHEETS
As of September 25, 2011 and December 26, 2010

   
September 25,
   
December 26,
 
   
2011
   
2010
 
   
(unaudited)
       
             
ASSETS
           
Current Assets
           
Cash and cash equivalents
  $ 15,653     $ 1,669,868  
Short-term investments
    12,305       12,305  
Accounts receivable (net of allowances of $24,320 and $26,120 for 2011 and 2010, respectively)
    5,336,701       4,376,929  
Unbilled contract receivables
    237,575       370,887  
Due from related party
    42,858       42,858  
Supply inventory
    70,785       60,271  
Prepaid expenses
    210,009       97,450  
Other receivables
    37,714       58,464  
Income tax receivable
    -       161,356  
Deferred tax asset
    484,167       474,235  
Assets held for sale
    1,047,367       1,045,367  
Total current assets
    7,495,134       8,369,990  
                 
Property, plant and equipment, net
    1,510,165       1,557,088  
                 
Other assets
               
Restricted cash
    451,000       450,000  
Deposits
    53,065       53,065  
Deferred financing costs
    87,346       104,499  
Goodwill
    2,740,913       2,740,913  
Total other assets
    3,332,324       3,348,477  
                 
TOTAL ASSETS
  $ 12,337,623     $ 13,275,555  

The accompanying notes are integral part of these consolidated financial statements

 
3

 

GLENROSE INSTRUMENTS INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
As of September 25, 2011 and December 26, 2010

   
September 25,
   
December 26,
 
   
2011
   
2010
 
   
(unaudited)
       
             
LIABILITIES AND STOCKHOLDERS' EQUITY
           
Current liabilities
           
Accounts payable
  $ 1,181,159     $ 653,130  
Deferred revenue
    426,835       -  
Accrued expenses
    296,229       363,327  
Accrued employee-related costs
    1,724,150       1,972,581  
Accrued interest, related party
    5,254       48,750  
Line of credit payable
    696,570       -  
Term note payable, current portion
    142,857       -  
Notes payable, current portion
    52,578       13,978  
Due to related party
    22,286       8,002  
Capital lease obligations, current portion
    11,612       10,752  
Income taxes payable
    351,979       18,130  
Total current liabilities
    4,911,509       3,088,650  
                 
Long-term liabilities
               
Convertible debentures due to related parties
    -       4,875,000  
Term note payable, net of current portion
    857,143       -  
Notes payable, net of current portion
    36,998       13,634  
Capital lease obligations, net of current portion
    29,707       38,527  
Deferred tax liability
    394,599       427,198  
Other long-term liabilities
    27,025       134,552  
Total liabilities
    6,256,981       8,577,561  
                 
Stockholders' equity
               
Common stock ($0.01 par value; 10,000,000 shares authorized; 3,117,647 shares issued and outstanding at September 25, 2011 and December 26, 2010)
    31,176       31,176  
Additional paid-in-capital
    8,001,338       7,972,098  
Accumulated deficit
    (1,951,872 )     (3,305,280 )
Total stockholders' equity
    6,080,642       4,697,994  
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
  $ 12,337,623     $ 13,275,555  
 
The accompanying notes are integral part of these consolidated financial statements

 
4

 

GLENROSE INSTRUMENTS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three Months Ended September 25, 2011 and September 26, 2010

   
Three Months Ended
 
   
September 25,
   
September 26,
 
   
2011
   
2010
 
   
(unaudited)
   
(unaudited)
 
             
Revenues
  $ 11,016,348     $ 9,898,694  
                 
Cost of sales
    9,926,112       8,894,138  
                 
Gross profit from operations
    1,090,236       1,004,556  
                 
General and administrative expenses
    579,154       487,391  
                 
Operating income
    511,082       517,165  
                 
Other income (expense)
               
Interest and other income
    1,122       5,357  
Interest expense
    (97,102 )     (352,102 )
Total other expense
    (95,980 )     (346,745 )
                 
Income from operations, before income taxes
    415,102       170,420  
                 
Provision for income taxes
    (185,388 )     -  
                 
Net income
  $ 229,714     $ 170,420  
                 
Net income per share - basic and diluted
  $ 0.07     $ 0.05  
                 
Weighted average shares outstanding -
               
basic and diluted
    3,102,647       3,102,647  

The accompanying notes are integral part of these consolidated financial statements

 
5

 

GLENROSE INSTRUMENTS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Nine Months Ended September 25, 2011 and September 26, 2010

   
Nine Months Ended
 
   
September 25,
   
September 26,
 
   
2011
   
2010
 
   
(unaudited)
   
(unaudited)
 
             
Revenues
  $ 32,850,589     $ 29,917,021  
                 
Cost of sales
    28,963,445       26,973,094  
                 
Gross profit from operations
    3,887,144       2,943,927  
                 
General and administrative expenses
    1,673,867       1,515,061  
                 
Operating income
    2,213,277       1,428,866  
                 
Other income (expense)
               
Interest and other income
    2,669       10,745  
Interest expense
    (222,833 )     (710,714 )
Total other expense
    (220,164 )     (699,969 )
                 
Income from operations, before income taxes
    1,993,113       728,897  
                 
Provision for income taxes
    (639,705 )     -  
                 
Net income
  $ 1,353,408     $ 728,897  
                 
Net income per share - basic and diluted
  $ 0.44     $ 0.23  
                 
Weighted average shares outstanding -
               
basic and diluted
    3,102,647       3,102,647  

The accompanying notes are integral part of these consolidated financial statements

 
6

 

GLENROSE INSTRUMENTS INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 25, 2011 and September 26, 2010

   
September 25,
   
September 26,
 
   
2011
   
2010
 
   
(unaudited)
   
(unaudited)
 
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net income
  $ 1,353,408     $ 728,897  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    362,359       315,189  
Provision for deferred income taxes
    (42,531 )     -  
Amortization of deferred financing costs
    17,153       315,388  
Stock-based compensation
    29,240       59,694  
Bad debt expense
    (1,800 )     -  
Loss on disposal of fixed assets
    -       (3,132 )
Changes in operating assets and liabilities
               
(Increase) decrease in:
               
Accounts receivable
    (957,972 )     (989,050 )
Restricted cash
    (1,000 )     (35,000 )
Due from related party
    -       (42,858 )
Other receivables
    20,750       993  
Unbilled contract receivables
    133,312       307,600  
Prepaid expenses
    (112,559 )     (66,843 )
Inventory
    (10,514 )     4,888  
Assets held for sale
    (2,000 )     -  
Income tax receivable
    161,356       -  
Increase (decrease) in:
               
Accounts payable
    528,029       (328,419 )
Accrued interest, related party
    (43,496 )     (235,096 )
Due to related party
    14,284       (16,545 )
Deferred revenue
    426,835       77,477  
Other long-term liabilities
    (107,527 )     70,193  
Other accrued liabilities
    18,320       12,032  
Net cash provided by operating activities
    1,785,647       175,408  
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Purchase of property and equipment
    (315,436 )     (125,778 )
Proceeds from the sale of short-term investments
    -       10,048,611  
Net cash (used in) provided by investing activities
    (315,436 )     9,922,833  
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Redemption of convertible debentures
    (4,875,000 )     (10,000,000 )
Proceeds from term note payable
    1,000,000       -  
Advance on line of credit
    6,389,617       -  
Proceeds from notes payable
    77,502          
Payments on line of credit
    (5,693,047 )     -  
Payments on notes payable
    (15,538 )     -  
Principal payments on capital lease obligations
    (7,960 )     (11,067 )
Net cash used in financing activities
    (3,124,426 )     (10,011,067 )
                 
Net increase in cash and cash equivalents
    (1,654,215 )     87,174  
Cash and cash equivalents, beginning of the period
    1,669,868       1,012,250  
Cash and cash equivalents, end of the period
  $ 15,653     $ 1,099,424  

The accompanying notes are integral part of these consolidated financial statements

 
7

 

GLENROSE INSTRUMENTS INC.
 
Notes to Interim Financial Statements (Unaudited) for the period ending September 25, 2011

Note 1 – Organization and Significant Accounting Policies:

Organization

GlenRose Instruments Inc., a Delaware corporation, or the company, we, our, or us, was incorporated in September 2005 by the GlenRose Partnership L.P., or the GlenRose Partnership, a private-equity partnership with its headquarters in Waltham, Massachusetts. The company was organized to serve as a holding company through which the GlenRose Partnership’s partners would hold the shares of Eberline Services, Inc. or Eberline Services or ESI (all of which had previously been held by the GlenRose Partnership). In order to effect such change in structure, the GlenRose Partnership entered into a stock exchange agreement with the company in September 2005 pursuant to which all outstanding shares of Eberline Services owned by the GlenRose Partnership were exchanged for 3,000,000 shares of common stock of GlenRose Instruments. As a result of this exchange, the GlenRose Partnership owned all of the outstanding stock of the company, and the company owned all of the outstanding stock of its subsidiary, ESI.
 
GlenRose Instruments, through Eberline Services and its subsidiaries, provides radiological services and operates a radiochemistry laboratory network, as well as provides radiological characterization and analysis, hazardous, radioactive and mixed waste management, and facility, environmental, safety and health management. The subsidiaries of Eberline Services are Eberline Services Hanford, Inc. or ESHI, Eberline Analytical Corporation, Benchmark Environmental Corp., and Lionville Laboratory Inc., or Lionville.

In March 2011 the company retained the services of Raymond James & Associates, Inc. to act as its sole, external investment banking advisor in helping the company evaluate strategic alternatives, including the possible sale of all or a material portion of the assets or securities of the company to, or merger of the company with, various third parties. On October 14, 2011, the company terminated the engagement with Raymond James & Associates. Starting in the fourth quarter the company will increase its efforts in the development and manufacturing of a line of radiation monitoring instruments.
 
As of September 25, 2011, the company has three segments – the Environmental Services segment, the Analytical Laboratories segment and the Instruments segment. The Environmental Services operating segment provides radiological and waste management services primarily to the federal government in connection with the clean-up of the former and present atomic weapons and energy sites operated by the federal government. The Analytical Laboratories operating segment provides analytical radiological services and involves the operation of a radiochemistry laboratory network and a radioactive check source manufacturing facility. The Instruments segment was formed in 2006 with the intent to acquire instrument companies, which have well-established and proven technology. This segment also includes the research and development of a new line of instruments that the company expects to begin manufacturing later this year. As of the date of this report the company has not made any commitments, nor has it acquired any instrument businesses.
 
Principles of Consolidation and Basis of Presentation

The accompanying consolidated financial statements include the company and its subsidiaries. All significant intercompany transactions have been eliminated. In the opinion of management, the unaudited financial statements contain all adjustments (all of which were considered normal and recurring) necessary to present fairly the company's financial position at September 25, 2011, and the results of operations and cash flows for the three and nine months ended September 25, 2011 and September 26, 2010. The unaudited financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the company’s Form 10-K for the year ended December 26, 2010.
Reclassifications

Certain prior period balances have been reclassified to conform with current period presentation.

Fiscal Year

The company’s fiscal year-end is the last Sunday of each calendar year. Each quarter is comprised of two four-week and one five-week period to ensure consistency in prior-year comparative analysis. The company changed the fiscal year-end to the current format in 2006. The previous fiscal year-end was December 26, 2010.

 
8

 
 
GLENROSE INSTRUMENTS INC.
 
Use of Estimates in Preparation of Statements

The preparation of financial statements in conformity with generally accepted accounting principles, or GAAP, requires management to make estimates and underlying assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
 
Concentration of Credit Risk

Financial instruments, which potentially subject the company to concentrations of credit risk, consist of highly liquid cash equivalents and trade receivables. The company’s cash equivalents are placed with certain financial institutions and issuers. At September 25, 2011, the company did not have any cash and cash equivalents, short-term investments and restricted cash that exceeded the Federal Deposit Insurance Corporation limit of $250,000.

The company performs periodic credit evaluations of its customers’ financial condition and generally does not require collateral. The company provides for an allowance for doubtful accounts on receivable balances based upon the expected collectability of such receivables. Federal and state governments collectively account for more than 90% of all revenues for the three month periods ended September 25, 2011 and September 26, 2010. Two of the company’s customers account for more than 10% of revenue and trade accounts receivable. One customer represented approximately 73% and 70% of revenue and 39% and 74% of trade accounts receivable for the three months ended September 25, 2011 and September 26, 2010, respectively and approximately 77% and 70% of revenue and 39% and 74% of trade accounts receivable for the nine month periods ended September 25, 2011 and September 26, 2010, respectively. The other customer represented approximately 9% and 4% of revenue and 20% and 5% of trade accounts receivable for the three months ended September 25, 2011 and September 26, 2010, respectively and approximately 3% and 10% of revenue and 20% and 5% of trade accounts receivable for the nine month period ended September 25, 2011 and September 26, 2010, respectively.

Revenue Recognition

Revenue for laboratory services is recognized upon completion of the services and the shipment of the related data packages to the company’s customers. Revenue for government service contracts is recognized as the services are performed. Revenues are recognized based upon actual costs incurred plus specified fees or actual time and materials as required. The company performs certain contracts that are audited by either the Defense Contract Audit Agency, or the DCAA, or Los Alamos National Laboratories Internal Audit. Such contracts may be subject to adjustment dependent upon such factors as provisional billing rates or other contract terminology. The company records as revenue what it considers to be allowable costs under government service contracts. Calculations of allowable overhead and profit may also change after audits by the DCAA for cost reimbursable type contracts. Contracts are normally settled during the audit year the contract terminates performance and is submitted for closure. The company is currently audited and settled through December 2005 for all contracts subject to review by DCAA and audited through December 2002 for contracts subject to review by the Los Alamos Internal Audit. Contracts performed after 2005 for DCAA purposes, or after 2002 for the Los Alamos Internal Audit, and are either active or have not been submitted for closure may be subject to adjustment during subsequent audits during the year they are closed and audited.
 
The company is engaged principally in three types of service contracts with the federal government and its contractors:

Cost Reimbursable Contracts. Revenue from “cost-plus-fixed-fee” contracts is recognized on the basis of reimbursable contract costs incurred during the period plus an earned fee. Costs incurred for services which have been authorized and performed, but may not have been billed, are allocated with operational fringe, overhead, general and administrative expenses and fees, and are presented as Unbilled Contract Receivables on the accompanying consolidated balance sheets contained herein.

Time-and-Materials Contracts. Revenue from “time and material” contracts is recognized on the basis of man-hours utilized plus other reimbursable contract costs incurred during the period.

Fixed-Price Contracts. Revenue from “fixed-price” contracts is recognized on the percentage-of-completion method.  For fixed-price contracts, the amount of revenues recognized is that portion of the total contract amount that the actual cost expended bears to the anticipated final total cost based on current estimates of cost to complete the project (cost-to-cost method).  However, when it becomes known that the anticipated final total cost will exceed the contract amount, the excess of cost over the contract amount is immediately recognized as a loss on the contract. Recognition of profit commences on an individual project only when cost to complete the project can reasonably be estimated and after there has been some meaningful performance achieved on the project (greater than 10% complete). Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions (when applicable) and final contract settlements, may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Claims and change orders are not recorded and recognized until such time as they have been accepted.

 
9

 
 
GLENROSE INSTRUMENTS INC.
 
Direct costs of contracts include direct labor, subcontractors and consultants, materials and travel. The treatment of direct costs is outlined in the Federal Acquisition Regulations. The balance of costs, including facilities costs, insurance, administrative costs, overhead labor and fringe costs, are classified as either indirect costs or general and administrative expense and are allocated to jobs as a percentage of each division’s total cost base consistent with our approved cost structure. Direct materials, direct travel, other direct costs, and minor subcontract costs are passed through to the customer at cost, with or without fee depending on contract type and/or direct cost element and are burdened with general and administrative expenses. Major subcontracts are passed through at cost, without fee and are burdened with a material handling fee. The company is exempt from federal cost accounting standards coverage based on its size standard, but otherwise complies with applicable regulations.
 
Goodwill
 
Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. Goodwill is subject to an impairment test annually. Goodwill is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The company performs impairment testing at the reporting unit level. An impairment loss is recognized when the fair value of the discounted cash flows of the reporting unit including its tangible assets is less than the carrying value. Model assumptions are based on the company’s projections and best estimates using appropriate and customary market participant assumptions. Changes in forecasted cash flows or the discount rate would affect the estimated fair value of the reporting unity and could result in a goodwill impairment charge in a future period.
 
At September 25, 2011, the company’s entire $2,740,913 goodwill balance was related to the Environmental Services segment which includes Eberline Services, ESHI and Benchmark Environmental Corp. The Analytical Laboratories goodwill was written off in prior years. No goodwill impairment was identified during the years ended December 26, 2010 and December 27, 2009. No events occurred or circumstances changed that required the company to further test goodwill for impairment during the nine month period ended September 25, 2011.
 
Income Taxes
 
The company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The amount of such provisions is based on various factors, such as the amount of taxable income in the current and prior periods, and the likelihood of continued taxable income. Additionally, management is responsible for estimating the probability that certain tax assets or liabilities can and will be utilized in future periods. The company believes it records and/or discloses such potential tax liabilities as appropriate and has reasonably estimated its income tax liabilities and recoverable tax assets. During the three and nine month period ended September 25, 2011, the company recorded a tax provision of $185,388 and $639,705, respectively. There was no tax provision recorded during the three and nine month period ended September 26, 2010, as a result of the availability of net loss carryforwards.

Earnings per Common Share

The company computes basic earnings per share by dividing net income for the period by the weighted average number of shares of common stock outstanding during the period. The company computes its diluted earnings per common share using the treasury stock method. For purposes of calculating diluted earnings per share, the company considers its shares issuable in connection with convertible debentures and stock options to be dilutive common stock equivalents when the exercise price is less than the average market price of the company’s common stock for the period. There were no dilutive common shares during the three and nine month periods ended September 25, 2011 and September 26, 2010. See “Note 5 – Earnings per Share.”

Stock Based Compensation
 
Stock based compensation cost is measured at the grant date based on the estimated fair value of the award and is recognized as an expense in the statement of operations over the requisite service period. The fair value of stock options granted is estimated using the Black-Scholes option pricing valuation model. The company recognizes compensation on a straight-line basis for each separately vesting portion of the option award. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. Expected volatility is calculated based on the average volatility of 20 companies in the same industry as the company. The average expected life is estimated using the simplified method for “plain vanilla” options. The simplified method determines the expected life in years based on the vesting period and contractual terms as set forth when the award is made. The company uses the simplified method for awards of stock-based compensation since it does not have the necessary historical exercise and forfeiture data to determine an expected life for stock options. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term which approximates the expected life assumed at the date of grant. When options are exercised the company normally issues new shares.

 
10

 
 
GLENROSE INSTRUMENTS INC.
 
Fair Value of Financial Instruments

At September 25, 2011 the Company’s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, accounts payable, capital lease obligations, line of credit payable, term note payable and notes payable. The recorded values of cash and cash equivalents, accounts receivable and accounts payable approximate fair value based on their short-term nature. The fair value of capital lease obligations and notes payable is estimated at its carrying value based on current rates. The carrying value of the Company’s line of credit and term loan approximates its fair value due to its variable interest rate. Short-term investments are recorded at fair value.  See “Note 6 – Fair Value Measurements.”

Recovery of Long-Lived Assets
 
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the remaining estimated useful life of such assets might warrant revision or that the balances may not be recoverable. If undiscounted cash flows are insufficient to recover the net book value of long-term assets further analysis is performed in order to determine the amount of the impairment. In such circumstances an impairment loss would be recorded equal to the amount by which the net book value of the assets exceeds fair value. Fair value is usually determined based on the present value of estimated expected future cash flows using a discount rate commensurate with the risks involved. No events occurred or circumstances changed at September 25, 2011, that would indicate that the remaining net book value of the company’s long-lived assets are not recoverable.

Assets Held for Sale

The company owns property in Albuquerque, New Mexico. In 2009, the company entered into an agreement, subject to closing conditions, with a buyer to sell the property for approximately $1.9 million. At September 25, 2011, $507,700 in land, $2,265,764 in buildings and improvements less $1,916,926 in accumulated depreciation is classified as “Assets held for sale” on the company’s balance sheet. The assets held for sale balance of $1,047,367 also includes selling costs incurred to date of $37,477 and an accrual of $153,352 towards decommissioning of the site. In 2010, the company submitted a detailed site assessment of the facility to the New Mexico Environmental Department, or NMED, as part of the closure process which was approved in June 2011. The company characterized and classified all radiological waste associated with the facility and all waste was crated and packaged for disposal in 2010. In January 2011, the company applied for a shipment permit to transfer the remaining waste to an appropriate facility, which was shipped during the quarter. The company is currently communicating with NMED on the report in preparation for the demolition of the building. The company believes that it has adequately accrued for decommissioning of the site; however, it is possible that additional funds up to $100,000 may be needed. The company expects to complete the sale in 2011.

Note 2 – Debt:

On July 25, 2008, the company entered into subscription agreements with four investors for the sale of convertible debentures in the aggregate principal amount of $14,875,000. The primary investor was Blum Strategic Partners IV, L.P., who subscribed for $12,000,000 of the debentures. Additional investors included John N. Hatsopoulos, the company’s Chairman of the board, Arvin H. Smith, the company’s President and Chief Executive Officer, and Philip Frost M.D., a holder of more than 10% of the outstanding equity securities of the company immediately prior to the sale of the debentures, who subscribed for $2,875,000 of debentures by exchanging existing promissory notes of the company for the debentures. The debentures carried interest at 4%, payable quarterly in cash, and matured on July 25, 2013. The debentures were convertible at the option of the holder at any time into shares of common stock at a conversion price equal to $7.00 per share.

On July 23, 2010, the holders of the outstanding principal amount of the company’s convertible debentures, agreed to amend the debenture agreements to eliminate subsections (i) and (ii) of Section 6(a) of the debentures. With this amendment the holders gave the company the option to redeem any portion of the debentures by written notice to the holders; provided that a redemption notice is delivered by the company and be received by the holder of the debentures at least ten (10) trading days but not more than thirty (30) trading days prior to the date of the redemption. In connection with the amendment described above, the company redeemed $10,000,000 on August 9, 2010, $575,000 on January 13, 2011, and $500,000 on March 31, 2011.
 
On July 1, 2011, the company redeemed the outstanding amount of the convertible debentures with Blum Strategic Partners IV, L.P., in the principal amount of $3,065,546, plus accrued interest. In connection with that transaction, the company entered into a $500,000 Demand Note Agreement with John N. Hatsopoulos, the company’s Chairman of the Board, and into a $1,500,000 Demand Note Agreement with Arvin H. Smith, the company’s Chief Executive Officer. Both demand note agreements accrued interest at the rate of 4.50% per year.

 
11

 
 
GLENROSE INSTRUMENTS INC.
 
On August 31, 2011, the company entered into a line of credit agreement with Wells Fargo Bank for a $5,000,000 credit facility. The facility included a $1,000,000 term real-estate note, or Term Note, with a 7 year straight line amortization, at Libor plus 3.5%, and up to $4,000,000 in a revolving line of credit, or Line of Credit, for 5 years, at Libor plus 3.5%, based on a borrowing base of the company’s trade receivables subject to certain adjustments.

The Term Note and Line of Credit are payable by Eberline Services Inc., Eberline Services Hanford Inc., Eberline Analytical Laboratory Inc., and Lionville Laboratory Inc., subsidiaries of the Company. The Term Note is secured by the company’s real estate assets which are included in fixed assets which at September 25, 2011 had a net book value of $1,510,165. The Line of Credit is secured by the company’s trade receivables. The undrawn portion of the Line of Credit at September 25, 2011 was $3,342,540. The loan is also subject to various financial statement covenants including EBITDA, book value, and fixed charge coverage ratio. On August 31, 2011, the company borrowed $1,000,000 against the Term Note and $1,000,000 against the Line of Credit and used the proceeds to redeem the remaining balance of the convertible debentures and pay down the Demand Note Agreements with John N. Hatsopoulos and Arvin H. Smith.
 
As of September 25, 2011, there were no convertible debentures outstanding and the Demand Note Agreements were paid in full. The balance outstanding on the Term Note was $1,000,000 and the balance outstanding on the revolving line of credit was $696,570.

Note 3 – Commitments and Contingencies:

The company and its subsidiaries lease facilities and equipment under various operating leases. Future minimum rental commitments for long-term, non-cancelable operating leases at September 25, 2011 are as follows:
 
Summary of Lease Obligations:

   
2012
   
2013
   
2014
   
2015
   
Totals
 
                               
Facilities
  $ 224,541     $ 139,655     $ 49,128     $ 12,282     $ 425,606  
Equipment
    10,145       10,145       10,145       4,227       34,662  
    $ 234,686     $ 149,800     $ 59,273     $ 16,509     $ 460,268  

For the three and nine month periods ending September 25, 2011, rent expense was $79,893 and $249,967, respectively, and for the three and nine month periods ending September 26, 2010, rent expense was $53,281 and $292,827, respectively.

The company performs services under numerous subcontract agreements on cost-reimbursable contracts with the federal government. During the period from 1998 to 2003, the company was party to a subcontract agreement with Johnson Control Northern New Mexico, or JCNNM, to provide services to Los Alamos on a cost-reimbursable basis. On May 14, 2007, the company received notification from IAP-Northern New Mexico, or IAPNNM, the successor corporation to JCNNM, that the results of a Los Alamos audit for the period ending in 2003 determined that certain costs previously claimed and billed by the company were subsequently deemed unallowable or otherwise not reimbursable. IAPNNM requested that the company reimburse the amount of $321,836 that was paid to the company during the subject time period. In January 2009, the company protested the Los Alamos audit results claiming they were inaccurate and requested to resubmit a claim for the subject contract. The Los Alamos audit team agreed to review the audit results and adjust the claim as needed. Management believes that the company will prevail in this decision and has therefore not provided a specific reserve for this claim. In the event it is determined that the company has to reimburse such amount in full, the resultant cost could materially affect its results of operations.
 
The company is not currently a party to any material litigation and is not aware of any pending or threatened litigation against it that could have a material adverse effect on its business, operating results or financial condition.

Note 4 – Stockholders’ Equity:

Stock-based compensation expense was $29,240 and $59,694 as of September 25, 2011 and September 26, 2010, respectively. At September 25, 2011, there were 10,000 shares of unvested restricted stock outstanding and 67,200 of unvested stock options outstanding.

 
12

 
 
GLENROSE INSTRUMENTS INC.
 
Note 5 – Earnings per Share:

Basic and diluted earnings per share for the three and nine month periods ended September 25, 2011 and September 26, 2010 was as follows:

   
Three Months
   
Nine Months
 
   
September 25,
   
September 26,
   
September 25,
   
September 26,
 
   
2011
   
2010
   
2011
   
2010
 
Earnings per share
                       
Earnings available to stockholders
  $ 229,714     $ 170,420     $ 1,353,408     $ 728,897  
                                 
Weighted average shares outstanding - basic
    3,102,647       3,102,647       3,102,647       3,102,647  
Net earnings per share - basic
  $ 0.07     $ 0.05     $ 0.44     $ 0.23  
                                 
Assumed exercise of dilutive stock options and warrants
    -       -       -       -  
Weighted average shares outstanding - diluted
    3,102,647       3,102,647       3,102,647       3,102,647  
Net earnings per share - diluted
  $ 0.07     $ 0.05     $ 0.44     $ 0.23  
                                 
Anti-dilutive restricted stock outstanding
    10,000       15,000       10,000       15,000  
Anti-dilutive shares underlying stock options outstanding
    168,000       173,000       168,000       173,000  
Anti-dilutive convertible debentures
    -       696,429       -       696,429  

Note 6 – Fair Value Measurements:

The fair value topic of FASB’s Accounting Standards Codification defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities. The company currently does not have any Level 1 financial assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1. Level 2 inputs include quoted prices for identical assets or liabilities in non-active markets, quoted prices for similar assets or liabilities in active markets and inputs other than quoted prices that are observable for substantially the full term of the asset or liability.   
 
Level 3 — Unobservable inputs reflecting management’s own assumptions about the input used in pricing the asset or liability. The company currently does not have any Level 3 financial assets or liabilities.

At September 25, 2011, the company had $12,305 in short-term investments that are comprised of certificates of deposits which are categorized as Level 2. The company determines the fair value of certificates of deposits using information provided by the issuing bank which includes discounted expected cash flow estimates using current market rates offered for deposits with similar remaining maturities.
 
Note 7 - Segment Data:

The company’s executive officers include Arvin Smith, Dr. Richard Chapman and Dr. Shelton Clark. Collectively, they are the Chief Operating Decision Maker, or CODM, as defined by Disclosures about Segments of an Enterprise and Related Information. The office of the CODM is responsible for assessing the performance of each segment, as well as the allocation of company resources.

 
13

 
 
GLENROSE INSTRUMENTS INC.
 
The company currently operates three business segments: Environmental Services, Analytical Laboratories and Instruments. The Environmental Services operating segment provides radiological and waste management services primarily to the federal government in connection with the clean-up of the former and present atomic weapons and energy sites operated by the federal government. The Analytical Laboratories operating segment provides analytical radiological services and involves the operation of a radiochemistry laboratory network and a radioactive check source manufacturing facility. The Instruments segment was formed in 2006 with the intent to acquire instrument companies, which have well-established and proven technology. This segment also includes the research and development of a new line of instruments that the company expects to begin manufacturing later this year. As of the date of this report the company has not made any commitments, nor has it acquired any instrument businesses. Acquisition of instrument businesses is no longer a focus in our strategy. Intercompany costs and sales are eliminated in the consolidated financial statements.

Segment data for the periods ending September 25, 2011 and September 26, 2010 are included below:

   
Three Months Ended
   
Nine Months Ended
 
   
September 25,
   
September 26,
   
September 25,
   
September 26,
 
   
2011
   
2010
   
2011
   
2010
 
   
(unaudited)
   
(unaudited)
   
(unaudited)
   
(unaudited)
 
Revenues
                       
Environmental Services
  $ 8,402,364     $ 7,430,660     $ 24,794,721     $ 22,407,413  
Analytical Laboratories
    2,613,984       2,468,034       8,055,868       7,509,608  
Instruments
    -       -       -       -  
      11,016,348       9,898,694       32,850,589       29,917,021  
Cost of Sales
                               
Environmental Services
    7,630,428       6,680,747       22,249,310       20,581,248  
Analytical Laboratories
    2,295,684       2,213,391       6,714,135       6,391,846  
Instruments
    -       -       -       -  
      9,926,112       8,894,138       28,963,445       26,973,094  
Gross Profit (Loss)
                               
Environmental Services
    771,936       749,913       2,545,411       1,826,165  
Analytical Laboratories
    318,300       254,643       1,341,733       1,117,762  
Instruments
    -       -       -       -  
      1,090,236       1,004,556       3,887,144       2,943,927  
General and administrative expenses
                               
Environmental Services
    377,127       330,906       1,116,144       986,637  
Analytical Laboratories
    105,450       101,793       311,777       286,193  
Instruments
    96,577       54,692       245,946       242,231  
      579,154       487,391       1,673,867       1,515,061  
Operating profit (Loss)
                               
Environmental Services
    394,809       419,007       1,429,267       839,528  
Analytical Laboratories
    212,850       152,850       1,029,956       831,569  
Instruments
    (96,577 )     (54,692 )     (245,946 )     (242,231 )
      511,082       517,165       2,213,277       1,428,866  
Supplemental Disclosure
                               
Depreciation Expense
                               
Environmental Services
    36,183       16,273       84,413       44,060  
Analytical Laboratories
    80,377       95,247       277,946       271,129  
Instruments
    -       -       -       -  
      116,560       111,520       362,359       315,189  
Capital Expenditures
                               
Environmental Services
    44,157       -       164,604       60,257  
Analytical Laboratories
    35,166       21,963       150,832       65,521  
Instruments
    -       -       -       -  
      79,323       21,963       315,436       125,778  
  
                   
September 25,
   
December 26,
 
                    2011     2010  
                   
(unaudited)
         
Total Assets
                               
Environmental Services
                    8,451,101       8,905,345  
Analytical Laboratories
                    3,546,154       4,250,758  
Instruments
                    340,368       119,452  
                    $ 12,337,623     $ 13,275,555  
 
 
14

 
 
GLENROSE INSTRUMENTS INC.
 
Note 8 – Subsequent Events:

The company has evaluated subsequent events through the filing date of this Form 10-Q and determined that no additional subsequent events occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto.

 
15

 
 
GLENROSE INSTRUMENTS INC.
 
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking statements are made throughout this Management's Discussion and Analysis of Financial Condition and Results of Operations. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “seeks,” “estimates” and similar expressions are intended to identify forward-looking statements. While the company may elect to update forward-looking statements in the future, it specifically disclaims any obligation to do so, even if the company's estimates change and readers should not rely on those forward-looking statements as representing the company's views as of any date subsequent to the date of the filing of this Quarterly Report on Form 10-Q. There are a number of important factors that could cause the actual results of the company to differ materially from those indicated by such forward-looking statements, including those detailed under the heading “Risk Factors” in this Quarterly Report on Form 10-Q.

Third Quarter 2011 Compared to Third Quarter 2010

Revenues
 
Revenues in the third quarter of 2011 were $11,016,348 compared to $9,898,694 for the same period in 2010, an increase of $1,117,654 or 11.3%. The increase in revenues was due to an increase in both our Environmental Services revenues, and Analytical Laboratory revenues. The increase in our Environmental Services revenues was due to increased work at Hanford and increased work at Argonne National Laboratory. The increase in revenue in our Analytical Laboratory revenues was due to increased sample volume primarily at our Lionville location.

Revenues from our Environmental Services in the third quarter of 2011 were $8,402,364 compared to $7,430,660 for the same period in 2010, an increase of $971,704 or 13.1%. Our Environmental Services contributed 76.3% to total revenues in the third quarter of 2011 compared to 75.1% for the same period in 2010. The increase in our Environmental Services revenue was due to increased work at Hanford and new work at Argonne National Laboratory. Work continued on our CHPRC contract at Hanford and we added additional contract work in radiological mapping for CHPRC. At Los Alamos our work changed from a long-term support contract to contracts which include an on-site screening facility, remediation support and environmental well drilling and sampling. We also performed work at the Argonne National Laboratory this quarter in support of a decontamination and demolition project.

Revenues from our Analytical Laboratories in the third quarter of 2011 were $2,613,984 compared to $2,468,034 for the same period in 2010, an increase of $145,950 or 5.9%. Our Analytical Laboratories contributed 23.7% to total revenues in the third quarter of 2011 compared to 24.9% for the same period in 2010. The increase in revenues was the result of increased sample loads primarily at the Lionville laboratory. In addition to the number of samples there was also an increased emphasis on performing quick-turn analyses as customers required faster results. Faster analyses carry a premium price which helped increase revenues.
 
Cost of Sales

The cost of sales in the third quarter of 2011 was $9,926,112 compared to $8,894,138 for the same period in 2010, an increase of $1,031,974 or 11.6%. The increase in cost of sales was primarily due to increased variable costs associated with the sales increases at both the Analytical Services and Laboratory segments. We also increased the number of employees, subcontracts and direct materials in those segments. The cost of sales from our Environmental Services in the third quarter of 2011 was $7,630,428 compared to $6,680,747 for the same period in 2010, an increase of $949,681 or 14.2% primarily due to salaries of new employees and an increase in subcontracts. The cost of sales from our Analytical Laboratories in the third quarter of 2011 was $2,295,684 compared to $2,213,391 for the same period in 2010, an increase of $82,293 or 3.7%, primarily due to increased direct labor and direct material costs during the period.

Gross Profit

Gross profit in the third quarter of 2011 was $1,090,236 compared to $1,004,556 for the same period in 2010, an increase of $85,680 or 8.5%. The gross profit margin decreased to 9.9% in the third quarter of 2011 from 10.1% for the same period in 2010. The gross profit from our Environmental Services in the third quarter of 2011 was $771,936 compared to $749,913 for the same period in 2010, an increase of $22,023 or 2.9% due to the use of on-site screening facility which carried a higher profit margin than labor dominated contracts. The gross profit from our Analytical Laboratories in the third quarter of 2011 was $318,300 compared to $254,643 for the same period in 2010, an increase of $63,657 or 25.0% due to net revenue increase across the segment.

 
16

 
 
GLENROSE INSTRUMENTS INC.
 
Operating Expenses

General and administrative expenses in the third quarter of 2011 were $579,154 compared to $487,391 for the same period in 2010, an increase of $91,763 or 18.8%. The general and administrative expenses increased to meet the demands of increased work and to accommodate increased business development efforts.
 
Operating Income

The operating income in the third quarter of 2011 was $511,082 compared to $517,165 for the same period in 2010. The operating income consisted of $394,809 at the Environmental Services and $212,850 at the Analytical Laboratories, offset by corporate general and administrative expenses of $96,577. The decrease in operating income was due to an increase in our general and administrative costs related to increased business development efforts.

Other Income (Expense)

Other expenses in the third quarter of 2011 were $95,980 compared to $346,745 for the same period in 2010, a decrease of $250,765. Interest and other miscellaneous income in the third quarter of 2011 was $1,122 compared to $5,357 for the same period in 2010. The decrease was primarily due to a lower return on invested cash balances. Interest expense in the third quarter of 2011 was $97,102 compared to $352,102 for the same period in 2010 due a smaller principal amount of our related party convertible debentures outstanding offset by amortization of the associated financing expenses associated with those convertible debentures.

Provision for Income Taxes

The company recorded a tax provision of $185,338 in the third quarter of 2011 as the company had fully utilized the majority of its available non separate return limitation year (“SRLY”), net loss carryforwards in prior periods. The company recorded no tax provision in the third quarter of 2010.

Net Income/Loss

Net income in the third quarter of 2011 was $229,714 compared to $170,420 for the same period in 2010.

First Nine Months 2011 Compared to First Nine Months 2010

Revenues
 
Revenues in the first nine months of 2011 were $32,850,589 compared to $29,917,021 for the same period in 2010, an increase of $2,933,568 or 9.8%. The increase in revenues was due to an increase in both our Environmental Services revenues and Analytical Laboratory revenues. The increase in our Environmental Services revenues was due to increased work at Hanford and increased work at Argonne National Laboratory. The increase in revenue in our Analytical Laboratory revenues was due to increased sample volume at our Oak Ridge and Lionville laboratories because of increased demand on quick-turn analyses which carry a higher price and margin per sample.
 
Revenues from our Environmental Services in the first nine months of 2011 were $24,794,721 compared to $22,407,413 for the same period in 2010, an increase of $2,387,308 or 10.7%. Our Environmental Services contributed 75.5% to total revenues in the first nine months of 2011 compared to 74.9% for the same period in 2010. The increase in our Environmental Services revenue was due to increased work at Hanford and new work at Argonne National Laboratory. At Hanford our efforts are centered on all three contracts, however, the largest increase was with the River Corridor contract where we reached our highest level of effort as that contract is at its peak this year. Work continued on our CHPRC contract at Hanford and we added additional contract work in radiological mapping for CHPRC. At Los Alamos our work changed from a long-term support contract to a contract which includes an on-site screening facility and remediation support. We also performed work at the Argonne National Laboratory this period in support of a decontamination and demolition project.
 
Revenues from our Analytical Laboratories in the first nine months of 2011 were $8,055,868 compared to $7,509,608 for the same period in 2010, an increase of $546,260 or 7.3%. Our Analytical Labs contributed 24.5% to total revenues in the first nine months of 2011 compared to 25.1% for the same period in 2010. The increase in revenues was the result of increased sample loads. In addition to the number of samples there was also an increased customer demand in performing quick-turn analyses which carry a premium price. The largest increase was at the Lionville laboratory.

 
17

 
 
GLENROSE INSTRUMENTS INC.
Cost of Sales

The cost of sales in the first nine months of 2011 was $28,963,445 compared to $26,973,094 for the same period in 2010, an increase of $1,990,351 or 7.4%. The increase in cost of sales was primarily due to increased variable costs associated with the sales increases experienced in both the Analytical Services and Laboratory segments. We increased the number of employees, subcontracts and direct materials. The cost of sales from our Environmental Services in the first nine months of 2011 was $22,249,310 compared to $20,581,248 for the same period in 2010, an increase of $1,668,062 or 8.1% primarily due to salaries of new employees and an increase in subcontracts. The cost of sales from our Analytical Laboratories in the first nine months of 2011 was $6,714,135 compared to $6,391,846 for the same period in 2010, an increase of $322,289 or 5.0%, primarily due to increased direct labor and direct materials associated with the increased sales during the period. Our direct labor was affected by increased overtime required to meet response times despite our efforts to utilize our capacity more efficiently and establish better cost controls.

Gross Profit

Gross profit in the first nine months of 2011 was $3,887,144 compared to $2,943,927 for the same period in 2010, an increase of $943,217 or 32.0%. The gross profit margin increased to 11.8% in the first nine months of 2011 from 9.8% for the same period in 2010. The increase in the gross profit was primarily due to increased revenue at our Analytical Laboratories and Environmental Services segments. The gross profit from our Environmental Services in the first nine months of 2011 was $2,545,411 compared to $1,826,165 for the same period in 2010, an increase of $719,246 or 39.4%. The gross profit from our Analytical Laboratories in the first nine months of 2011 was $1,341,733 compared to $1,117,762 for the same period in 2010, an increase of $223,971 or 20.0%.

Operating Expenses

General and administrative expenses in the first nine months of 2011 were $1,673,867 compared to $1,515,061 for the same period in 2010, an increase of $158,806 or 10.5%. The general and administrative expenses increased as we increased business development efforts.
 
Operating Income

The operating income in the first nine months of 2011 was $2,213,277 compared to $1,428,866 for the same period in 2010. The operating income consisted of $1,429,267 at the Environmental Services and $1,029,956 at the Analytical Laboratories, offset by corporate general and administrative expenses of $245,946. The increase in operating income was due to the increased revenue in both operating segments. During the period we added direct personnel and were able to better utilize existing personnel in more direct roles on large contracts. The increase in our Analytical Laboratory revenues allowed for better utilization of existing infrastructure, staff and capacity, as the cost structure of the laboratories is generally fixed in the short-term. Increases in revenue at the laboratories require a lower incremental increase in direct costs, resulting in higher margins and subsequently a greater operating income.

Other Income (Expense)

Other expenses in the first nine months of 2011 were $220,164 compared to $699,969 for the same period in 2010, a decrease of $479,805. Interest and other miscellaneous income in the first nine months of 2011 was $2,669 compared to $10,745 for the same period in 2010. The decrease was primarily due to a lower return on our overall invested cash balances. Interest expense in the first nine months of 2011 was $222,833 compared to $710,714 for the same period in 2010 due the repayment of principal amount of our related party convertible debentures outstanding, offset by amortization of the associated financing expenses associated with those convertible debentures.

Provision for Income Taxes

The company recorded a tax provision of $639,705 in the first nine months of 2011 as the company had fully utilized the majority of its available non SRLY net loss carryforwards in prior periods. The company recorded no tax provision in the first nine months of 2010.

Net Income/Loss

Net income in the first nine months of 2011 was $1,353,408 compared to $728,897 for the same period in 2010.

 
18

 
 
GLENROSE INSTRUMENTS INC.
  
Liquidity and Capital Resources

Consolidated working capital at September 25, 2011 was $2,583,625 compared to $5,281,340 at December 26, 2010. Included in working capital were cash, cash equivalents and short-term investments of $27,958 as of September 25, 2011, compared to $1,682,173 at December 26, 2010. The decrease in working capital was primarily due to cash generated from operations offset by the redemption of $4,875,000 of convertible debentures including accrued interest.
 
Cash provided by operating activities was $1,785,647 in the first nine months of 2011, compared to $175,408 for the same period in 2010. Our net receivables balance increased to $5,336,701 in the first nine months of 2011 compared to $4,376,929 at December 26, 2010, resulting in a decrease in cash of $959,772 primarily due to timing of invoicing related to a new contract at Los Alamos. Our unbilled contract receivables decreased to $237,575 in the first nine months of 2011 compared to $370,887 at December 26, 2010, resulting in an increase in cash of $133,312 due to timing of billings on our major cost-type contracts. Our prepaid expenses increased to $210,009 in the first nine months of 2011, compared to $97,450 at December 26, 2010, resulting in a decrease in cash of $112,559 primarily due to the payment and timing of normal operating expenses. Our other receivables decreased to $37,714 in the first nine months of 2011, compared to $58,464 at December 26, 2010, resulting in an increase in cash of $20,750. Our income tax receivable decreased to $0 in the first nine months of 2011, compared to $161,356 at December 26, 2010, resulting in an increase in cash of $161,356.

Accounts payable increased to $1,181,159 in the first nine months of 2011, compared to $653,130 at December 26, 2010 resulting in an increase in cash of $528,029 due to increased subcontract invoices on a new contract. Other accrued liabilities, including accrued expenses, accrued employee-related costs and income taxes payable, increased to $2,372,358 in the first nine months of 2011, compared to $2,354,038 at December 26, 2010, resulting in an increase in cash of $18,320. Our accrued interest balance associated with the previously issued subordinated notes decreased to $5,254 in the first nine months of 2011, compared to $48,750 at December 26, 2010, resulting in a decrease in cash of $43,496 due to interest payments.
 
The primary investing activities of the company’s operations included the purchase of equipment. The company continues to manage its capital expenditures very selectively and in the first nine months of 2011 used $315,436 for purchases of equipment. The company’s financing activities used $3,124,426 of cash in the first nine months of 2011, primarily due to redemption of convertible debentures and payments on capital lease obligations offset by proceeds from a Term Note payable and an advance on a Line of Credit.
 
The company owns property in Albuquerque, New Mexico. In 2009, the company entered into an agreement, subject to closing conditions, with a buyer to sell the property for approximately $1.9 million. At September 25, 2011, $507,700 in land, $2,265,764 in buildings and improvements less $1,916,926 in accumulated depreciation is classified as “Assets held for sale” on the company’s balance sheet. The assets held for sale balance of $1,047,367 also includes selling costs incurred to date of $37,477 and an accrual of $153,352 towards decommissioning of the site. In 2010, the company submitted a detailed site assessment of the facility to the New Mexico Environmental Department, or NMED, as part of the closure process which was approved in June 2011. The company characterized and classified all radiological waste associated with the facility and all waste was crated and packaged for disposal in 2010. In January 2011, the company applied for a shipment permit to transfer the remaining waste to an appropriate facility, which was shipped during the quarter. The company is currently communicating with NMED on the report in preparation for the demolition of the building. The company believes that it has adequately accrued for decommissioning of the site; however, it is possible that additional funds up to $100,000 may be needed. The company expects to complete the sale in 2011.

The company believes that its existing resources, including cash and cash equivalents and future cash flow from operations, are sufficient to meet the working capital requirements of its existing business for the foreseeable future, including the next 12 months. We believe that our cash and cash equivalents, available borrowings under the Line of Credit and our ability to control certain costs, including those related to general and administrative expenses will enable us to meet our anticipated cash expenditures for the next 12 months. The company’s long-term liabilities primarily include a Term Note secured by the company’s real estate assets with a 7 year straight line amortization at Libor plus 3.50%.

On July 1, 2011, the company redeemed the outstanding amount of the convertible debentures with Blum Strategic Partners IV, L.P., in the principal amount of $3,065,546, plus accrued interest. In connection with that transaction, the company entered into a $500,000 Demand Note Agreement with John N. Hatsopoulos, the company’s Chairman of the Board, and into a $1,500,000 Demand Note Agreement with Arvin H. Smith, the company’s Chief Executive Officer. Both demand note agreements accrue interest at the rate of 4.50% per year.

On August 31, 2011, the company entered into a credit agreement with Wells Fargo Bank for a $5,000,000 credit facility. The facility included a $1,000,000 term real-estate note with a 7 year straight line amortization, at Libor plus 3.5%, and up to $4,000,000 in a revolving line of credit for 5 years, at Libor plus 3.5%. On August 31, 2011, the company borrowed $1,000,000 against the Term Note and $1,000,000 against the line of credit and used the proceeds to redeem the remaining balance of the convertible debentures and pay down the Demand Note Agreements with John N. Hatsopoulos and Arvin H. Smith.

 
19

 
 
GLENROSE INSTRUMENTS INC.
 
As of September 25, 2011, there were no convertible debentures outstanding and the Demand Note Agreements were paid in full. The balance outstanding on the Term Note was $1,000,000 and the balance outstanding on the revolving line of credit was $696,570.

The company believes that its existing resources, including cash and cash equivalents, available borrowings under the Line of Credit, future cash flow from operations, and potential future property sales in Albuquerque, New Mexico and Richmond California will be sufficient to meet those obligations. Our ability to continue to access capital, however, could be impacted by various factors including general market conditions and the continuing slowdown in the economy, interest rates, the perception of our potential future earnings and cash distributions, any unwillingness on the part of lenders to make loans to us and any deterioration in the financial position of lenders that might make them unable to meet their obligations to us.

In March 2011 the company retained the services of Raymond James & Associates, Inc. to act as its sole, external investment banking advisor in helping the company evaluate strategic alternatives, including the possible sale of all or a material portion of the assets or securities of the company to, or merger of the company with, various third parties. On October 14, 2011, the company terminated the engagement of Raymond James & Associates. Starting in the fourth quarter the company will increase its efforts in the development and manufacturing of a line of radiation monitoring instruments.

 
20

 
 
GLENROSE INSTRUMENTS INC.
 
Item 3: Quantitative and Qualitative Disclosures about Market Risk

Not applicable.

Item 4T: Controls and Procedures

Management’s evaluation of disclosure controls and procedures:
 
Our chief executive officer and our chief financial officer, after evaluating the effectiveness of our “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”) Rules 13a−15(e) and 15d−15(e); collectively, “Disclosure Controls”) as of the end of the period covered by this report (the “Evaluation Date”) has concluded that as of the Evaluation Date, our Disclosure Controls were effective to provide reasonable assurance that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission, and that material information relating to our company and any consolidated subsidiaries is made known to management, including the chief executive officer and chief financial officer, particularly during the period when our periodic reports are being prepared to allow timely decisions regarding required disclosure.
 
Changes in Internal Controls over Financial Reporting:

In connection with the evaluation referred to in the foregoing paragraph, we have identified no change in our internal control over financial reporting that occurred during the period ending September 25, 2011 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 
21

 
 
GLENROSE INSTRUMENTS INC.
 
PART II – OTHER INFORMATION
 
Item 1A: Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed under “Risk Factors” in our Annual Report on Form 10-K for our fiscal year ended December 26, 2010. The risks discussed in our Annual Report on Form 10-K could materially affect our business, financial condition and future results. The risks described in our Annual Report on Form 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition or operating results.

Item 6: Exhibits

Exhibit
Number
 
Description of Exhibit
     
31.1*
Rule 13a-14(a) Certification of Chief Executive Officer
     
31.2*
Rule 13a-14(a) Certification of Chief Financial Officer
     
32.1*
Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer
 


* Filed herewith.

 
22

 
 
GLENROSE INSTRUMENTS INC.
 
SIGNATURES
 
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 9, 2011.

 
GLENROSE INSTRUMENTS INC.
 
(Registrant)
   
 
By:
/s/ ARVIN H. SMITH
   
Chief Executive Officer
   
(Principal Executive Officer)
 
 
By:
/s/ ANTHONY S. LOUMIDIS
   
Chief Financial Officer
   
(Principal Financial Officer)

 
23

 
 
EX-31.1 2 v238568_ex31-1.htm EXHIBIT 31.1
EXHIBIT 31.1
 
GLENROSE INSTRUMENTS INC.
CERTIFICATION REQUIRED BY EXCHANGE ACT RULES 13a-14(a) and 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Arvin H. Smith, certify that:
 
 
1.
I have reviewed this Quarterly Report on Form 10-Q of GlenRose Instruments Inc.;
 
 
2.
Based on my knowledge, th is report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
 
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2011

/s/ Arvin H. Smith
 
Chief Executive Officer
 

 
 

 
EX-31.2 3 v238568_ex31-2.htm EXHIBIT 31.2
EXHIBIT 31.2
 
GLENROSE INSTRUMENTS INC.
CERTIFICATION REQUIRED BY EXCHANGE ACT RULES 13a-14(a) and 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Anthony S. Loumidis, certify that:
 
 
1.
I have reviewed this Quarterly Report on Form 10-Q of GlenRose Instruments Inc.;
 
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
 
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: November 9, 2011

/s/ Anthony S. Loumidis
 
Chief Financial Officer
 

 
 

 
EX-32.1 4 v238568_ex32-1.htm EXHIBIT 32.1
EXHIBIT 32.1
 
GLENROSE INSTRUMENTS INC.
CERTIFICATION REQUIRED BY EXCHANGE ACT RULES 13a-14(b) and 15d-14(b),
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

We, Arvin H. Smith, Chief Executive Officer, and Anthony S. Loumidis, Chief Financial Officer, of GlenRose Instruments Inc., or the company, certify, pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Quarterly Report on Form 10-Q of the company for the quarter ending September 25, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, (15 U.S.C. 78 m or 78o(d)); and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
 
Date: November 9, 2011
 
/s/ Arvin H. Smith
 
Chief Executive Officer
   
/s/ Anthony S. Loumidis
 
Chief Financial Officer

 
 

 
EX-101.INS 5 nonr-20110925.xml XBRL INSTANCE DOCUMENT 0001340095 2010-06-27 2010-09-26 0001340095 2009-12-28 2010-09-26 0001340095 2010-12-26 0001340095 2011-06-26 2011-09-25 0001340095 2010-12-27 2011-09-25 0001340095 2011-09-25 0001340095 2009-12-27 0001340095 2010-09-26 xbrli:shares iso4217:USD iso4217:USDxbrli:shares GlenRose Instruments Inc. 0001340095 --12-25 Smaller Reporting Company nonr 3112647 10-Q false 2011-09-25 Q3 2011 1669868 15653 1012250 1099424 12305 12305 4376929 5336701 370887 237575 42858 42858 60271 70785 97450 210009 58464 37714 161356 0 474235 484167 1045367 1047367 8369990 7495134 1557088 1510165 450000 451000 104499 87346 2740913 2740913 3348477 3332324 13275555 12337623 653130 1181159 363327 296229 1972581 1724150 48750 5254 0 426835 8002 22286 10752 11612 18130 351979 3088650 4911509 4875000 0 38527 29707 427198 394599 134552 27025 8577561 6256981 31176 31176 7972098 8001338 -3305280 -1951872 4697994 6080642 13275555 12337623 26120 24320 0.01 0.01 10000000 10000000 3117647 3117647 3117647 3117647 9898694 29917021 11016348 32850589 8894138 26973094 9926112 28963445 1004556 2943927 1090236 3887144 487391 1515061 579154 1673867 517165 1428866 511082 2213277 5357 10745 1122 2669 352102 710714 97102 222833 -346745 -699969 -95980 -220164 170420 728897 415102 1993113 0 0 185388 639705 170420 728897 229714 1353408 0.05 0.23 0.07 0.44 3102647 3102647 3102647 3102647 315189 362359 0 -42531 315388 17153 59694 29240 0 -1800 989050 957972 35000 1000 -993 -20750 -307600 -133312 66843 112559 -4888 10514 0 -161356 -328419 528029 -235096 -43496 -16545 14284 77477 426835 70193 -107527 12032 18320 175408 1785647 125778 315436 10048611 0 9922833 -315436 11067 7960 10000000 4875000 -10011067 -3124426 87174 -1654215 <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 1 &#8211; Organization and Significant Accounting Policies:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Organization</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">GlenRose Instruments Inc., a Delaware corporation, or the company, we, our, or us, was incorporated in September 2005 by the GlenRose Partnership L.P., or the GlenRose Partnership, a private-equity partnership with its headquarters in Waltham, Massachusetts. The company was organized to serve as a holding company through which the GlenRose Partnership&#8217;s partners would hold the shares of Eberline Services, Inc. or Eberline Services or ESI (all of which had previously been held by the GlenRose Partnership). In order to effect such change in structure, the GlenRose Partnership entered into a stock exchange agreement with the company in September 2005 pursuant to which all outstanding shares of Eberline Services owned by the GlenRose Partnership were exchanged for 3,000,000 shares of common stock of GlenRose Instruments. As a result of this exchange, the GlenRose Partnership owned all of the outstanding stock of the company, and the company owned all of the outstanding stock of its subsidiary, ESI.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">GlenRose Instruments, through Eberline Services and its subsidiaries, provides radiological services and operates a radiochemistry laboratory network, as well as provides radiological characterization and analysis, hazardous, radioactive and mixed waste management, and facility, environmental, safety and health management. The subsidiaries of Eberline Services are Eberline Services Hanford, Inc. or ESHI, Eberline Analytical Corporation, Benchmark Environmental Corp., and Lionville Laboratory Inc., or Lionville.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In March 2011 the company retained the services of Raymond James &amp; Associates, Inc. to act as its sole, external investment banking advisor in helping the company evaluate strategic alternatives, including the possible sale of all or a material portion of the assets or securities of the company to, or merger of the company with, various third parties. On October 14, 2011, the company terminated the engagement with Raymond James &amp; Associates. Starting in the fourth quarter the company will increase its efforts in the development and manufacturing of a line of radiation monitoring instruments.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of September 25, 2011, the company has three segments &#8211; the Environmental Services segment, the Analytical Laboratories segment and the Instruments segment. The Environmental Services operating segment provides radiological and waste management services primarily to the federal government in connection with the clean-up of the former and present atomic weapons and energy sites operated by the federal government. The Analytical Laboratories operating segment provides analytical radiological services and involves the operation of a radiochemistry laboratory network and a radioactive check source manufacturing facility. The Instruments segment was formed in 2006 with the intent to acquire instrument companies, which have well-established and proven technology. This segment also includes the research and development of a new line of instruments that the company expects to begin manufacturing later this year. As of the date of this report the company has not made any commitments, nor has it acquired any instrument businesses.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Principles of Consolidation and Basis of Presentation</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying consolidated financial statements include the company and its subsidiaries. All significant intercompany transactions have been eliminated. In the opinion of management, the unaudited financial statements contain all adjustments (all of which were considered normal and recurring) necessary to present fairly the company's financial position at September 25, 2011, and the results of operations and cash flows for the three and nine months ended September 25, 2011 and September 26, 2010. The unaudited financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the company&#8217;s Form 10-K for the year ended December 26, 2010.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Reclassifications</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Certain prior period balances have been reclassified to conform with current period presentation.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Fiscal Year</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company&#8217;s fiscal year-end is the last Sunday of each calendar year. Each quarter is comprised of two four-week and one five-week period to ensure consistency in prior-year comparative analysis. The company changed the fiscal year-end to the current format in 2006. The previous fiscal year-end was December 26, 2010.</font></div> <div>&#160;</div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" id="pgbrk"> <div id="ftr"> <div align="left" style="width: 100%;" id="glftr"><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div>&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Use of Estimates in Preparation of Statements</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles, or GAAP, requires management to make estimates and underlying assumptions that affect the amounts reported in the financial statements and accompanying notes.&#160;Actual results could differ from those estimates.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Concentration of Credit Risk</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Financial instruments, which potentially subject the company to concentrations of credit risk, consist of highly liquid cash equivalents and trade receivables. The company&#8217;s cash equivalents are placed with certain financial institutions and issuers. At September 25, 2011, the company did not have any cash and cash equivalents, short-term investments and restricted cash that exceeded the Federal Deposit Insurance Corporation limit of $250,000.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company performs periodic credit evaluations of its customers&#8217; financial condition and generally does not require collateral. The company provides for an allowance for doubtful accounts on receivable balances based upon the expected collectability of such receivables. Federal and state governments collectively account for more than 90% of all revenues for the three month periods ended September 25, 2011 and September 26, 2010. Two of the company&#8217;s customers account for more than 10% of revenue and trade accounts receivable. One customer represented approximately 73% and 70% of revenue and 39% and 74% of trade accounts receivable for the three months ended September 25, 2011 and September 26, 2010, respectively and approximately 77% and 70% of revenue and 39% and 74% of trade accounts receivable for the nine month periods ended September 25, 2011 and September 26, 2010, respectively. The other customer represented approximately 9% and 4% of revenue and 20% and 5% of trade accounts receivable for the three months ended September 25, 2011 and September 26, 2010, respectively and approximately 3% and 10% of revenue and 20% and 5% of trade accounts receivable for the nine month period ended September 25, 2011 and September 26, 2010, respectively.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Revenue Recognition</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Revenue for laboratory services is recognized upon completion of the services and the shipment of the related data packages to the company&#8217;s customers. Revenue for government service contracts is recognized as the services are performed. Revenues are recognized based upon actual costs incurred plus specified fees or actual time and materials as required. The company performs certain contracts that are audited by either the Defense Contract Audit Agency, or the DCAA, or Los Alamos National Laboratories Internal Audit. Such contracts may be subject to adjustment dependent upon such factors as provisional billing rates or other contract terminology. The company records as revenue what it considers to be allowable costs under government service contracts. Calculations of allowable overhead and profit may also change after audits by the DCAA for cost reimbursable type contracts. Contracts are normally settled during the audit year the contract terminates performance and is submitted for closure. The company is currently audited and settled through December 2005 for all contracts subject to review by DCAA and audited through December 2002 for contracts subject to review by the Los Alamos Internal Audit. Contracts performed after 2005 for DCAA purposes, or after 2002 for the Los Alamos Internal Audit, and are either active or have not been submitted for closure may be subject to adjustment during subsequent audits during the year they are closed and audited.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company is engaged principally in three types of service contracts with the federal government and its contractors:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cost Reimbursable Contracts.&#160;Revenue from &#8220;cost-plus-fixed-fee&#8221; contracts is recognized on the basis of reimbursable contract costs incurred during the period plus an earned fee.&#160;Costs incurred for services which have been authorized and performed, but may not have been billed, are allocated with operational fringe, overhead, general and administrative expenses and fees, and are presented as Unbilled Contract Receivables on the accompanying consolidated balance sheets contained herein.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Time-and-Materials Contracts.&#160;Revenue from &#8220;time and material&#8221; contracts is recognized on the basis of man-hours utilized plus other reimbursable contract costs incurred during the period.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Fixed-Price Contracts.&#160;Revenue from &#8220;fixed-price&#8221; contracts is recognized on the percentage-of-completion method.&#160; For fixed-price contracts, the amount of revenues recognized is that portion of the total contract amount that the actual cost expended bears to the anticipated final total cost based on current estimates of cost to complete the project (cost-to-cost method).&#160; However, when it becomes known that the anticipated final total cost will exceed the contract amount, the excess of cost over the contract amount is immediately recognized as a loss on the contract.&#160;Recognition of profit commences on an individual project only when cost to complete the project can reasonably be estimated and after there has been some meaningful performance achieved on the project (greater than 10% complete).&#160;Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions (when applicable) and final contract settlements, may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Claims and change orders are not recorded and recognized until such time as they have been accepted.</font></div> <div>&#160;</div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" id="a0b4a2df0-f119-4bf7-9ba1-c01fa4b43028"> <div id="a9ca5882a-e11c-408d-91f3-1419c9c19eb4"> <div align="left" style="width: 100%;" id="a722f4879-3dbb-40fe-ab41-f60704946da2"><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Direct costs of contracts include direct labor, subcontractors and consultants, materials and travel. The treatment of direct costs is outlined in the Federal Acquisition Regulations. The balance of costs, including facilities costs, insurance, administrative costs, overhead labor and fringe costs, are classified as either indirect costs or general and administrative expense and are allocated to jobs as a percentage of each division&#8217;s total cost base consistent with our approved cost structure. Direct materials, direct travel, other direct costs, and minor subcontract costs are passed through to the customer at cost, with or without fee depending on contract type and/or direct cost element and are burdened with general and administrative expenses. Major subcontracts are passed through at cost, without fee and are burdened with a material handling fee. The company is exempt from federal cost accounting standards coverage based on its size standard, but otherwise complies with applicable regulations.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Goodwill</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. Goodwill is subject to an impairment test annually. Goodwill is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The company performs impairment testing at the reporting unit level. An impairment loss is recognized when the fair value of the discounted cash flows of the reporting unit including its tangible assets is less than the carrying value. Model assumptions are based on the company&#8217;s projections and best estimates using appropriate and customary market participant assumptions. Changes in forecasted cash flows or the discount rate would affect the estimated fair value of the reporting unity and could result in a goodwill impairment charge in a future period.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">At September 25, 2011, the company&#8217;s entire $2,740,913 goodwill balance was related to the Environmental Services segment which includes Eberline Services, ESHI and Benchmark Environmental Corp. The Analytical Laboratories goodwill was written off in prior years. No goodwill impairment was identified during the years ended December 26, 2010 and December 27, 2009. No events occurred or circumstances changed that&#160;required the company to further test&#160;goodwill for impairment during the nine month period ended September 25, 2011.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline;">Income Taxes</font></font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The amount of such provisions is based on various factors, such as the amount of taxable income in the current and prior periods, and the likelihood of continued taxable income. Additionally, management is responsible for estimating the probability that certain tax assets or liabilities can and will be utilized in future periods. The company believes it records and/or discloses such potential tax liabilities as appropriate and has reasonably estimated its income tax liabilities and recoverable tax assets. During the three and nine month period ended September 25, 2011, the company recorded a tax provision of $185,388 and $639,705, respectively. There was no tax provision recorded during the three and nine month period ended September 26, 2010, as a result of the availability of net loss carryforwards.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Earnings per Common Share</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company computes basic earnings per share by dividing net income for the period by the weighted average number of shares of common stock outstanding during the period. The company computes its diluted earnings per common share using the treasury stock method. For purposes of calculating diluted earnings per share, the company considers its shares issuable in connection with convertible debentures and stock options to be dilutive common stock equivalents when the exercise price is less than the average market price of the company&#8217;s common stock for the period. There were no dilutive common shares during the three and nine month periods ended September 25, 2011 and September 26, 2010. See &#8220;Note 5 &#8211; Earnings per Share.&#8221;</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Stock Based Compensation</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock based compensation cost is measured at the grant date based on the estimated fair value of the award and is recognized as an expense in the statement of operations over the requisite service period. The fair value of stock options granted is estimated using the Black-Scholes option pricing valuation model. The company recognizes compensation on a straight-line basis for each separately vesting portion of the option award. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. Expected volatility is calculated based on the average volatility of 20 companies in the same industry as the company. The average expected life is estimated using the simplified method for &#8220;plain vanilla&#8221; options. The simplified method determines the expected life in years based on the vesting period and contractual terms as set forth when the award is made. The company uses the simplified method for awards of stock-based compensation since it does not have the necessary historical exercise and forfeiture data to determine an expected life for stock options. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term which approximates the expected life assumed at the date of grant. When options are exercised the company normally issues new shares.</font></div> <div>&#160;</div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" id="a5c0e07ce-b48b-4d92-84d5-1156d3e6b24c"> <div id="a1edaae0d-73e4-48be-87be-a377a58c8f47"> <div align="left" style="width: 100%;" id="a9d4ce937-7dfc-4a08-92de-4629d40eb84c"><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> <font style="display: inline; font-weight: bold;"></font></div> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Fair Value of Financial Instruments</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">At September 25, 2011 the Company&#8217;s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, accounts payable, capital lease obligations, line of credit payable, term note payable and notes payable.&#160;The recorded values of cash and cash equivalents, accounts receivable and accounts payable approximate fair value based on their short-term nature. The fair value of capital lease obligations and notes payable is estimated at its carrying value based on current rates.&#160;The carrying value of the Company&#8217;s line of credit and term loan approximates its fair value due to its variable interest rate. Short-term investments are recorded at fair value.&#160; See &#8220;Note 6 &#8211; Fair Value Measurements.&#8221;</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Recovery of Long-Lived Assets</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the remaining estimated useful life of such assets might warrant revision or that the balances may not be recoverable. If undiscounted cash flows are insufficient to recover the net book value of long-term assets further analysis is performed in order to determine the amount of the impairment. In such circumstances an impairment loss would be recorded equal to the amount by which the net book value of the assets exceeds fair value. Fair value is usually determined based on the present value of estimated expected future cash flows using a discount rate commensurate with the risks involved.&#160;No events occurred or circumstances changed at September 25, 2011, that would indicate that the remaining net book value of the company&#8217;s long-lived assets are not recoverable.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Assets Held for Sale</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company owns property in Albuquerque, New Mexico. In 2009, the company entered into an agreement, subject to closing conditions, with a buyer to sell the property for approximately $1.9 million. At September 25, 2011, $507,700 in land, $2,265,764 in buildings and improvements less $1,916,926 in accumulated depreciation is classified as &#8220;Assets held for sale&#8221; on the company&#8217;s balance sheet. The assets held for sale balance of $1,047,367 also includes selling costs incurred to date of $37,477 and an accrual of $153,352 towards decommissioning of the site. In 2010, the company submitted a detailed site assessment of the facility to the New Mexico Environmental Department, or NMED, as part of the closure process which was approved in June 2011. The company characterized and classified all radiological waste associated with the facility and all waste was crated and packaged for disposal in 2010. In January 2011, the company applied for a shipment permit to transfer the remaining waste to an appropriate facility, which was shipped during the quarter. The company is currently communicating with NMED on the report in preparation for the demolition of the building. The company believes that it has adequately accrued for decommissioning of the site; however, it is possible that additional funds up to $100,000 may be needed. The company expects to complete the sale in 2011.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 2 &#8211; Debt:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On July 25, 2008, the company entered into subscription agreements with four investors for the sale of convertible debentures in the aggregate principal amount of $14,875,000. The primary investor was Blum Strategic Partners IV, L.P., who subscribed for $12,000,000 of the debentures. Additional investors included John N. Hatsopoulos, the company&#8217;s Chairman of the board, Arvin H. Smith, the company&#8217;s President and Chief Executive Officer, and Philip Frost M.D., a holder of more than 10% of the outstanding equity securities of the company immediately prior to the sale of the debentures, who subscribed for $2,875,000 of debentures by exchanging existing promissory notes of the company for the debentures. The debentures carried interest at 4%, payable quarterly in cash, and matured on July 25, 2013. The debentures were convertible at the option of the holder at any time into shares of common stock at a conversion price equal to $7.00 per share.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On July 23, 2010, the holders of the outstanding principal amount of the company&#8217;s convertible debentures, agreed to amend the debenture agreements to eliminate subsections (i) and (ii) of Section 6(a) of the debentures. With this amendment the holders gave the company the option to redeem any portion of the debentures by written notice to the holders; provided that a redemption notice is delivered by the company and be received by the holder of the debentures at least ten (10) trading days but not more than thirty (30) trading days prior to the date of the redemption. In connection with the amendment described above, the company redeemed $10,000,000 on August 9, 2010, $575,000 on January 13, 2011, and $500,000 on March 31, 2011.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On July 1, 2011, the company redeemed the outstanding amount of the convertible debentures with Blum Strategic Partners IV, L.P., in the principal amount of $3,065,546, plus accrued interest. In connection with that transaction, the company entered into a $500,000 Demand Note Agreement with John N. Hatsopoulos, the company&#8217;s Chairman of the Board, and into a $1,500,000 Demand Note Agreement with Arvin H. Smith, the company&#8217;s Chief Executive Officer. Both demand note agreements accrued interest at the rate of 4.50% per year.</font></div> <div style="text-align: center; text-indent: 0pt; display: block;"><font style="display: inline; font-weight: bold;">&#160; </font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On August 31, 2011, the company entered into a line of credit agreement with Wells Fargo Bank for a $5,000,000 credit facility. The facility included a $1,000,000 term real-estate note, or Term Note, with a 7 year straight line amortization, at Libor plus 3.5%, and up to $4,000,000 in a revolving line of credit, or Line of Credit, for 5 years, at Libor plus 3.5%, based on a borrowing base of the company&#8217;s trade receivables subject to certain adjustments.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Term Note and Line of Credit are payable by Eberline Services Inc., Eberline Services Hanford Inc., Eberline Analytical Laboratory Inc., and Lionville Laboratory Inc., subsidiaries of the Company.&#160;The Term Note is secured by the company&#8217;s real estate assets which are included in fixed assets which at September 25, 2011 had a net book value of $1,510,165. The Line of Credit is secured by the company&#8217;s trade receivables. The undrawn portion of the Line of Credit at September 25, 2011 was $3,342,540. The loan is also subject to various financial statement covenants including EBITDA, book value, and fixed charge coverage ratio. On August 31, 2011, the company borrowed $1,000,000 against the Term Note and $1,000,000 against the Line of Credit and used the proceeds to redeem the remaining balance of the convertible debentures and pay down the Demand Note Agreements with John N. Hatsopoulos and Arvin H. Smith.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of September 25, 2011, there were no convertible debentures outstanding and the Demand Note Agreements were paid in full. The balance outstanding on the Term Note was $1,000,000 and the balance outstanding on the revolving line of credit was $696,570.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 3 &#8211; Commitments and Contingencies:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company and its subsidiaries lease facilities and equipment under various operating leases. Future minimum rental commitments for long-term, non-cancelable operating leases at September 25, 2011 are as follows:</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Summary of Lease Obligations:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px;" valign="bottom" width="40%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2012</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2013</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2014</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2015</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Totals</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td valign="bottom" width="40%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="40%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Facilities</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">224,541</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">139,655</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">49,128</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12,282</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">425,606</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="40%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Equipment</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">10,145</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">10,145</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">10,145</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">4,227</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">34,662</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td style="padding-bottom: 4px;" valign="bottom" width="40%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">234,686</font></font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">149,800</font></font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">59,273</font></font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">16,509</font></font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">460,268</font></font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the three and nine month periods ending September 25, 2011, rent expense was $79,893 and $249,967, respectively, and for the three and nine month periods ending September 26, 2010, rent expense was $53,281 and $292,827, respectively.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company performs services under numerous subcontract agreements on cost-reimbursable contracts with the federal government. During the period from 1998 to 2003, the company was party to a subcontract agreement with Johnson Control Northern New Mexico, or JCNNM, to provide services to Los Alamos on a cost-reimbursable basis. On May 14, 2007, the company received notification from IAP-Northern New Mexico, or IAPNNM, the successor corporation to JCNNM, that the results of a Los Alamos audit for the period ending in 2003 determined that certain costs previously claimed and billed by the company were subsequently deemed unallowable or otherwise not reimbursable. IAPNNM requested that the company reimburse the amount of&#160;$321,836 that was paid to the company during the subject time period. In January 2009, the company protested the Los Alamos audit results claiming they were inaccurate and requested to resubmit a claim for the subject contract. The Los Alamos audit team agreed to review the audit results and adjust the claim as needed. Management believes that the company will prevail in this decision and has therefore not provided a specific reserve for this claim. In the event it is determined that the company has to reimburse such amount in full, the resultant cost could materially affect its results of operations.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company is not currently a party to any material litigation and is not aware of any pending or threatened litigation against it that could have a material adverse effect on its business, operating results or financial condition.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 4 &#8211; Stockholders&#8217; Equity:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock-based compensation expense was $29,240 and $59,694 as of September 25, 2011 and September 26, 2010, respectively. At September 25, 2011, there were 10,000 shares of unvested restricted stock outstanding and 67,200 of unvested stock options outstanding.</font></div> <div>&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 5 &#8211; Earnings per Share:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic and diluted earnings per share for the three and nine month periods ended September 25, 2011 and September 26, 2010 was as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Three&#160;Months</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Nine&#160;Months</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;25,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;26,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;25,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;26,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2011</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2010</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2011</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2010</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Earnings per share</font></div> </td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Earnings available to stockholders</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">229,714</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">170,420</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,353,408</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">728,897</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average shares outstanding - basic</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net earnings per share - basic</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.07</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.05</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.44</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.23</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Assumed exercise of dilutive stock options and warrants</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average shares outstanding - diluted</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">3,102,647</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net earnings per share - diluted</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.07</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.05</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.44</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.23</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Anti-dilutive restricted stock outstanding</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">15,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">15,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Anti-dilutive shares underlying stock options outstanding</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">168,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">173,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">168,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">173,000</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Anti-dilutive convertible debentures</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">696,429</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">696,429</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 6 &#8211; Fair Value Measurements:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The fair value topic of FASB&#8217;s Accounting Standards Codification defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline;">Level 1 </font>&#8212; Unadjusted quoted prices in active markets for identical assets or liabilities. The company currently does not have any Level 1 financial assets or liabilities.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline;">Level 2 &#8212; </font>Observable inputs other than quoted prices included in Level 1. Level 2 inputs include quoted prices for identical assets or liabilities in non-active markets, quoted prices for similar assets or liabilities in active markets and inputs other than quoted prices that are observable for substantially the full term of the asset or liability.&#160;&#160;&#160;</font></div> <div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline;">Level 3 </font>&#8212; Unobservable inputs reflecting management&#8217;s own assumptions about the input used in pricing the asset or liability. The company currently does not have any Level 3 financial assets or liabilities.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">At September 25, 2011, the company had $12,305 in short-term investments that are comprised of certificates of deposits which are categorized as Level 2.&#160;The company determines the fair value of certificates of deposits using information provided by the issuing bank which includes discounted expected cash flow estimates using current market rates offered for deposits with similar remaining maturities.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 7 - Segment Data:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company&#8217;s executive officers include Arvin Smith, Dr. Richard Chapman and Dr. Shelton Clark.&#160;Collectively, they are the Chief Operating Decision Maker, or CODM, as defined by Disclosures about Segments of an Enterprise and Related Information.&#160;The office of the CODM is responsible for assessing the performance of each segment, as well as the allocation of company resources.</font></div> <div> <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" >&#160;<font style="display: inline; font-weight: bold;">&#160;</font><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company currently operates three business segments: Environmental Services, Analytical Laboratories and Instruments.&#160;The Environmental Services operating segment provides radiological and waste management services primarily to the federal government in connection with the clean-up of the former and present atomic weapons and energy sites operated by the federal government. The Analytical Laboratories operating segment provides analytical radiological services and involves the operation of a radiochemistry laboratory network and a radioactive check source manufacturing facility. The Instruments segment was formed in 2006 with the intent to acquire instrument companies, which have well-established and proven technology. This segment also includes the research and development of a new line of instruments that the company expects to begin manufacturing later this year. As of the date of this report the company has not made any commitments, nor has it acquired any instrument businesses. Acquisition of instrument businesses is no longer a focus in our strategy. Intercompany costs and sales are eliminated in the consolidated financial statements.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Segment data for the periods ending September 25, 2011 and September 26, 2010 are included below:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Three&#160;Months&#160;Ended</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Nine&#160;Months&#160;Ended</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;25,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;26,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;25,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September&#160;26,</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2011</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2010</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2011</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2010</font></font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(unaudited)</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(unaudited)</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(unaudited)</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(unaudited)</font></div> </td> <td style="text-align: left;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Revenues</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8,402,364</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">7,430,660</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">24,794,721</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">22,407,413</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,613,984</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,468,034</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8,055,868</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">7,509,608</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">11,016,348</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9,898,694</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,850,589</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">29,917,021</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Cost of Sales</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">7,630,428</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6,680,747</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">22,249,310</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,581,248</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,295,684</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,213,391</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6,714,135</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6,391,846</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9,926,112</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8,894,138</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">28,963,445</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">26,973,094</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Gross Profit (Loss)</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">771,936</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">749,913</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,545,411</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,826,165</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">318,300</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">254,643</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,341,733</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,117,762</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,090,236</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,004,556</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,887,144</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,943,927</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">General and administrative expenses</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">377,127</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">330,906</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,116,144</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">986,637</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">105,450</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">101,793</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">311,777</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">286,193</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">96,577</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">54,692</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">245,946</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">242,231</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">579,154</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">487,391</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,673,867</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,515,061</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Operating profit (Loss)</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">394,809</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">419,007</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,429,267</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">839,528</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">212,850</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">152,850</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,029,956</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">831,569</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(96,577</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(54,692</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(245,946</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(242,231</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr bgcolor="#ccffcc"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">511,082</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">517,165</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,213,277</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,428,866</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Supplemental Disclosure</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Depreciation Expense</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">36,183</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16,273</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">84,413</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">44,060</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">80,377</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">95,247</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">277,946</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">271,129</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">116,560</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">111,520</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">362,359</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">315,189</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Capital Expenditures</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">44,157</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">164,604</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">60,257</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">35,166</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">21,963</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">150,832</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">65,521</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">-</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">79,323</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">21,963</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">315,436</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">125,778</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div>&#160;&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 25,</font></div> </td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 26,</font></div> </td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: center;" valign="bottom" width="1%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2011</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: center;" valign="bottom" width="1%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">2010</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(unaudited)</font></div> </td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;"><font style="display: inline;">Total Assets</font></font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Environmental Services</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8,451,101</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8,905,345</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Analytical Laboratories</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,546,154</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,250,758</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Instruments</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">340,368</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">119,452</font></font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#ccffcc"> <td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12,337,623</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">13,275,555</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 8 &#8211; Subsequent Events:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The company has evaluated subsequent events through the filing date of this Form 10-Q and determined that no additional subsequent events occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto.</font></div> <div>&#160;</div> 53065 53065 0 696570 0 857143 13634 36998 0 142857 13978 52578 3132 0 42858 0 0 2000 0 1000000 0 6389617 77502 0 5693047 0 15538 EX-101.SCH 6 nonr-20110925.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:definitionLink link:calculationLink 002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Organization and Significant Accounting Policies: link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Debt: link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Commitments and Contingencies: link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Stockholders' Equity: link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Earnings per Share: link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Fair Value Measurements: link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Segment Data: link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Subsequent Events: link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 nonr-20110925_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 nonr-20110925_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 nonr-20110925_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 nonr-20110925_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R3.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)
Sep. 25, 2011
Dec. 26, 2010
Allowances for accounts receivable$ 24,320$ 26,120
Common stock par value (in dollars per share)$ 0.01$ 0.01
Common stock, shares authorized10,000,00010,000,000
Common stock, shares issued3,117,6473,117,647
Common stock, shares outstanding3,117,6473,117,647
XML 12 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended9 Months Ended
Sep. 25, 2011
Sep. 26, 2010
Sep. 25, 2011
Sep. 26, 2010
Revenues$ 11,016,348$ 9,898,694$ 32,850,589$ 29,917,021
Cost of sales9,926,1128,894,13828,963,44526,973,094
Gross profit from operations1,090,2361,004,5563,887,1442,943,927
General and administrative expenses579,154487,3911,673,8671,515,061
Operating income511,082517,1652,213,2771,428,866
Other income (expense)    
Interest and other income1,1225,3572,66910,745
Interest expense(97,102)(352,102)(222,833)(710,714)
Total other expense(95,980)(346,745)(220,164)(699,969)
Income from operations, before income taxes415,102170,4201,993,113728,897
Provision for income taxes(185,388)0(639,705)0
Net income$ 229,714$ 170,420$ 1,353,408$ 728,897
Net income per share - basic and diluted (in dollars per share)$ 0.07$ 0.05$ 0.44$ 0.23
Weighted average shares outstanding - basic and diluted (in shares)3,102,6473,102,6473,102,6473,102,647
XML 13 R1.htm IDEA: XBRL DOCUMENT v2.3.0.15
DOCUMENT AND ENTITY INFORMATION
9 Months Ended
Sep. 25, 2011
Entity Registrant NameGlenRose Instruments Inc.
Entity Central Index Key0001340095
Current Fiscal Year End Date--12-25
Entity Filer CategorySmaller Reporting Company
Trading Symbolnonr
Entity Common Stock, Shares Outstanding3,112,647
Document Type10-Q
Amendment Flagfalse
Document Period End DateSep. 25, 2011
Document Fiscal Period FocusQ3
Document Fiscal Year Focus2011
XML 14 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 15 R12.htm IDEA: XBRL DOCUMENT v2.3.0.15
Segment Data:
9 Months Ended
Sep. 25, 2011
Segment Reporting [Abstract] 
Segment Reporting Disclosure [Text Block]
Note 7 - Segment Data:
 
The company’s executive officers include Arvin Smith, Dr. Richard Chapman and Dr. Shelton Clark. Collectively, they are the Chief Operating Decision Maker, or CODM, as defined by Disclosures about Segments of an Enterprise and Related Information. The office of the CODM is responsible for assessing the performance of each segment, as well as the allocation of company resources.
 
  The company currently operates three business segments: Environmental Services, Analytical Laboratories and Instruments. The Environmental Services operating segment provides radiological and waste management services primarily to the federal government in connection with the clean-up of the former and present atomic weapons and energy sites operated by the federal government. The Analytical Laboratories operating segment provides analytical radiological services and involves the operation of a radiochemistry laboratory network and a radioactive check source manufacturing facility. The Instruments segment was formed in 2006 with the intent to acquire instrument companies, which have well-established and proven technology. This segment also includes the research and development of a new line of instruments that the company expects to begin manufacturing later this year. As of the date of this report the company has not made any commitments, nor has it acquired any instrument businesses. Acquisition of instrument businesses is no longer a focus in our strategy. Intercompany costs and sales are eliminated in the consolidated financial statements.
 
Segment data for the periods ending September 25, 2011 and September 26, 2010 are included below:
 
   
Three Months Ended
   
Nine Months Ended
 
   
September 25,
   
September 26,
   
September 25,
   
September 26,
 
   
2011
   
2010
   
2011
   
2010
 
   
(unaudited)
   
(unaudited)
   
(unaudited)
   
(unaudited)
 
Revenues
                       
Environmental Services
  $ 8,402,364     $ 7,430,660     $ 24,794,721     $ 22,407,413  
Analytical Laboratories
    2,613,984       2,468,034       8,055,868       7,509,608  
Instruments
    -       -       -       -  
      11,016,348       9,898,694       32,850,589       29,917,021  
Cost of Sales
                               
Environmental Services
    7,630,428       6,680,747       22,249,310       20,581,248  
Analytical Laboratories
    2,295,684       2,213,391       6,714,135       6,391,846  
Instruments
    -       -       -       -  
      9,926,112       8,894,138       28,963,445       26,973,094  
Gross Profit (Loss)
                               
Environmental Services
    771,936       749,913       2,545,411       1,826,165  
Analytical Laboratories
    318,300       254,643       1,341,733       1,117,762  
Instruments
    -       -       -       -  
      1,090,236       1,004,556       3,887,144       2,943,927  
General and administrative expenses
                               
Environmental Services
    377,127       330,906       1,116,144       986,637  
Analytical Laboratories
    105,450       101,793       311,777       286,193  
Instruments
    96,577       54,692       245,946       242,231  
      579,154       487,391       1,673,867       1,515,061  
Operating profit (Loss)
                               
Environmental Services
    394,809       419,007       1,429,267       839,528  
Analytical Laboratories
    212,850       152,850       1,029,956       831,569  
Instruments
    (96,577 )     (54,692 )     (245,946 )     (242,231 )
      511,082       517,165       2,213,277       1,428,866  
Supplemental Disclosure
                               
Depreciation Expense
                               
Environmental Services
    36,183       16,273       84,413       44,060  
Analytical Laboratories
    80,377       95,247       277,946       271,129  
Instruments
    -       -       -       -  
      116,560       111,520       362,359       315,189  
Capital Expenditures
                               
Environmental Services
    44,157       -       164,604       60,257  
Analytical Laboratories
    35,166       21,963       150,832       65,521  
Instruments
    -       -       -       -  
      79,323       21,963       315,436       125,778  
  
                   
September 25,
   
December 26,
 
                    2011     2010  
                   
(unaudited)
         
Total Assets
                               
Environmental Services
                    8,451,101       8,905,345  
Analytical Laboratories
                    3,546,154       4,250,758  
Instruments
                    340,368       119,452  
                    $ 12,337,623     $ 13,275,555  
 
XML 16 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
Commitments and Contingencies:
9 Months Ended
Sep. 25, 2011
Commitments and Contingencies Disclosure [Abstract] 
Commitments and Contingencies Disclosure [Text Block]
Note 3 – Commitments and Contingencies:
 
The company and its subsidiaries lease facilities and equipment under various operating leases. Future minimum rental commitments for long-term, non-cancelable operating leases at September 25, 2011 are as follows:
 
Summary of Lease Obligations:
 
   
2012
   
2013
   
2014
   
2015
   
Totals
 
                               
Facilities
  $ 224,541     $ 139,655     $ 49,128     $ 12,282     $ 425,606  
Equipment
    10,145       10,145       10,145       4,227       34,662  
    $ 234,686     $ 149,800     $ 59,273     $ 16,509     $ 460,268  
 
For the three and nine month periods ending September 25, 2011, rent expense was $79,893 and $249,967, respectively, and for the three and nine month periods ending September 26, 2010, rent expense was $53,281 and $292,827, respectively.
 
The company performs services under numerous subcontract agreements on cost-reimbursable contracts with the federal government. During the period from 1998 to 2003, the company was party to a subcontract agreement with Johnson Control Northern New Mexico, or JCNNM, to provide services to Los Alamos on a cost-reimbursable basis. On May 14, 2007, the company received notification from IAP-Northern New Mexico, or IAPNNM, the successor corporation to JCNNM, that the results of a Los Alamos audit for the period ending in 2003 determined that certain costs previously claimed and billed by the company were subsequently deemed unallowable or otherwise not reimbursable. IAPNNM requested that the company reimburse the amount of $321,836 that was paid to the company during the subject time period. In January 2009, the company protested the Los Alamos audit results claiming they were inaccurate and requested to resubmit a claim for the subject contract. The Los Alamos audit team agreed to review the audit results and adjust the claim as needed. Management believes that the company will prevail in this decision and has therefore not provided a specific reserve for this claim. In the event it is determined that the company has to reimburse such amount in full, the resultant cost could materially affect its results of operations.
 
The company is not currently a party to any material litigation and is not aware of any pending or threatened litigation against it that could have a material adverse effect on its business, operating results or financial condition.
XML 17 R13.htm IDEA: XBRL DOCUMENT v2.3.0.15
Subsequent Events:
9 Months Ended
Sep. 25, 2011
Subsequent Events [Abstract] 
Subsequent Events [Text Block]
Note 8 – Subsequent Events:
 
The company has evaluated subsequent events through the filing date of this Form 10-Q and determined that no additional subsequent events occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto.
 
XML 18 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
Organization and Significant Accounting Policies:
9 Months Ended
Sep. 25, 2011
Organization, Consolidation and Presentation Of Financial Statements [Abstract] 
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
Note 1 – Organization and Significant Accounting Policies:
 
Organization
 
GlenRose Instruments Inc., a Delaware corporation, or the company, we, our, or us, was incorporated in September 2005 by the GlenRose Partnership L.P., or the GlenRose Partnership, a private-equity partnership with its headquarters in Waltham, Massachusetts. The company was organized to serve as a holding company through which the GlenRose Partnership’s partners would hold the shares of Eberline Services, Inc. or Eberline Services or ESI (all of which had previously been held by the GlenRose Partnership). In order to effect such change in structure, the GlenRose Partnership entered into a stock exchange agreement with the company in September 2005 pursuant to which all outstanding shares of Eberline Services owned by the GlenRose Partnership were exchanged for 3,000,000 shares of common stock of GlenRose Instruments. As a result of this exchange, the GlenRose Partnership owned all of the outstanding stock of the company, and the company owned all of the outstanding stock of its subsidiary, ESI.
 
GlenRose Instruments, through Eberline Services and its subsidiaries, provides radiological services and operates a radiochemistry laboratory network, as well as provides radiological characterization and analysis, hazardous, radioactive and mixed waste management, and facility, environmental, safety and health management. The subsidiaries of Eberline Services are Eberline Services Hanford, Inc. or ESHI, Eberline Analytical Corporation, Benchmark Environmental Corp., and Lionville Laboratory Inc., or Lionville.
 
In March 2011 the company retained the services of Raymond James & Associates, Inc. to act as its sole, external investment banking advisor in helping the company evaluate strategic alternatives, including the possible sale of all or a material portion of the assets or securities of the company to, or merger of the company with, various third parties. On October 14, 2011, the company terminated the engagement with Raymond James & Associates. Starting in the fourth quarter the company will increase its efforts in the development and manufacturing of a line of radiation monitoring instruments.
 
As of September 25, 2011, the company has three segments – the Environmental Services segment, the Analytical Laboratories segment and the Instruments segment. The Environmental Services operating segment provides radiological and waste management services primarily to the federal government in connection with the clean-up of the former and present atomic weapons and energy sites operated by the federal government. The Analytical Laboratories operating segment provides analytical radiological services and involves the operation of a radiochemistry laboratory network and a radioactive check source manufacturing facility. The Instruments segment was formed in 2006 with the intent to acquire instrument companies, which have well-established and proven technology. This segment also includes the research and development of a new line of instruments that the company expects to begin manufacturing later this year. As of the date of this report the company has not made any commitments, nor has it acquired any instrument businesses.
 
Principles of Consolidation and Basis of Presentation
 
The accompanying consolidated financial statements include the company and its subsidiaries. All significant intercompany transactions have been eliminated. In the opinion of management, the unaudited financial statements contain all adjustments (all of which were considered normal and recurring) necessary to present fairly the company's financial position at September 25, 2011, and the results of operations and cash flows for the three and nine months ended September 25, 2011 and September 26, 2010. The unaudited financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the company’s Form 10-K for the year ended December 26, 2010.
Reclassifications
 
Certain prior period balances have been reclassified to conform with current period presentation.
 
Fiscal Year
 
The company’s fiscal year-end is the last Sunday of each calendar year. Each quarter is comprised of two four-week and one five-week period to ensure consistency in prior-year comparative analysis. The company changed the fiscal year-end to the current format in 2006. The previous fiscal year-end was December 26, 2010.
 
 
 
Use of Estimates in Preparation of Statements
 
The preparation of financial statements in conformity with generally accepted accounting principles, or GAAP, requires management to make estimates and underlying assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
 
Concentration of Credit Risk
 
Financial instruments, which potentially subject the company to concentrations of credit risk, consist of highly liquid cash equivalents and trade receivables. The company’s cash equivalents are placed with certain financial institutions and issuers. At September 25, 2011, the company did not have any cash and cash equivalents, short-term investments and restricted cash that exceeded the Federal Deposit Insurance Corporation limit of $250,000.
 
The company performs periodic credit evaluations of its customers’ financial condition and generally does not require collateral. The company provides for an allowance for doubtful accounts on receivable balances based upon the expected collectability of such receivables. Federal and state governments collectively account for more than 90% of all revenues for the three month periods ended September 25, 2011 and September 26, 2010. Two of the company’s customers account for more than 10% of revenue and trade accounts receivable. One customer represented approximately 73% and 70% of revenue and 39% and 74% of trade accounts receivable for the three months ended September 25, 2011 and September 26, 2010, respectively and approximately 77% and 70% of revenue and 39% and 74% of trade accounts receivable for the nine month periods ended September 25, 2011 and September 26, 2010, respectively. The other customer represented approximately 9% and 4% of revenue and 20% and 5% of trade accounts receivable for the three months ended September 25, 2011 and September 26, 2010, respectively and approximately 3% and 10% of revenue and 20% and 5% of trade accounts receivable for the nine month period ended September 25, 2011 and September 26, 2010, respectively.
 
Revenue Recognition
 
Revenue for laboratory services is recognized upon completion of the services and the shipment of the related data packages to the company’s customers. Revenue for government service contracts is recognized as the services are performed. Revenues are recognized based upon actual costs incurred plus specified fees or actual time and materials as required. The company performs certain contracts that are audited by either the Defense Contract Audit Agency, or the DCAA, or Los Alamos National Laboratories Internal Audit. Such contracts may be subject to adjustment dependent upon such factors as provisional billing rates or other contract terminology. The company records as revenue what it considers to be allowable costs under government service contracts. Calculations of allowable overhead and profit may also change after audits by the DCAA for cost reimbursable type contracts. Contracts are normally settled during the audit year the contract terminates performance and is submitted for closure. The company is currently audited and settled through December 2005 for all contracts subject to review by DCAA and audited through December 2002 for contracts subject to review by the Los Alamos Internal Audit. Contracts performed after 2005 for DCAA purposes, or after 2002 for the Los Alamos Internal Audit, and are either active or have not been submitted for closure may be subject to adjustment during subsequent audits during the year they are closed and audited.
 
The company is engaged principally in three types of service contracts with the federal government and its contractors:
 
Cost Reimbursable Contracts. Revenue from “cost-plus-fixed-fee” contracts is recognized on the basis of reimbursable contract costs incurred during the period plus an earned fee. Costs incurred for services which have been authorized and performed, but may not have been billed, are allocated with operational fringe, overhead, general and administrative expenses and fees, and are presented as Unbilled Contract Receivables on the accompanying consolidated balance sheets contained herein.
 
Time-and-Materials Contracts. Revenue from “time and material” contracts is recognized on the basis of man-hours utilized plus other reimbursable contract costs incurred during the period.
 
Fixed-Price Contracts. Revenue from “fixed-price” contracts is recognized on the percentage-of-completion method.  For fixed-price contracts, the amount of revenues recognized is that portion of the total contract amount that the actual cost expended bears to the anticipated final total cost based on current estimates of cost to complete the project (cost-to-cost method).  However, when it becomes known that the anticipated final total cost will exceed the contract amount, the excess of cost over the contract amount is immediately recognized as a loss on the contract. Recognition of profit commences on an individual project only when cost to complete the project can reasonably be estimated and after there has been some meaningful performance achieved on the project (greater than 10% complete). Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions (when applicable) and final contract settlements, may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Claims and change orders are not recorded and recognized until such time as they have been accepted.
 
 
 
Direct costs of contracts include direct labor, subcontractors and consultants, materials and travel. The treatment of direct costs is outlined in the Federal Acquisition Regulations. The balance of costs, including facilities costs, insurance, administrative costs, overhead labor and fringe costs, are classified as either indirect costs or general and administrative expense and are allocated to jobs as a percentage of each division’s total cost base consistent with our approved cost structure. Direct materials, direct travel, other direct costs, and minor subcontract costs are passed through to the customer at cost, with or without fee depending on contract type and/or direct cost element and are burdened with general and administrative expenses. Major subcontracts are passed through at cost, without fee and are burdened with a material handling fee. The company is exempt from federal cost accounting standards coverage based on its size standard, but otherwise complies with applicable regulations.
 
Goodwill
 
Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. Goodwill is subject to an impairment test annually. Goodwill is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The company performs impairment testing at the reporting unit level. An impairment loss is recognized when the fair value of the discounted cash flows of the reporting unit including its tangible assets is less than the carrying value. Model assumptions are based on the company’s projections and best estimates using appropriate and customary market participant assumptions. Changes in forecasted cash flows or the discount rate would affect the estimated fair value of the reporting unity and could result in a goodwill impairment charge in a future period.
 
At September 25, 2011, the company’s entire $2,740,913 goodwill balance was related to the Environmental Services segment which includes Eberline Services, ESHI and Benchmark Environmental Corp. The Analytical Laboratories goodwill was written off in prior years. No goodwill impairment was identified during the years ended December 26, 2010 and December 27, 2009. No events occurred or circumstances changed that required the company to further test goodwill for impairment during the nine month period ended September 25, 2011.
 
Income Taxes
 
The company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The amount of such provisions is based on various factors, such as the amount of taxable income in the current and prior periods, and the likelihood of continued taxable income. Additionally, management is responsible for estimating the probability that certain tax assets or liabilities can and will be utilized in future periods. The company believes it records and/or discloses such potential tax liabilities as appropriate and has reasonably estimated its income tax liabilities and recoverable tax assets. During the three and nine month period ended September 25, 2011, the company recorded a tax provision of $185,388 and $639,705, respectively. There was no tax provision recorded during the three and nine month period ended September 26, 2010, as a result of the availability of net loss carryforwards.
 
Earnings per Common Share
 
The company computes basic earnings per share by dividing net income for the period by the weighted average number of shares of common stock outstanding during the period. The company computes its diluted earnings per common share using the treasury stock method. For purposes of calculating diluted earnings per share, the company considers its shares issuable in connection with convertible debentures and stock options to be dilutive common stock equivalents when the exercise price is less than the average market price of the company’s common stock for the period. There were no dilutive common shares during the three and nine month periods ended September 25, 2011 and September 26, 2010. See “Note 5 – Earnings per Share.”
 
Stock Based Compensation
 
Stock based compensation cost is measured at the grant date based on the estimated fair value of the award and is recognized as an expense in the statement of operations over the requisite service period. The fair value of stock options granted is estimated using the Black-Scholes option pricing valuation model. The company recognizes compensation on a straight-line basis for each separately vesting portion of the option award. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. Expected volatility is calculated based on the average volatility of 20 companies in the same industry as the company. The average expected life is estimated using the simplified method for “plain vanilla” options. The simplified method determines the expected life in years based on the vesting period and contractual terms as set forth when the award is made. The company uses the simplified method for awards of stock-based compensation since it does not have the necessary historical exercise and forfeiture data to determine an expected life for stock options. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term which approximates the expected life assumed at the date of grant. When options are exercised the company normally issues new shares.
 
 
Fair Value of Financial Instruments
 
At September 25, 2011 the Company’s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, accounts payable, capital lease obligations, line of credit payable, term note payable and notes payable. The recorded values of cash and cash equivalents, accounts receivable and accounts payable approximate fair value based on their short-term nature. The fair value of capital lease obligations and notes payable is estimated at its carrying value based on current rates. The carrying value of the Company’s line of credit and term loan approximates its fair value due to its variable interest rate. Short-term investments are recorded at fair value.  See “Note 6 – Fair Value Measurements.”
 
Recovery of Long-Lived Assets
 
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the remaining estimated useful life of such assets might warrant revision or that the balances may not be recoverable. If undiscounted cash flows are insufficient to recover the net book value of long-term assets further analysis is performed in order to determine the amount of the impairment. In such circumstances an impairment loss would be recorded equal to the amount by which the net book value of the assets exceeds fair value. Fair value is usually determined based on the present value of estimated expected future cash flows using a discount rate commensurate with the risks involved. No events occurred or circumstances changed at September 25, 2011, that would indicate that the remaining net book value of the company’s long-lived assets are not recoverable.
 
Assets Held for Sale
 
The company owns property in Albuquerque, New Mexico. In 2009, the company entered into an agreement, subject to closing conditions, with a buyer to sell the property for approximately $1.9 million. At September 25, 2011, $507,700 in land, $2,265,764 in buildings and improvements less $1,916,926 in accumulated depreciation is classified as “Assets held for sale” on the company’s balance sheet. The assets held for sale balance of $1,047,367 also includes selling costs incurred to date of $37,477 and an accrual of $153,352 towards decommissioning of the site. In 2010, the company submitted a detailed site assessment of the facility to the New Mexico Environmental Department, or NMED, as part of the closure process which was approved in June 2011. The company characterized and classified all radiological waste associated with the facility and all waste was crated and packaged for disposal in 2010. In January 2011, the company applied for a shipment permit to transfer the remaining waste to an appropriate facility, which was shipped during the quarter. The company is currently communicating with NMED on the report in preparation for the demolition of the building. The company believes that it has adequately accrued for decommissioning of the site; however, it is possible that additional funds up to $100,000 may be needed. The company expects to complete the sale in 2011.
XML 19 R9.htm IDEA: XBRL DOCUMENT v2.3.0.15
Stockholders' Equity:
9 Months Ended
Sep. 25, 2011
Stockholders Equity Note [Abstract] 
Stockholders' Equity Note Disclosure [Text Block]
Note 4 – Stockholders’ Equity:
 
Stock-based compensation expense was $29,240 and $59,694 as of September 25, 2011 and September 26, 2010, respectively. At September 25, 2011, there were 10,000 shares of unvested restricted stock outstanding and 67,200 of unvested stock options outstanding.
 
XML 20 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Earnings per Share:
9 Months Ended
Sep. 25, 2011
Earnings Per Share [Abstract] 
Earnings Per Share [Text Block]
Note 5 – Earnings per Share:
 
Basic and diluted earnings per share for the three and nine month periods ended September 25, 2011 and September 26, 2010 was as follows:
 
   
Three Months
   
Nine Months
 
   
September 25,
   
September 26,
   
September 25,
   
September 26,
 
   
2011
   
2010
   
2011
   
2010
 
Earnings per share
                       
Earnings available to stockholders
  $ 229,714     $ 170,420     $ 1,353,408     $ 728,897  
                                 
Weighted average shares outstanding - basic
    3,102,647       3,102,647       3,102,647       3,102,647  
Net earnings per share - basic
  $ 0.07     $ 0.05     $ 0.44     $ 0.23  
                                 
Assumed exercise of dilutive stock options and warrants
    -       -       -       -  
Weighted average shares outstanding - diluted
    3,102,647       3,102,647       3,102,647       3,102,647  
Net earnings per share - diluted
  $ 0.07     $ 0.05     $ 0.44     $ 0.23  
                                 
Anti-dilutive restricted stock outstanding
    10,000       15,000       10,000       15,000  
Anti-dilutive shares underlying stock options outstanding
    168,000       173,000       168,000       173,000  
Anti-dilutive convertible debentures
    -       696,429       -       696,429  
XML 21 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 22 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Fair Value Measurements:
9 Months Ended
Sep. 25, 2011
Fair Value Disclosures [Abstract] 
Fair Value Disclosures [Text Block]
Note 6 – Fair Value Measurements:
 
The fair value topic of FASB’s Accounting Standards Codification defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
 
Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities. The company currently does not have any Level 1 financial assets or liabilities.
 
Level 2 — Observable inputs other than quoted prices included in Level 1. Level 2 inputs include quoted prices for identical assets or liabilities in non-active markets, quoted prices for similar assets or liabilities in active markets and inputs other than quoted prices that are observable for substantially the full term of the asset or liability.   
 
Level 3 — Unobservable inputs reflecting management’s own assumptions about the input used in pricing the asset or liability. The company currently does not have any Level 3 financial assets or liabilities.
 
At September 25, 2011, the company had $12,305 in short-term investments that are comprised of certificates of deposits which are categorized as Level 2. The company determines the fair value of certificates of deposits using information provided by the issuing bank which includes discounted expected cash flow estimates using current market rates offered for deposits with similar remaining maturities.
XML 23 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 25, 2011
Sep. 26, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:  
Net income$ 1,353,408$ 728,897
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization362,359315,189
Provision for deferred income taxes(42,531)0
Amortization of deferred financing costs17,153315,388
Stock-based compensation29,24059,694
Bad debt expense(1,800)0
Loss on disposal of fixed assets0(3,132)
Changes in operating assets and liabilities (Increase) decrease in:  
Accounts receivable(957,972)(989,050)
Restricted cash(1,000)(35,000)
Due from related party0(42,858)
Other receivables20,750993
Unbilled contract receivables133,312307,600
Prepaid expenses(112,559)(66,843)
Inventory(10,514)4,888
Assets held for sale(2,000)0
Income tax receivable161,3560
Increase (decrease) in:  
Accounts payable528,029(328,419)
Accrued interest, related party(43,496)(235,096)
Due to related party14,284(16,545)
Deferred revenue426,83577,477
Other long-term liabilities(107,527)70,193
Other accrued liabilities18,32012,032
Net cash provided by operating activities1,785,647175,408
CASH FLOWS FROM INVESTING ACTIVITIES:  
Purchase of property and equipment(315,436)(125,778)
Proceeds from the sale of short-term investments010,048,611
Net cash (used in) provided by investing activities(315,436)9,922,833
CASH FLOWS FROM FINANCING ACTIVITIES:  
Redemption of convertible debentures(4,875,000)(10,000,000)
Proceeds from term note payable1,000,0000
Advance on line of credit6,389,6170
Proceeds from notes payable77,502 
Payments on line of credit(5,693,047)0
Payments on notes payable(15,538)0
Principal payments on capital lease obligations(7,960)(11,067)
Net cash used in financing activities(3,124,426)(10,011,067)
Net increase in cash and cash equivalents(1,654,215)87,174
Cash and cash equivalents, beginning of the period1,669,8681,012,250
Cash and cash equivalents, end of the period$ 15,653$ 1,099,424
XML 24 R7.htm IDEA: XBRL DOCUMENT v2.3.0.15
Debt:
9 Months Ended
Sep. 25, 2011
Debt Disclosure [Abstract] 
Debt Disclosure [Text Block]
Note 2 – Debt:
 
On July 25, 2008, the company entered into subscription agreements with four investors for the sale of convertible debentures in the aggregate principal amount of $14,875,000. The primary investor was Blum Strategic Partners IV, L.P., who subscribed for $12,000,000 of the debentures. Additional investors included John N. Hatsopoulos, the company’s Chairman of the board, Arvin H. Smith, the company’s President and Chief Executive Officer, and Philip Frost M.D., a holder of more than 10% of the outstanding equity securities of the company immediately prior to the sale of the debentures, who subscribed for $2,875,000 of debentures by exchanging existing promissory notes of the company for the debentures. The debentures carried interest at 4%, payable quarterly in cash, and matured on July 25, 2013. The debentures were convertible at the option of the holder at any time into shares of common stock at a conversion price equal to $7.00 per share.
 
On July 23, 2010, the holders of the outstanding principal amount of the company’s convertible debentures, agreed to amend the debenture agreements to eliminate subsections (i) and (ii) of Section 6(a) of the debentures. With this amendment the holders gave the company the option to redeem any portion of the debentures by written notice to the holders; provided that a redemption notice is delivered by the company and be received by the holder of the debentures at least ten (10) trading days but not more than thirty (30) trading days prior to the date of the redemption. In connection with the amendment described above, the company redeemed $10,000,000 on August 9, 2010, $575,000 on January 13, 2011, and $500,000 on March 31, 2011.
 
On July 1, 2011, the company redeemed the outstanding amount of the convertible debentures with Blum Strategic Partners IV, L.P., in the principal amount of $3,065,546, plus accrued interest. In connection with that transaction, the company entered into a $500,000 Demand Note Agreement with John N. Hatsopoulos, the company’s Chairman of the Board, and into a $1,500,000 Demand Note Agreement with Arvin H. Smith, the company’s Chief Executive Officer. Both demand note agreements accrued interest at the rate of 4.50% per year.
 
On August 31, 2011, the company entered into a line of credit agreement with Wells Fargo Bank for a $5,000,000 credit facility. The facility included a $1,000,000 term real-estate note, or Term Note, with a 7 year straight line amortization, at Libor plus 3.5%, and up to $4,000,000 in a revolving line of credit, or Line of Credit, for 5 years, at Libor plus 3.5%, based on a borrowing base of the company’s trade receivables subject to certain adjustments.
 
The Term Note and Line of Credit are payable by Eberline Services Inc., Eberline Services Hanford Inc., Eberline Analytical Laboratory Inc., and Lionville Laboratory Inc., subsidiaries of the Company. The Term Note is secured by the company’s real estate assets which are included in fixed assets which at September 25, 2011 had a net book value of $1,510,165. The Line of Credit is secured by the company’s trade receivables. The undrawn portion of the Line of Credit at September 25, 2011 was $3,342,540. The loan is also subject to various financial statement covenants including EBITDA, book value, and fixed charge coverage ratio. On August 31, 2011, the company borrowed $1,000,000 against the Term Note and $1,000,000 against the Line of Credit and used the proceeds to redeem the remaining balance of the convertible debentures and pay down the Demand Note Agreements with John N. Hatsopoulos and Arvin H. Smith.
 
As of September 25, 2011, there were no convertible debentures outstanding and the Demand Note Agreements were paid in full. The balance outstanding on the Term Note was $1,000,000 and the balance outstanding on the revolving line of credit was $696,570.
ZIP 25 0001144204-11-062508-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-11-062508-xbrl.zip M4$L#!!0````(`%Q^:3^/GTAWZU(``,WS!``1`!P`;F]NQ=D]YQM+DU9%QHA]I-`G3B"635T<_?WHW\H_^ M]OK/?WKY7Z.1]LN;FP]:E(:+&4UR+>24Y#32'E@^U2[_&(G2LB?-.M%/C!-? MTT:CJO4;DD%M*!,5S1.C*GR\XS$[PW\U`)-D9S%+?GMU-,WS^=GIZ]41I^/6'MQ3*%U!I/D.4H(.5*G->MXXZTXQZZNJ8;I(#)) M[T_+0FAG&"/=&%G&JMF"W*TH:&$67-;:"@H3I]#*?-];&DH0%+[FF6 M-SSWE+?2AI:+#(1A-"YJLV8Y+=B3DL M"]J;C$B>MS>#0L[N%CG-I&8HXUEC&U'20.LQWK$L?_D@Z0I8;[Q6=Q+3A*<9 MQ>7.A;K,3L)T)HCH@>D:T#YGY8K:K:-.YSR=4YXSP"UI M0]$!CN;54<9F\WCU;"K6(*(<50A.'K/HZ+32S6_3)*>/N79+PQS5=TTSAV4A M`TU05OS5^NGR5],=W=(Y]J@?K6O#6%F^7/_.(GPR9I1K8JSUH542\O;]CT>O M=="ME@V+W7EYNMD8.SQMI@"<8&FT_ATT+,\O0'/!(P0WTMV1Z:W;R^4KT%&M M03`R79E@55H]69,\K?%H-]."KX9IP`##')G^,V#:>?;KU1C9=D'#Y\>VPI[G M%0^0:1(/UJ7]>"!6FU,)CO&L.+"QV@RQVEQUP3&$X#@'6FU?!],*P>F@H@[& MM'*U/5.VU5;;%@^&6FTE#[Q2X^C!L^5!J::]@_'@F1JK#:V[87FZ\0#=GY\3 MUN+[++`$&7,[)1S\R=?E\QDEV8+3U^5R%855YU59]3OVT=#CS[<76]V5P=X9 ME'7O[9IR@7+5:\3N@;VOI:H?,<;#"&U/PEOM\>$%3=(92YJZ565/K8O3.OJ- M<>-\7<94I"#D*7L)P=79I1"<&SIAX'>##'PD,ZJ5DWV#/G"K//8;\-BU M]VN7'7X.3UZ>MG6,:-9E;Z$%)_'[)**//]*E&E5Y/;1V5=%Y*R+._!W+0A+_ MDQ)^62A]-5(CH2I*.FU=U8?TCL64OX7'$PCIU:CZ).J06TB(8,1@KQ)"A&RS!,U_9J,[B#:`7OHDRD?8*`36V\ MH.K^7E"1VU;]G<.#"!^^BTGSR+8Z',,0:-%CK?4FQ&NA/SN)V]I`UQ'7NMJD M4\AC4>4=/,O4:/W=JM/8ZJ:9#LI]!RKX;Q.=53=(I4Q!G+TEV?0\B?"_R]\7 M[)[$J%#.\[>$\R4(P?^1>-',R>UX9RU^:#+JLF>X;N"[_LO33H0'1=JX4!J0 M.JYC?4FU&VD0V*;=`^GM%)3T)\IG[T76L#!Z`PBE M:>G.&E83E3XH5`6N&XKS4&2"LQL:4F#=74P_TKRTDP/PQ+8\-S"#-9Y=](;` MI<@EQ[)<3S>ZX_HYN6-@ZB,DRTDH-QB`79:G^[ZW1K6#V@"@%'EE6I[C.9U! M72SH.Y[.;FB,NRG71.1M!Y0LTWAJCAV3_=\YVFJUYS."8LN'^AP`A%XMFR_&LGTPJ&Z7`P(;X(. M0*[R*>7K-90-JH`=WW8E6]E.JS\B1?Y8GF=T1@0A:3JCG\@C'5;A&JYA.:XL MM`UT>@%1Y(K>`<,%'5/@4`15SK.,YL-*C.W9IB6MXQW4!@"EJE=]VW"]SJ"* MLA]H#`$1OP7'<#@V&;KM6#*D-EI]\:CZ?;KM[8EG.*;XEAL$@;X)H@]E5>-C M!XYAV0J4KXM-Y.5U3)(;H%P]C>PW'02=.UO_M](;`I1R(0HCG.MUQ MW4#8P%D(_DL9:$F1Q,,CT'_FP:PVW[.TR^R?)X MYD8B\&E`E[-YG"XI+1,H!^&4$7BFXTOIDB>)#H905;0\TS;DW(82PD(G%5Q^ M#V0Y."12(FI9X?N"AL/V/1R6(E+93'R98:DFETW'[CBJ31?HAM[39#&@IM2W MW:PZC2;?3QV%KHQJQ=(-1?X%I=G7=;.<]N[` M)>%^)J-6U>NFZ;L]A[W>R9NSG,0?*,GHU5W,)@3/N0RIZW7/,>6=PUWT7@^" M3-E]<(V]D*TTS"II.""[_$WOJIE4;SRJ_K8#QGK;A]@-Z##NE>[[KFR2=WL) M!W$+[``<3GFG83>&AL4Y;/H&C;F<%-E)@EL1Q6X$S/"/QM9Z*-Y%#P5)558#M-V3<5>&)3[$.:3/#D MQ@6]RP=EG&'9CFP&=U`;`)1R4DPWGX1J-&W8.JXLA=TW$# M_VFJTNG*H<[168;A20G830K[4E==(>K4SZ.(H;8A\35A8/!+720U&8`;7N"9 MNJQ1GJ8Z'$;5E#D>G;;VQGA#<\(2&ET2GH!3GH$'M9@MA#D$_<1"-H1^&5F6 M[IA^;7_D*;+#@51DY,@(',/WS'U!"M9.TSBB/,.$;MY\5+RC27/!OPVD7$&H;8P\,M7CWXWR13U/._J!19VXVOF^".^[U`P([ M2`Z`3/U-F.&0O<^RQ5#\$MZ5[>T`55#K":C3"T/]`2F^QC0DFS9>8NH+;4B& MM4##TUY9F5._I?R>A>)<92.JS2LM=AZQ]0/?K;DGS83VQ;)Y4\3NY$1@0,AH M'`S,YNT#N[.WNN%:MG]8SJB&5:;OZ(X?=`*#AVVNQG@013@L9:5;\%EZ2XWO M![8AARSMM'H@ZB0[X&9;NBS(!X'418*"`-RRV@[`P9BDZF[Y`8BT[72%]#U/ ML^R:I^.6,*V+Z(!EM1WY?+;4>1>:W12+;05R7G9/FIWTAQ[HIC70.%75A.][ MAFT_39,FE),89OP\FK%$O`F>LWM:OM#0>XYMW[,"28T_0:\OM"ZB8#B&H[N? M#UL7D7&\P'#LS\LV56EV/[1P(1S?OU30/R0Y5X7#=8!\8I1:1SU;UEA#+,0V]@2D-M/I` MZB(M'HB+_.+<@2!U1+*LSI(]IDM8UT5#>S]D2Y+%M"@M&YI MDKVAXY13Z:#2Y2/X0"F/6$+X\GU.9^(D`+3D:1Q+Q^7ZAU">;LMI\P-B_9(L MZ:1)P1<+O&^>)5V6H8VO!YK?/$LZ13%!8!F&]85X`LU+1?,&@JR+0GGMC:Q#PNCD\OJ.);^D>PB.J.ZW6X&G.YV@?*3Y@.'QIH6H]=Z-;!\M MW(-LEYDWS:#F1O<=K:K`68YEZ[X"W>KX2;7)^H9D+(0HZ(+%B[QE+V[G=+?O M]DI2]P35O@!W"D8K0/E$Q8$![A2A=@YZGY>#G0'*^5T%@.(MCG]0-IG"@_-[ ML&L3NK73N(EVT)=/VB6Y98M4+RZAW`>Y],[-%QUS^^+X=L?*GP'^:Z.O!0*KN>KFF MY?0"69SB/XA_W/R>IH)#N#L/2OEU;4.^\E454V63\6+%&7)SF%7I!/43.XU4^N!0?IG(M/4N.*YY>L_P MJVH-YSN'7&:[Z/3'HWP:W=?WP`3KC^/K6!>T^/]]LGT"MC>O`C_0G7K8_B31 MX4"J;D4X^/;&D"#K=SK!1*SV*L_#G-VWO_W328'57YG<#\4AQZ%\@.70P]B\ M)[+_3D@06+L@;Q(<"I[R3H3N[5YUW0`B!KRMMW[59G\N6KKG[I[[9LK#HE56 MLY9E&3O5Q#YHZU>\]N:IZ_KV3M<QL&F_I9`<<)A@)7W1$\A"H=V?Y&1K>= MV`"HE!6C4]^T[X%*]>;9/1TA19*#HE1>M]OW]/;'NG%#UP"ZT/1M8^?BV"`Y M$#[E>XE\W>P*3R0?&FNV76STN9)C3383_*F@NHVF$V@I1_2E!ZLFVB"X6Y$J MH]OS&K.>\(0CO[[?XJG;)3KQ43<4HIQ&VL-C5C;V>$O7SMG?%_7VI9/]#_&: MNO54WF&#YG`8E4\[6.93"9P=&/%N?8C:15(JHM&;Y<\9&I9#Y$,,S]G<)5T=P/,6A;808^I>?A[PO&:?M]Q_T%UO$\^7YZ9=)#`U:^)L:Q MY7>C]@3,TY#22)S=PO$QJ^<2'=LTG/ZPK_B$).7./B#)TIA%I#P_<@TQ-/12W_4GL;A$ M1ZR5"Y:%<8J?!,=WZ=DD86,6HO]2I.#PLQ'07PBS^PE&^"9NNSYNZX.]W\7Y MBXC=:P3T5?+J**;C_$C+\F5,7QUABQ%+\./S9YH^SU]H$:7=(X84V M(WS"DA&V*FN43S@>/RH>'7TWR5\@F3%@J+I>=<22F"7TA8:%HS&9L1@>YFP& M:R2A#QIX&"0I2S/V!SW3#$%&/'B@!96[-(X*,A_3G&J&]AV9S5_\MV\:Q@M- M9KM&DDB3N*>MV:=5_#M#J*?8?X7[%/B#/__Y3Q6S5/E3#%V`,5R]I;//S/F" ME?@S,!_,%0NESO>;#4%'YO.S8Z'E/B?I%7U^#VKC!KP4[?W:38&?PY-CC6@7 M-"8/Q75=?)X6[XL<:RG7\BD^$Q^+/]8>*#Q;<%&PR.!WD@&BJ@F-X!<-5CJH MD#O*-5/7'>UN*;I8$<=\7D)Y-F5S[?3/NT'HS`GA8B!,#S M5,LHOZ<:/"4:WH577)-4U,VG/%U,IMK#E(735K0K)>"]R%8XM8=T$4>B1]$P M$P50D M8G'*H1L"3=`"T,>R$S+A5!B28I(D*6J0D?F"9PO4CM!3,3(Q3.F^JAU(:9"M+%2 M.*4SO`9EJ<7D#G5["C\F-'](^6_'J",?*(@A_-_<-ZP&/*,"'JKD!I&$Q,N, M`:`I^8/P*$4+(IH1C!2HJ#1CCR#CH)O!K0*^D(E0(L5:&),0L[\@TS2Y9SQ- ML(C$QUI&QA1,`]8!2P"J7VI:*'V9(7)A>V=V4RQMH-68*RC[3_)4A`,`7_@GK/4CQOOS+' M:-W`0J*G@RLKC4'+`SLHAZD'S%7V4;LCR6^HB$ETSS*8029L\1P?R8`HA&\+ MZ%X3EPQ16"_`<=$;K@$@"OY4L=,IFLW3+,-L!<@X_`.XA?KGL$YG!-<78)CC M^6U88Z51(,67\Z!.1L,%+Z+_NFF!,0DAFU$^`1N\48@&^UB[A[4"*Q3M&X^$ M-P/]G&A7B785YBF:;L,^%OP^KG=-^0RBR;QD.4TFY4(L'(&GV7ZB01#*180$ M+,0^QN!R0M/2P=O`&N,DE*$W3A`X-,"/K&H;T7L:IT6B7^@7DBQ`CX!O@P20 MGYI8R/`3JJ)"6P%"AD>>!(2UZ?]&C@/06]>)),T&.L,]-D#)?,T*1P+O%EMLM0REJ_&L';6MXD7+&CCX0X>D'63 M=B\'M'4:@Y(MG.?J6H1""SSI]A0^3,UA@>K@@GD*ZH5DJ7Z484,-DB_A3 M\%!$S1`'N6M>0TQ%BW"(%%N(DAXJ!59X=E48"%C0(1N!+2)W,(B0'. M@B*DX31!E@@X3!+&.$M+@U-R!6=26%)L+BM/P21<:96ZE#0CM"1YW+*'%Z'3$LB)H*H4JPAM8Q57<8K&;6N9)FD.'4;H,2Y%U,;R MTC5.P*I-A:FN.!=I1R+G16-6^IPBN55H=Y:4NET.([%HD1#P MKUNAXB8&A`S"T2;1OQ;5<89ZZDVDE'#<8'U0R8#BF976EZ/;C6KNK\!),#T9 MX<+<5E9R3!B/ES(K_I))4,#C9X6,YHT^2^5`%"DH(<`K4U:8N9!D4VT?`G>:%R8*(KIT3:5T\TM&UC*P[V!*0&I'/ZZX@+:F M'/0%S$Q]N?[IX98$""$BE1UI#LK=I8HL!!S\S5/7V:;KF,*"$[`@]F:0X` ME.$4*I-9<(,'C0@P3(3Y!S.0I%)U?X.?:=],E-/H690#^E&+OT[)?=.Y%D): M4"D4`G^(5L%0#Z.UA`J"'/ MR!12*3W+RN0D__K?S\\_N*`1D",B-QUR((X6P1?AB&I/43:"G!5@&E`4(<_+ MQ5+J].1="62@GG3EA2SJ(;TCM1*\47=N&&ND2)_5VWH>%B5ZS90Y$9*Z/HO@ M=9DSAU6$H3$"65%Z0HKR*7I-7J6@T"9%S1FOP+R-"N=CE']AV;*-/JJ9,#)C M]M)KL$S1KQN1_,C+Z7\U1]=Q.10X]?K+M!2Y`:!3?7&U?H2?7\)L8)PX`O&B MC'Y1IX=*/T&&7M*L+A714)@:"N#Z]T$;@]4(,1Q/MHLR@.:-"49%63L>(NR/ MEZ$3I]UU84YU%I%-+RTGTMZ0@,I]85#BH@\A*SH8630"KKERMNC"+?)[)"O% M5[PMHC3!WU60X;4@SPKZXLL,K38S8N^@!XE6]:4_H+P@^^PQ"\%N:M^@RN-) MF2N=/@HU<%7$6\,977YAF1?I`J!B0-``%H!\%E5^VOK(G:5".O_5D0H/QA1* M".*F)5"%A=#S$Y`O3_9BI0]FJF*5/KF!K,1@DMJJGP9HQI3+5)ZO,JA!]4_C M&'Z2EQ'),*+\N0:?:=CA#.@X-J)'\F M;^FNNO/(BZ>6^S[./+#-FJ'_ID#0>[2!/D_2IV@SQ$VUJO5Z8-Z`J$9$Q45Z M/E![6L)F?275`I9BU/N.1AJM#]Z;J#_UZ4\;W]6V2#NO#FIM^;+>H62-T-'^ M"*U=LO?=S":YDA=2])5NL^:*W/[:1/RN_,O`A@57P&A!W:YDKBWW`U?;NH/B M,!1-7>S@HPC3BR3BX-MNRX9H-I(4JCP'BIK3BOZ?/KM0NLO"L5K>-[(B9%9Z M5(7Y97")BF]@-#YPED'X!0S7O'*BW79:G#DFA49:B7HGQ=) M83*=+D="E'XQ6]$JM(:C5>%Z*M)$S^HXUO3&$1%)8)P4EMO`ZF:Z>)MSCH\Y MYQ?HYZQN0+Q^=7XNDS_3W#F/PD.*TFPE`1%/R4QCES/E'Z?D7-(L#+ M`+6%D1J!3&--!?,S$BSO$KHS>4[0;_!+B".3`T&PM29HFJ78J8J-T2I9K)\%.X;^4!NQ@KJ# MUUQ>]+)+1S8>E0IQI&@J(G2&>.VUQFL6I`S'L0$4`R'H_`;1`^M!:T$'L!JY M;31?K=:M(^&L#2ROHK9>R8K/U>94Y!(MRQ+LM%SYU*H'_.I`W_@*&2S';5*\ MJ/*V*$GH2I`I04&[UC6_@XWD/F/R`@@+2J:2B#(`H+?^AFC`8=4^J97EC-(# MG>`*,\HDYYEV_Y(\()\LZL,H/TA*K1^`5?9#2Q:FSH[13X-XMN^BJ(5;@W7+ M05DP!'@E9@RG=Z6CH(-;*S)^]V<4_QW4&#ISO(C2`6VA^JOW\T;=13D(ICJC MK'&`5')_13$Q!(7.!T!5!4QK$!N)5%4,DE\UOSVG!'^E*QEYH"3/@K*X!$WA M_W0:J!:OKC,MY8%8N=[H>3SH\:^DPNJI;%AB>;.OQ+Y]EHY,LL4JY7=G&ZFG#6@P0I19V]5 M^4=/99WA.1'-;PZ&;3[#4QW8G\[;2@_>A6_6U.C[<`U0U[E,@6VH0X M0FJ=]^,I^ZQS"S?_=Y)U'[(HW$U:2AFYQ._ML-^P,1CA@!.SD\X[AG&Z$""U M9L9[,87/,5Y2C^P:@5##']1X7:3,LI7[445:!+4.K,>H,M@-(U**,'0-34$B M5^9OD!01GO(Z73&NALP+98ZBT:TR3>H(+]TPS@L9Y*%)RWQ8,%-(O_R>#I\B M[=!3 M&I"F`+8*7X@`6Y%AC*!AH867$>Q`C62]LS]>T7F)V45_#>= MF@.[]$$5]5`G94VL7!D5;FC>$,30?)"!P8YW3I`]JRT"Z`9Q<5,;]+GS/:U9 ML%S&48AB]`=Y-A-$JN])&U*%+5%54'?=HX0L.SD2+7E>Z&LUU%]=G^XF"R:F M>@._U044ZK'P.S,AC6)TN;R*@VBA,IFEQ4[5"K2]72CO@MI$T]D%N(^E0T.> M1[DTO@R]2.5LV).\%72G_<"?S;N=N>=-.OWI?-293`.O$W:]>="?]GM=?]R2 MW!5,PF`P'OM!1WA>V.EWQ[/.Q)OW.E[?FX23T)N(:?]>Z5_!R/?G_?%HTNG- MIE,8>0Z*P;3O=>;#[JC;G_2'L\"W/CV,#_77428J!8DD>74JJ\L8,_D$>9%= M]&08MJ9D/V!/8/U`B8+*02I#?5="15T+E'[:>SPS7XMZ75G$I(\K6:#CHE0; M4]UT^"@NM#M/CJB5>G4`-6Y%JYMULJ:9^IN*Z+NK-HAZH/(*TE2ET"-31C\@ MW3-5VC8(#N4PPL/'7,9L"XNG$H2U)07B$B1\+D_%6O^I4FKQA$-AV'"IKV@5 M=6JLNDH-FK*,D5U12#HOZK(M9X[:_6K37+TQ`00MZ MM-OP;GGM#ZQR:E6(,9#/NHJ\C/Z%_4?K3[F=Z=)U[3B7SE5X[8]I@Q9'R!.H M6DI0_('1M$VZA=5YYKP-_MN<2.L<&C1K6MO?:ERYAV-I1IYQ--%77;/BJU@L M"WD::\<.3Z$P7,7#TDK7;:L.LHE^^*$?^2K.HX MA[.PYJ/3R5@[Q2R]OZ?I##7Y[6=\JT/B@9,^PM-3+["^"%%;1*30EAFHICE: M`&B65O817NUS,-U)WI#&V<&)0KR9B$*7YJAN)L.1J&\C(U-/,2@D#T'S]6;\ M`:0#R)DHDTG$`H5*DI3H<&Y^A^)=,A"C?(7&]]`*0$/20:-9GFIA;9N$41:6 M"Y0]%$X&F8UGF''%.\@RF:(L;4#M39Q*S1^E&67\M$9.5ZBG80IE#Y"=#A]@ M;4PG%J1>G#2L:-R*K`'?C=;5Z@=(7YGY!15?4 MAL$K8]PC,N\::T`OA+,FG8FXD;--QX>6Z)N"YLI^K/(GI[BAM<.@)*N.CGC` M&6X"*65TW.*=4JPO!*BBVBQH[R>%20(84O6FPNJ+$*M"--HM.S@L3NLVJ&G$1.[ M.^>W@7T4C;#G+WUWU.^Z$Z]7HT1K_]>4/A!K#?KN"BS*O5`5M&BIL(CUN^3M M_]LJ=-U:A:2B$^F[SC!NC/ZK>75?C>*^P'_OTE;D4]%,=30T7=;TO4T7E(GJ M^M,1?MJ=T%NT'`^5%QP%>D.*US?C@J(&HLYR64U!GV.Y)3S1@//KIZNIK)PF M!OW;9]9QY'O%14&3_I#LD+9M+//Q7%M1`;[[!)?Q.\I@H4;GB?U)=$$E"2/GXCT]LO$YI$EH.:]V]]D:&^4*">-NHND4;:*/P!RU2&HG7)=$A) MJM+F2V7!#(J"RN.H#G:1A]MPZT=YO;:Z;)_*Z'/EPRJWLAX"2""K1.VSKJ*A M8E8R>:ZNU0N2O/F%E'10'F^IJ)?DN)2!9YJ!3J2WE?%6LUA5"Q# MV4_&9,^T#LJ'-'E)V\\<'OC,;W@Y;`W<4?=0%%<9]L%JE648XBJ(8N/.#5K49!&2-09`ND:'FGT!_\/P M*+T),@QY4BXF*,%4"?L3EL:V;CTM/V;QW[*0M\>BD'*YJG6E6N.8&4LA;;J- M+0HM$70ZJZXM(_-G9J@J_GPSBMM%+B:A27^*(& MQ7ID(EP>L(4*^>0EWCN@5ZK,#XG"/> M+%7GRUIQRK#NZ0-G[!0P4F9*H*H%T??HZ50E.F1PR%@T\^9KY5,27T461I6; M;\T-I+=$.V*D,_"6*W7F&YO;78E504'N=2KE.FPG5^]Q&?`3C&5D]E!;DT&C M`&I#0)!D.#.2?JR3$H`R0D<& M#@HVE+?2^WF1H5^5JI(V#)C;O*+8266F[W.L)$4E59A8*=VUG=.LY%<%%$2[S(2KR:V%^&]Q$'[I?`HO4\JTI2^1$-.>;5T->R;B M]?L]-*>\N8AH&5%A<]S)#KG>I-%&:CY&NG-9=06SQ51OP=7\/$4'K2&8GK+V M3;!*SZU55;3!8#KDZ:A0BJSL]A)+6TL.%R5P$(*J_4:;8%FMMCD@.VM64GEA99"I]50&GAJKL@+C:"XV[5T>80R8 M'(C*B,F2R/18GV8RF#7<:\&,8FRG1N+4&VD5%Q4 MY@C%W.F*G<#(3X!>6KI#7ES6)ZSD%&2[8+82,ZK<%>U3I6_F%>8[+2P-BX6G M=E'7#:!,,/)45O;Y992C7Q>]O-5Q3PDB:387$9F.=`D2(%,MC>;B>F$H&]_D M/3D7K-G1F>,Y':FVY3+&8EKL_SK[!`]K?>K_1(8)H'0UC\IIZ"@_8'X>J*FZ('1:Q41RQ* MHQN$7=$=A:(S[8^GG?YLXG?&_=F@XWF#X:PGAE._'[:ET7EB%@2B.^N,>J+? M@>^*SG@$_PEZHU$P&(?C>7]TOS2ZR:P?BDEOU!G-YF&G'W3'G8D_$YW^T(<_ M=<5TK"AZTC2ZNU^\WO-NI\R\(U+6?L>C]M_ZJ*T+_1C5W:U3@RU4P5H#A21Q M7K46IFRIIU2E,.Y<-,AM*PUA?+@,;N0GH>RM"Q8?YGFD57==&$%7P%?U;:JO MT+NPO)K^R"A3>3>/-4,/5#\]".,G.! MDJ"H+ADW%]\Y5,B?7K$5G0K$;W>2V[0NN%;>!8V0ER4N-\ MXC1(FF?/"#-DS\F9SG'GPYP@;61,&ZFC?YEX MI`RW6M,V+2^!MX%(J]8A.$7(`J?O@#E"G@)]KT4F5ZD1JXIBFY+E_IACX8O6 MA+5`=G\IYW/L%IRH$@MAY1Y`#_(T3;_4TC+&M2+!I2C4"1VZ;#)*ZKKD0F2T M`ZU-G)5X(?Q6KR]U69`M0QM+&:QGZUW7U?^5S(0CC6ZDF6^8WABAV/4)T9-R M*O+FFBG+SZ0HE0]'&`4N9;&X#9%GW8:A&KW>Y,IX4C%#8Q=4+MY*KIR\JX:W M#S!Q3M_F1ZLOU\V&S/N,NZ3J;.C^0)"2BWH;<-O7L,TG';BN^1F%*0@E3XIKA)-%H4YS4C8E=,[$:0_VJM$!U!U/Y7:;EC92-.;8\50D* MDACR0S6JU+WTSB9P(,0Q=G385`;UY:`[ M4?MI=;MR05=\I/9)\:>7GCOQAN[$'U+Z+(B2A?)-SK#(7ZBZ&*+;LG&GR5!( M%3`O-3"QNV3#2;@Y:;E1<$%Y+EM&,^]P`<'=_LCM#46R-V[QXT&D M7%4O>R.W/QI).XFYOX,/3TA4X$]0*+,?35S5WE.Y#U.8)&YA8 M8&*C+OL3X'$11%B&@CSM.*,\-RNBZ89N^N2J@;>20/H:/=R%1!BLQ;NW;UY3 M.@-^6@EB56$(=I:N%:B>0CJ5Y$J>RO\LX1RF;,G5-@>ZN:ZZ`VMN<[S2`$_V M`@QT>\V9471&SXC6-M:/(A5A5EV25L7?Y,8B;Z(J;@CK^L\@*=&3NIYJ M0E>3U%>#NL;<$L]E8COJYS2OXASZ])*$*'XUV,W8_=FYU/?^(XI052UA9=&Y*M$*M)8$V*!N0B"Y4_OLXL@49V>&VW6SI.9V5OM M_;SRF=7]"E[+/"O@!GCZ4]WXZ[Q*2/P`XX'FFW^&0^LW/)Q^??[L;_K=K\6T MJ(>H'J$`!/SR4?%*_OS7Y.V;O_Q!!T1R!Z?VXM?#O$ZPR2U+3@:_X63` MU>&J45LH'.]1V@)/RD.Z.[Y%A\"*;V$6J2BEUB94F`9[W2AW$5ZBUB)#-V_> MD*JB0H3!!8QV@8*N*B1FF&`OO;X['@VH-KGJ5Q/1-2#].A*'O\7EPOE4M9;^ M`)(PP5R:/_[M.G^>?3A#T5G-8:JDSTO/QV%)7NC+4Q5U9BZG,;6J`]L_T\O$ M>7?F_",H\G0)EDF:;[[U\>H2K<.@EIPIW6\]SZY@#?YQYGQ:4//I35]':4)7 M)^AH>G49B;GSYJL(9:K,>S2144[B'S]2UN;NFA;18^DS0 M`'9U72?*BD@;C.+UUL;7C1$KG"O;5(7U%<%J(_#\PCLG$<7&D;G:4]KP.35H MKI,41.U)>#DZ@Q6L\LGLLU9MEG@]U]",Y;[D;0S1)I,V)[JUR3E7BDO2[X.% M4!GEU=]-88H-P7133UEC4UV3_#Z216N^C^`'ZNHM,P&'WP<_M,FN_TAM%Z_$ MXAMEFH@QT0N=$5#=?ZJQ*E/W@20"Z4J:2I-9]34PX$I$II($ZB4_ZWX$,Z6R MT;`R,45_(T+[!=TPR&331G=0=35417WJ/]?";(6>H*!P#5ZQ39SOO>X/5!2= M>`652)ZEXKEZX@>C5BWX35?T0=! M@$@'AXMH_#/".E+$]+VSP7>2@93CI5^]EVH;9`+#0"B6FE.7A?[51Z_41SC= M@4RQ;']/%V<@0WZB'Y>CCHL)+R^I]1@8[` M5LT,,U:ETZRDWM0SPL(S:/NNJ:,-:"%7.8JK5!1`):92U+INTDY57%<>:$S&Z&O[J>G> M-R)#MRAH,OB`3=^NI0[6JH[D&Y4@&J"II[`=<*`3/,^EK=]ZL]FX-;T[G2<,MAV8T\L`[W/^\J(K?U]B MPH#\W7AC9OP\TZ]6CW:F:5&DBY\/*27J5M.8X@5>G(Q#.1>W3`DV!V0B@@'^Z+=? M:&N^RM[C>ZLQZ2&0W/[Z0M]RF=!.T#PG%C`9&`Z.!TP MQFGVRXO_+PSG\]"L95@;8S(4>X=Z?-!=M'ZOT@1V-)2L%K7W`>QCD?WR/M32 MUF\F=_)XY/I^WQWTO9.0"0SCHX6QUYNXPT&+TY1AS#`^'!CW)Z[GCQG%%A#' M*+Z_,/9=?]R2.,0H9A0?#HK[_L`==H.-UO+U952(6VSEAV2Z'K0A_48G MV.]H1Q]NP'J[$+5CA:AYW&D]G4RZ:TQY_'9=KW]7_LBIQ,&9Y8YB6LQRS'*V M8I-9CEG.FAUFECO@:5G.:[7=X?#NRYAG@K3 M[9;4L>%$[!_"+>S[T&X_"P+YSBPMI[&P1+1L[9+>:3J6BQ0?9Z$DR6\,+]",5^S-^YPJB:W=^5%.KXC(3LBAU M@L5R%_#L)7:!B-)9[@A95[>M1#"6!*5>ATFN:O2.P*:9]&1]:Q\,G,EPA(_E MV`XQNA+QC2JS?;\7#W7+FO47#WJN/_;4BR>^._977LRE]WXRD"36=[60B6DS++*>2F_K!W&B2*F"T('8N ML,IZ(IN?OZY;C4H4.',@U_$FDS'6//>[W5ZSY/JU:O]*S6.#=I+J.N8YT(9U MAK,T=MZEU+D],=K-4N.(?[YZ]^ZMB\.IUE+U_.&S/]/<.8^#19K+5A'K,YT& M>913K?BWP8WC]:GKX6BUOX[J-X4MJN;4+!6[H.)4_SC_T-E$&OQ-TH:M\,H0 M^]MBD_,T6Z:JD2I0J.FO.Y?G95Q0E>_`)#\HJ=N'8D2UVHKEJ$-IMVJ?Q M=$<+V51XF8DK+!V,75_C(%JHMK93[)2PUFF+JG]3N['_E;)3K&HQ5"8!%OZ5 M%8,S)\697T>Y;I1>K^R9FC]\"$/DA2:JN;#R>:'Z9*F&0C6KONSYGCON#56W M=T)/---]N/0P1L?;JL<`-M*3J[32FG>U+3;`IM#DB?45U_M!2Z;>HI8G2K#C M-/7BP84TYIG2U["E,F(.OUGMG"90XU[U<%A];2&"A=$D#K<.P$6KU""+.A93 MPQ+53AG?%>15E]NW01)<2+9J=N%M;#9`@.`11-30F+K$S40848M!?`4V[*4" M\_,TDUM=-7(#+@:AC6R!1`'O"3772"T:K3^^#EZ>%*IU[RI437+H9:D!#F"> M2XT.58S>-9@EH*81.?ZGC*E!(^P[H/3&">9S7&NLM&WPE2ITG29;]7U#HQ#!OZN$>'@A6E9XUI68)??"ZZQICD*7#I&55^" MC+0=^"9BU/RB:OZ!3$I"ED!WB=T3@_I-P0P[=`+F)0*Q"7V!#0=SF&^>NT:Q M]0J8F=$-!:2#[#2[3<7*_RU?.MDF"/U&$P1S MO:K/1S\[=Q"3NR>Q?R+Y@$DJ\:YH$_5LS@T;7%-EUTVB\6U*+9X$G>UYD48@_RBZ\JVU4P&KR9>?B MZCOJP:5LUFI\88LS9_/>UTR_->N:_/XFR+#O4/Y!9)]PFLS?@P9_Z_6AEHJT M0LS36_#T;V!#A<0(LR@N$?W"7$CBJ*U]"&*V/9.3L-BM&I&.H,]2.!.DMUAOJ10OWY,Y;KVYH=#VA?THJ@`\G!H#'?K"4% M[(@,^P3#'0QOA]@Z/%N=]YKWVB:*>*]YKWFO]Z3XW%6)?L/]U8%_#,7FM0H4 MX%T;RA,L4IDKK-/*'Z0267D?_;"NF]MQF]SW)^[(ZS_*$MLF*1C&1PMC;]1U M^WZ+.X!AS#`^(!B[O4'/[7>YH9L-Q#&0[TWNR!^[XTE+Z>\CA/%NGM<[K([' MGBJI%BE$'I4"6]<'WIN8GN`9ZVQ]1WR?6ZOCOL M<[\SYKHCFA9S'7.=Q?!DKF.N8ZYCKF.N.SVNV]^5AZ.RHM^)HJTNXOT,YT-@ M<2LDTX$%Z+MGW=.(SC.&CQG#`\:P!<0QAA^`X3XG7]M`'&/X`1CV6UJH'B&& M=XGH<9[?N>_[,OHDQWS'?'3O?V370\SW MD1C#!X]AOH]D`W&,8;Z/Q!@^80SS?22^CW2DO'BHD?832PIF2#.D&=+6K[&= M9#.D&=(,:2OH/CA(/,I$7611B@I^ZB53G]:TO[S$%))X_ M8PFR*]U>U^UVN;>D#<3Q@;@'.`\8SO;B@N',TIGA_-1DLW2V+'QQHH:*NG94 M`KE9?(.WCIJ5$T[&;F%!LK,@&8Y/1I(PGD\`SZ,>X]E>8#">63XSGI^<;);/ M'&2QQ'8)T^1*9$4TC84S$U.@N01;ALT4&\GF"BQ\`#*2'T;W<#)T^_Z$\6P! M<8SG;R"9GS]C+#.6#P++IR2;&\;)CT4`^K?QN]*V__9CF710&&!,# M4W,.5.3F<$'N%/`"\36\#)(+X2RS*(277`:%>$$LZL@*8(+D98Y+NP7&!S?A$]7KZK'A7%@9"H6$M_(5PJ5NRBC69#`$@1QGCHB1QD1 MY9>P:(&Y;)>1R((LO+QQKB^C\!*6Z']EA.%(G#2,!'3"NBR"K]$"MI->7&$!F\\"J(8OS(_Q%,Y\4)( M'B6)^9P8)\(E`IZ/)?OD)O]$(I>8#],%<,:-$Y99!H\#*\U2G&1:.)B#8.R&+\T='A.R8@&@O^?DTFI"`S4'Z",%K%2QB7,_@=@*,V]\S1 M+U!?5L^L?',+7.&@29ITFHAT6P;*0;+%0;9YF!50HSR\:VHDRU#6&2*2WE5. M,0VD`/3B<8&':1G'3B&R!4K"]D/FS$!@VT]WX_U09=@IS/%AG-B[34ZOG\^9 MF,4ZCU; MI?JAP>F\<,"2*\1B"H+)'[@.VG0N[9+>C!&YI=I5G1(`D7) M%>B89`S5$@R_ED6XZR"@0HP3D08O2'6;B66:1Z3XH>))S\/?+M(,Z)JA/J_D MN2'#3&3,!+Z8S("B:5G<]K(R1^1%"4C4A;0EEEEZ%>%1,I52-0($XS/3(/FB M:%,G28[[10HVM3Q:"KI<%`;YI3./TVM4LJ,%O5&^16%7J_&9(@;L"V6"U$L0 M%9?580):?1`EDL\*4(9OQW!MY-]JOYN&_B=Q@1OU$=Z>(3_7S[.Y/W(ZCEH? MYW50!&S9;VG9*[9L'`CBJPAEG!A0#\I-5BMEY]D5")!/"P"^Z[S.SIR/P&A@ MZ#NO+H/E`FUS4)7P\T^7(BZ`35\!:WPQ1,&K-*;C"$3$#0FI&V4@"A@B$G/G M_1(L6SJN7HLPRI'5WP9?1.;B\?#J_>NW+LH8Z4D@YC?81AU="@@D08"D-\`& M&0DTHNZCB`,4`'_4PF1%5,E9:^T,WPG2!2\F+N%XC+1BAX=6GNL#$:BFX1+Y M11&`_,DE'43PM8AC[>P`33!5'A&4>4HPPOAIF85;'7RMV"/(5.`C)RCN=O>[ MGU\X^X70>*LR,LWD@>W9;RN><-:9\NZYK0N/6_3-1^0V0SU*">YT&**+9(I' M$,!*8R?_">![%65I@K^!JO0)U#NT-USG/`GB&VD._0FXAU'@"!;26/DCR8NL MI`%6L-T^FB*#DMB5%%7G*^`^F$5IG%Y(PXO:`>:%,)1))]>C`)/!5D4Q.9_H M=!V\`-L5UFGVA$=1SROJ$Q^%$ET(!E[N[PWJM(Q"(\`CL41"2VQ`^T2,HB$:"_(*H19'> MCN*K4WLC9VIC8&43,&7#RP27A,B):AK(A5DI8?AFW$ET6]+79Z@GIDMZE!8) M.0C92WH(ZSF18FKJLU*)RW$&4P&2865U4+ZCC0ZDW,#KSISS7,,*?:[R9Y+H MJ$FM:,K26%D$,VFLP!_@L",Z7/A+1D]$A5ZY&3UD+)]F8'1SG>,S@$V%@M:G M\&1)4B=.DPOR7\_3L"07!&P[2!\$-*[K'WB&5=(CS953(@]B!!_LH(A!#4T( M_LK1#5Q&E:OIL]K6@CTLA)(,K"/=*;6U4@G+&%11`>#M*)V!HB2[#:V;7[0Y MQL=#^KA+.U7YP*:`_NLG552W^0L%*=N4BEU7$XR[.,Z7`?H0?GG1E;^KRN+X MN_%*,X-SMX+YC^^7NKM>GEWT;DON'>7OUZ/L88J["1\,VW$4"I19!V!8;C6F M4N%`1ZN7]BT\?YG7O[^!V;443;]%*=YO`7[+DAV8%8Z8%=[!3\P)][N3T)BI MA0>8?8RYD>'\8V"X2E&L5P04R3UQC/7,P8"S`G!#!IQ%%)T`X%C"V431"0#N M="3<;?JF72:9Q=Z4Y\^>R(@\"@;H'R/4 M6:HSU$\$ZBS5MS([++0L[..\X^:H[\LD*&=1(68_G(HASBACE#'*&&6,,D89 MH^S;EF]LW?]O===)KL'M=SIWO?]$Y,Y$F,K$\I]4Z?G*&-G*8ODHKD12MM5Z MW!E@P=*S>BP,CEZ'S%,KHOKH@/7]V8)?P M:IZOKP/M4]7SG/L]KN^VQOV'V61;9,0#.2C!?+([?>Z M[G!X&FTS&,A'"V2_[XXF\'^_)2N#DB>!9&YEU+I\&^JW ML/UA(]E/*"SCAG1 M%A#'B-Z'UVC0G;C#[FD@^MX!DIU"7,=DO!BU&GR\Y5I*WGH0%G?#M;V/+?K#=U>_S3\5PSIXX?T MQ!U/QNYPPE$S&XAC1#^<[I[OC@===S">,*0M((XAO8?4AHD[\49N]T1R5!_] M8A'?=U&FM9USD4)KM\D\IG/D"3;&-O'&[&+O M7)A=F%VLW!4[Y\+LPNQBSZX\?V;];)AAK&,8OD?6NGQB^(]GIN;W(:R2",Z.-' M]-`=>7W7ZPT8T180QXC>!Z)!/KOC_O`D$/V`$,I]8I5'8;YPJ0N^GLC7$[^E M8'O^[$33*9C?F-\.0Y%@;CN*:3&W,;=9"$OF-N8V"XWDEB`>%[I@]]735@68 M^$/7\_R3<%\QHH\?T6-W/,$0PVDDC#"BCQ_1_MB=#'MNO\]1,QN(8TCO`=)# M=S+JN=T3J49TA#>/Y'K@SY95NOA[EN:Y\R%+YU'A?/\G_/+#'7;I<5[LX'+*? ML-K%R',GO=/(Z68\GP">^UA8N,=XMH`XQO,^;D8.^@.W[_'-2!N(8T0_G&[/ M'6,BSO`T8KQ'&!#C2A-Z#-C?HN\,^6R2-W-#R-:P+W#IS<)SIY%(;+"=:XJ+,&^&8B MWTP\#,%VR/S&W,;ZKIW5? M=2==U^>$/ENAP8C>'='=OCL8,*)M((X1O8>D!G<\'KE>_S0J`C"BCQ_1OCOI M]]R)?QH-!H_NMI%<#?S9M@H7(A%9$#M!`BLY6T1)E!E2/*VC,'& M+\<9D=N?M6WG7/B*I75"C]G%WKE\*W9Y_LSBK6&&L7%7[)P+GR_,+E;NBIUS M87:QCEWX6EGK\G'-B\,A^PD=L*.1ZYV(LXKQ?`)X[G7=29<#9#80QWC>SQV< M(0?([(4&(WI'NB?CH3OLG8;&<73A,:YWP7+B6YU\W8';'W"]"QN(8SSO`\^> M.YIP=0`;B&,\[Z,>$>!Y=!IZ'./Y^/'L@UWB/9)\?O[,-D0_(&ARG]CD41@N M)UCO0K^5[RC:?D=Q,G0';:?Q?439P8>$F>6.8EJ6LQP6,)RT%,=BEF.6.]1I M6:Y0YV6]3SGNWZOI>G"2?+<+B$]KH#!+JVG9._!:.)Z M`TX=L8$XQO/#Z>Z/1VYOPNU_;"".\;R/Y+[AJ.>.AQQ$LX$X1O0^$#WP!FYW M>!HR^@AO'LGUP)\MJW_Q?BGPZ\F%L\S2>50XW_^9YOD/=UBEQQV5XTN6AWW) M\OFS`Q)VS##VSN54&(;9Y\MS#IN^/NY"0<5(SGX\=SWYNXW2Z'$&P@CO&\CQ!"WY^X/@?%;(4&(WI' MNL>]B3OPQR>!YR,,B7'-"Y84W^H.JN>[8ZYY82LP&,^[ZG(#QK/%P&`\[VR; M=,$VF3Q!`[;GSQC3C.G'L4X\=S`\#7_HO<,F]XE-'H7APC4O^&:BM3<3OS^) MHA>YW7&+*GJ$#BO&\RG@>>1ZPP'CV0+B&,][2&)P?:_G^EP:WE9H M,*+OD9(Z=L?#TV@K>'1WB^1JX,^6U;3X5"Z7L9#WE9X_1BG>9F).\S1 MXXZ[\35*OD;)MXZ979A=F%ULW!4[Y\+LPNQBY:[8.1=F%^O8Y0BOCEEK>;X6 MRTR$$8W@O/FZ%$G.1B?+.99SK!8PNS"[,+O8MBMVSH79A=G%REVQ9:EMDQ*/#.?GSQC0%@#:&[K^B`%M`W$,YST4 M=NB[?8_A;`-Q#.<]U+GMN]WA:922.L)(&!=19$'QKVXH+AO"/= MDX'K]QG.-A#'<-[#[;#1J+VX!>/9!F`PGG?&L^=Z/I=/Y/*);2O+Y1.Y^(VU MQ6\ZZW.^CP0[^!@P<]M13(NYC;G-0E@RMS&W[6D1GC]C?F-^8WZS^'3C4HKL MO#HP/7& MIX'GH[M9)%<#?[:LF,6K8(GTR#H6LZ@HL[:DP,8OQQUZX_N3?'^2O?G,+LPN MS"XV[HJ=[)26#D6P#)!C).Q=FZ;O#;I_Q;`%QC.>'TSWLNOZ)*!I'%P7C0A8L M)KY5M'S@>B?2@U$RZ+KC'K>AMX$XQO,>C)*! M._"]DX#S`^(D]PE''H7-PI4L^/8AWSZT7+`QMQW%M)C;F-N>&);/GS&_,;\Q MO_'IQMQVFMRV2^2.ZUBP[^HI&7LT<7L^AQ9L(([AS)$RAK.%9#_MK?]^CQ,9 M;"".\;R'R*\_<$>C\4G@N6$%_%@$TU@8OS?B/NH78^3F.U8?;D3!C(7#=^BI MTL(@W=WO=IZF$XHXSI=!"%;8+R^Z\G=EE>'O;-VPO#D(>?/(RVV;R&%(,Z09 MTD]*')R%<'#"!W[K4JX=X:%("I$=2BK+)[$LQ&(J,@<4N?6UV2:9A='X!,1U MOSMV9+X6H0+F\!2!N4O(X2&)>$^ML1]\%'/ONL_S9T^E_7`!$XL$`/.&%60S M9S!G/'&2B-3;;M\B0Q=\M$G>,:8,UW6]EGL3#%.&J6TP;>F,<)(PY=PF5HG8 M56HE:S*D&=(,:5N\_T?@4_V^3()R!L?Z[(<3=*G:CCT6IT]-]\%!^@BK',OU MP)]_LJNUSN<42R:?Y[EHN_:_LR@]7*<`5W$_%%%V\,X)9A=[Y\+LPNQBY:[8 M.9='8)?GSPYM:YAA;-P5.^?"YXMU[,(5K%L6[X1;ZAPR88E\K0]H*NAG2 M%JRQG60_':3';G_@N5[W-&K_,J)/`=&3[L#M]0@CC(?M8_FXR,QIF5Y9XU> MO^OVABT*+_,<\]RA3LMRGO.\B=L?M'0I/DF>VRU4QI4?6%UE/SY[/1G2EM#- MD+9@C1^+[)>'A63/=WN]D3ODMF.,Y`-'1WD8IWF9 MB<\PI]^0^%^?/_M;]7@YS<7_2OC&FRL,154/.2&\!G[Y*.:_O'@E?_YK\O;- M7_Z@\TDL.U@3\\6O>MD.*_ZV::'?I85PQHY<[['O>3\[]?HX=PT=1[OR>9@L8NO/_.T$R)4$21CAN M`1\LY(`9+K5B*?VU!("#,Q&9*-*SNQ&R>=\-1M[$F2;[O@8VSZ,BEP5H-)Y/QCO2L+.*C\%'[.QY&Q99+XO5]@,TNI-"J MF:NUOR7Q>I/1ZOZTO.FAU&PK;:"/5E[/KPG;[J7[)'/+!>P^A,8_DC`302X`./3O M'\GK4OP.2M='$:-V\B$`]1Z4CH>N)>+?V.4M7[M72G=?SKU0*76'?XAX!BHF M;LN#U_)6"M=>MS?JMEP_O]N]/X$`V%"(68Z+_$>>EZ`8`XREM*R.CWTNX%8O MW".%VYX77?K?GNAL:&Z/M7J-ESR0DFTUU-YX,O1&#Z#G3LUG%W)&HT'7;R=F MD]KS42R#&[+XWL\?;9,KY(H6'!W/V"Q6"P6O_SV$M&C)RPDX>R\=WI\ MTCO"+.`A8=/SWI?'Z_[/O=]^_>$_OU#"_AHCB8]4>R;/>[,XGG\8#)Z?GX]? MQH(>)"FU?C[+VYX._OS]YB&8X0CU"9,Q8L$W*MV- MB>[T_?OW@_1_55-)/LB4_H8'*$XEJ.3KR-I"_ZN?-^OKG_JG[_IGI\'*6?_Q`OYOB\)TDTIYKM]+>9P)/S'N-,*/K3TY/W[_ZKJ7]\B%&, M(\SBV\DU84I0@N@=ET3S?$&1E&1"<-@[TE_X] M=\I.)5(QR>>:`41[1\^83&>QLF$'A_!AQD7\B$4T8D]8QNGD<"!F;`X?(+.4 M&1X_0<)C&`0\4=S=XP"K@32F^#../>R`BPP^/FZI,YS^!PFG+VQ,*,7A!6>Q M0$&1=0=,+BKX*#EESD#Z&1)(EPF^5J+>8Z51'-XA$1/LL:@ZR>##Y)8ZP^GT M!!)0VBPSU?="37L',*5F\($H2Y4K'M3R?R?P')'PZF6.F<354\/<'CX4%CES M3$"Y`+?Q#(MOIE5Z.0`.(OCHN"3.(0*U^H^8VC_B1_2"_=9]\\9%!1\?I\RK[28DE)9L_A_3\)J+![51]HUQ&$C@XV.7 M-@>GVAL8K,6^VA4.VXPGZE\RQ7SF+%@JY.HEH(D.W-X)/LE1J"&*K[Q'GX M3"AUX+=JT@68OLGK'9-KMX^Q3\^TT@]MR&/>ZBBP6=_8[11O;E,`F0SKG',O M`TXRP(BXQ=WO8@UV0P`+FJV5XKT"O]G\^=<;@L:$$K]C(4/CIDZ'[]!"1^+\ MSX77"!H=\':EVXZ%U\6%N&3DSO$]?L(L\8#&0M`2:&SB0MS9J6$D$AS6FNQV MFI8`Y!`:XB;M*II3OL`X.[6NA54U;4LP\U#"?M,L;,[8;E,\",OIZ>M=K:YR:T$8]N> M@&.TM8)`YF1!K""$#B(ON+#S-#(?9]5ZH_W;LE` MTQ*D'$)_+YD:>X^H^872&G"1]Q#S`S"B[7ZQ==<(RBDV+')^*1-..NCH5$@- M,7RVYLY[@62G@0Z00UJ(<;/4E[_A;/J8D]$SGJR"%CEFU["`#;"6[<(G'L1=:+BKH0#DE]@^T MO6U9YE\?8A[\->-4Z4SJ1(IXX1@SAL8'7U5X%'&6,E)98&&]::/#VJ[HC:5C M0T2(.YAA&)(E%W>(A".6+7@%YETADVKBEH#EHP:(^YI['"/"<'B%!"-L*H=! MD$1)NC-3RR`)B/M*1B5Q2^#S4<-;4MEV`:8A"VNM+I6D#0;+ZH3S`#A.3M4[ M8F8PEYJ]^"AM0\74TGLA,5FBO11!6YX1[%;O+.OC<*7-L@\>^N:-8DW>"3YQ M+J7%5@>?5XCJJ^UI#N,#%D\D2*L/N":7A:+1&690],9DLDD*T=SIJV6W$WV1 M*;48&;L/RA0X-SM6(NC@N.2MMGC]IIVO9JS+[1P+)9A.B="?OU%:=@5[#*T/ M?A-Q.WO8U,!U*'CCSF%1,H@6Y1-F2ABJ9MK9+-*./9R?,KMFJF4IC^M:U+JRJ&$)6I@ M9`L79_(CGG"!"YEW5R]J95*P$X;$8J24G)X_ZIJCG-)"!JQS;KS>5YN=6R;0 MS57;7DGG,`UH)DAF03XJ5\?M8]LHV@*N0=;=#.5>0F.Z9-,UY<]RQ$(BO&L>U)[JB2B!/BZ^2)V?O'+XAX%RWJL"\S4Z.?2\98>=&P)^:O0H.@!B4!B?1*HU M"LP]=`YVBZ(\"A6`P'G](9E:$&\0=P[=3?5X%#<``6S^Y%SYD:!:\%JZZ!S( M-E7E4$/WS\I/==6">(VT<]"NJR:'%+I/EC^$5W?1+=)U#LR24G(DH3M2&P\: MU=L[;5!W#E6#@C)LSZ`[3UL\:N?50^]WG#XR,V$K0&A#;HI.60K>-NG(,7[>LI7$WO:="EWOINUN([U`D\PS4 M":!!M')Q_7J!JC7:EH)>0SFK1`O8H&95=_,J+7XWJVMUTSFH72K+40=UI&A= ME[9%VT#>.91-*LK1!5S!"&J&Z/+!U!TS1$V='#S+`BU2[3_R8?!WHE1$K7,TSHZ"4S=7@4+LDM1W2Y0(=`KFH(,X= M!UR;M:X<"@%O%$=2)OKAY=O)LDCQJ@BNITVTT[<<5D\E0[B,N`[Z>PT+8?.H0R/Y/L&EL0BPY[3 MSDK2(>R,T\Z5<5\+.LN9QXH![Z3K#G MNDYU>`L``00E#@``!#D!``#M75MSVS86?M^9_0\>]]F1=4G;9)KM*+ZDGG4C MC^WLY0E#D9"$+46H(&E;_?4+4*1,B00(4J!PF/%3704'/!\^$,#Y<`C\\NO+ MTC]YPBPD-/ATVG]W?GJ"`Y=Z))A_.OWV>'WV\^FO__C[WW[Q2?#'U`GQ"2\? MA)].%U&T^MCK/3\_OWN9,O\=9?/>X/Q\V,L*GFY*?GP)R4[IYV%6MM_[S^^W M#^X"+YTS$H21$[BO5J*:,KO^AP\?>LF_\J(A^1@F]K?4=:($0:5?)](2XO_. MLF)GXJ>S_N!LV'_W$GI;OW@9+]H^)E_!^][F'T]%192\MTW-\GS])^/`Q6J_PI].0+%<^SGY;,#R30LR>+SQ_+WS^0=36 M.\`;_C<.1,T(#Q&OK]\P^#32V7 MU(TYO&@<>%=!1*+U33"C;)D,4:+:I\_A3>`1AMWH,/^* MU26N\G&>!`G]M]RO'8_Q2X0#3W2SS:^B1D.O1[)VH>[.XWRQ6J"L=(A(AH>9 M$TZ3,2(.S^:.L^J)ENMA/PJS7Y*V/#OOI\N#']*?T;89.$9\P_\,LZ?XSA3[ MR;.1O#`ZW[25#8\?G>EKKU%YFQ1$_7U6QVS79SY&9[6EPW6M]<^,T:5&$KH3/8IS83`$?71I$O!]>^8D9?XOP7/SQ^N\^[W_> MIU/>_[`]DAY<'#B,T/$+T>I9^?)HT`9EB@6#@L(M+17T[?DO9?'HA*1^?0O" M%7:3J>QR9^591HK,!@W;($:V)E:PLM_:$G(4.+Y7@M!E/DIIC:C=,*M-IK:` M##,68O?=G#[U/$PV9/$_]CGB/Z'-3'V/YX3/Z$X0?76699./K"@:M<)$67C6 M;")2.)ZU>-]*DU]POYGC\[49?ODG7BO;?*\L>M^91B]ZGK7ZX,BM?A$S$4I< MDY!'$O_%#KL*O$L.1=+PLN+HQPZTO<+YK/F'5CK]-?$QN^">S"E3=_F=DNBG M#C1ZN=]9>X^.W-Z/S!':\<-Z.:6^I*5WRJ"?.]#&^QYGK?O>SA!.ETL:/$34 M_>-AX3`<3N)(R.?"1?5XKC!$'SK`@Q:,C)P?CTQ.ID,\\FHE-.2+H/YY!UI\ MW^.L<7\Z<.3:=V2=?*<,ZK>B4!ANWH++6?O^;*GSWF$>+WCJ-4II M6=1O15YHJ3L77,_:_8.E=M^LF39N7?/?RM0=97G4;T=%:*?]2]U_#8RLDB`6 MKOH4;$NC?A=B4H7SV^:7!*:]706_54U?<_?H3=U_4_>[K^Z/PQ!'X7@J5"(W M4I"T6[`=/=_@>"-UV[0"UKSIQ5[E./#$?Z[^C,F3XXMQ:!Q=.(RM>3CQ+\>/ M5:^-EGU+^KX>4<7&+R=)%PD,)AE$P@J@&NI+A5%5F7&(GC M<-ZAL>O2F#MUCUW,^PT?D;_B*)4"58.9PLRJTJQ+3`4`TX)S>Q@A^%E54Q6I<>M?^F]>CF[%S&^)J#O,<^GU&].X=%!(?5KX_*S*IN MK_"J7EK>K9NA3(/#5P,P M+:P?*K/\AGWOFK(''M]JQ"@2$[MBNW:`HO#>N-9^*"^Z9&PQ="%V+[A3._QF3E5`7U,MB0R+WXP87X)?7Q*PW< M39^X>G']6.0M2)U2R,('UHCZD,-X`^"V1-H/\N\Q=XNX/-!-==:"7V*FRJ<<.3L;#V[ MV7?&%S3,^ZJ>'"MM4=^&+-$FI1J`X2CA7RCUGHE?EIBZ7P0-;"@5[3&5QV5" M_#:VP#&WL$$#&TJ&>(UAH));I5H`'TY,(FB.#,2]E6\IVS%KJF_N;YK@$:V!1% M:C6]Y#V3P@*TOM^L>.[Q$PYB#:K*#=#`IE1B@"HY+#A+>=Z=6(R]'%JM-ZO< M!@ULRB5F7BXY,CACX=5RY=,UQFEB0"WR*FW1P&9JA`$2M1"VN;[?=**;(,(, MAU$N>V,MIT?3$@ULIDT<0$X-?'`6Z&(Q%4YF%WP,)QK[E&7%TZFU*X%4ZRD;F2G(8UH:%-*>/0Z:L97CC9-Q?.BD2.?XN= M$$^F/IDGY[]I#)AJ0S2TJ7P8>!&KX0'*T,F64-M<+^UXK6B#AMT70^3(`.7O MU(K02@*68<>5D')(@#)]<@Z^[B?44X>+=FC8<3FD$IV1/"!CWXCL3\YZF04J M.S0$HH5(FE^B.U9!`J,4[X4L6H1);=`0B#92BRPE'#@Z<1*LW-)@_IAYFJYT MJR*W,ALT!"**U&)*"0>.."Q9S6J]6Y6V:`1$)*G%G!8L0)\[OGXN4(I88R=- M9HI&0$23>A.:!BHXJO'..'&)IY$62#,7E$TLGMHLK*%)0N*$@A@@JJQ MYY'-H^\HGY[-**ZPT1B.[YRPWH$L/%)Q@ZQY'O"VP=^6P@`3S<.RZ M\3).XGF^%"(N47\&4V6,1G8/;6[`H!XH.$%8$62M^0N-[![YW("AIZ_';:)=S3+M_NLGJ[ MRZKV;/%VE]7;759'O\OJ@"C5]^FSF,6O*;ND\32:Q7[QN$B-Y)8Z]8"_$ZLI M*CBQ:RZHYDNS"4M0>XE*,X6E!&_GI= MIJL9V[<"?R&7'@8X,6S!SYLPC.NQL[$`?VM7M?]P]OMJWC6E8P;^QB]-$!6; M?):NRTAO!W_3"MZT@N]`*W!\<=YG\H7Q`V9/Q$T.8U6Q56[1F;LRY/Y#6@6' M?*`1!\HDBFKJY0/UU9.US,CJ]1CUY@,%!#A+W2]\F@CO&)TI=])RI3H3..[Z M#&?I^@4'F#D^[Q1C;\F;4.Q)1.0)I^=ZJUA06W8F'*S&`6=).UEAX9SXK$TL ME6YYGU*EKA5+=R;T*_<=3G+:5QK071?3_J*1%U5IVYDP4`<)G(^ M)$&F\8:7/H=!@J<3*ZDT:!J@JAP1G.2V% MV&3TLWO!Q@%L*1'!65R_SJ3B\B)QMQ0)8NYR.M72(/R,9Y3AW%>[5R\<.@=` M`H>MD[E`)(N+6ZFH[^>^KE>^G:T]%?X]V4=J!(#7NJ1OP&>^N%8'#?RRUU&\[!$%EF;+:U^-D)B<81Z!OVTDO6TD=7\C2=Q)QKOV':-/A+\GG]??0G&RSE8@&[L1>=KD MB&M(3[4KZ\SV4R-H@$+I1BLTFPNT9@VNLX`#E,`Z]OX7I[?VB+-;^$CADN2V M[%=W'ZFY][.-QUG=(S/925IJ'#ACP"5>\84+210!_K>/$[(";[RD+")_);\K M.H^.N=WKZ5LBL+R[:#8'F*$F.TVCOH9286GWSOLC]GP_G,PVUU!Q MN,E%5*HI0F%F=>/PN$Q7-`,B,U8-X^4&5G<=CTNMM`'@I,TD M.,7'0B7?@2BH59E9W:L\+L$5S0`GW^8+;SN!?1*(Y,;);.<",]4U5SN]5L$3K(/;P@FSJB[Q)O_YJ"G1Y9HA';ZE=C=USQN=ZC7*I!RB?;]+GX& M6*LS%,WM;H'6)$:7W7*88&*PHL.[]SCS":NDF]XAS+?I+:["[E]L2WU*D<&*S$N0B,_)U<*K'[;ZQW3W@EF@M`PDG M,"OZ*[*M!,B6"3/6U,96V:`!4L)+14E>TRN$TH%A)TI5+'R^[GEF6 MK%RK$G$";8=Y:P;8A,JDS:"YNUU-U(T&0-6F@_ANU@Z0M:@LF24]4Z6>S+AK MBP9`E:A#A^82G)#%J/1NZ>S"';TK;NI4@P9`1:E#B59#ABQ.I1-14ZZ+YF@` M5*0RL,XJ@0I'K-)/9E8G\&M6@@963YHPF]Y?`S.<.5GBMY#B0E/?WB@J0P.; MPI>!CV\JL,$AFB\,TXR7L?MG3!C>24L:!YY.LI=^)6AH]:B+9F25,U\/-)A$ M#^ZEB[&7G,>P241[6%`6B3L1-^V0@%*G:#@9C<+I<9!\>R0DR2?'%Z/('6:$>OM;40K.ZU2#1ETY/*LN*CC3 M9+GG8]Y'&5OS[IC;SSU[-.J*K*,-I_X58#WQP"GO`/Q__@]02P,$%``` M``@`7'YI/RK!R9_L(P``/1D"`!4`'`!N;VYR+3(P,3$P.3(U7VQA8BYX;6Q5 M5`D``[#GNDZPY[I.=7@+``$$)0X```0Y`0``U5UM<^,VDOY^5?3R>[&9WLIML:?R2N-89^RQ/]K925RF*A&Q>*%(A*8^]O_X`\$44"8``17;# M'U+Q2&BHFWR>!M!H-/[V]Z=U1!YIFH5)_-VKD[?O7A$:^TD0QO??O?I\=W'T MEU=___X__^-O41C_MO0R2EC[./ONU4.>;[X]/O[RYA%E"_ZOHZK9$?_HZ.3]T=DD955Z^.OR<3:/>!6W_R35.[*_ZS M717;C_+#7E^%$-,10L,;FH9)M\EN1<-TK@A M":3K)SKLV=9R4,^4>6(Z[)GN)$?4->_J:?T@=T^0CR/\[ROV^WN:T:>>GY>=214%]W_:BY[_'UE])Z.*I3 M*X.+Y[ZOC+>T4(8/KDR2#^TT/OJ\>/5])4:\.""%(&E(DE\JV?_]6_'[XYG# M)AW+I`:[(U;-TWTL>:E?Z<;^[#&K;''L)VPFL\F/]E[8*DW6MN"I5$EL'\FQ M,2^:LXR5ERV%-=5<@_/EF$9Y/?L0##IZ=U+-6LJ/?V6#3TZY5G?>-I"H%B_:NO(*M][PCX9",/O61_9B88W37&P&E3 M50T">#,BVN$#]G"549#;`842O6U$V"(XH_[;^^3Q.*!A`5[V1QNS[*-?"\]^ M2^]#[M#C_).WEGE595,`O&K4;+_Z<@3>M2.\(31:1U<8`JM]8*B0VH.$:7%Z MRIB1>M$EF\$__8,^:X':;@N*U*ZBBC=?-B2B)6%-\<`ZGLZP>%6`H@M8.2*F M0NSI-DW9#UZ$F>]%_Z)>>AX'9\R[*T"K;`Z$6XVZ;1B434G1EO#&;.T3$-X< M`[X3J0Z%XCZ@-('<@Y)IO>]%&-'TE/W:?9+J?>]^2U#/VU92X<-$,U*UPW.Z MHZ@+ZV^E,.AZ6QD&IL+G7>KQ?:3%\WJ9=)YWJ?Q^&R!,MA5KO][R>U(TP(#A M81I"(4_Z@IN8D[W=B>>BR7J=Q(L\\7];/'CL[5QO<[ZUR-703TQU@K"S5+T) MJNF?D")";$8*0=*01)S!@M@#/+LU@)EDJMN/L:G8486-[UBW"A[L-0%"?$LM M92"??X^!X$/T@T*D[-4VL2=YKU.A;,Y^)^"_=1%Y*G>[WP8(9VW%VB^R_I[P M!AA(.TQ#**Q)7W`3;+*W.[5/J],V-`MY>5M@+]=65.E.BH:HR_>Q=8;VAE)0 MR-RB#!%3([:(%!2_?,$^DVU'Z=L#(U>FL!()91BG!(1HCHG@L76'1K(2+#(T MJY`"@V@>^S+'\ZXU"IJ;RO;A080D'4'R.'KCH+@#$#6&V^A`R!:X7EV$L1?[ M(6-4DH4]26%6XA@9!7ISU!OVURM2"Y)*$C$U;#3#$DO#4+(3#$"HS%?H1R`< MJ^991O/,@#^MAH!,Z:C8682)!@Y`OU_3Q>+\;H$)8/G[;D-5^K+A0'GJ90_S M..#_._]]&SYZ$6---L]/O31]#N/[G[UHJ\MG-),'A+"I09TM6"8@TF7%'PW1 M&9GGI)(F0AP+]`?;YO,_Z$YT=$/RQI&(%VS&IG,B!4$VP[']'V=?OW\GAK<_O/]F=L+^7B4IX7`0 M'[(_WLU8/]F&^GGX2*/G-SBA%],JWD5>U)G7SACO!="C?F<38TL);T]*`5)*H(^F`^S@4&0D M*.S8,(GQLYJ-1L&AJJM>P8R((@Z8G#8A19O4!HR`8S6?G\>L[VG& M"X/SIPV-,]H_!LK;`])(I7`;!64[4C9$'^QL]:9%0Z3(SEC:0G)-"^4VZ70X MAF/?=?Y`T]U$.#,*ZFB$`'FH5;T-$]&XL?S*W`CG#+#!D058/W#:@.]%#>1$ MS4_6],Y[HF;A!WE[T*F;7.'N'(ZW(Z+A7NP2&>>6^N?>4P/GN-,G#5*Z\R@U M3`!C"W1%V%L/HMIV+1/L MR)CM9HZK-'Q"J!KF\M10)<:A^6E*2C0F]B'!$<*IU13#/_'+8D!B8H,431I# M4WAJ&?$)BT0W:<*F*OGS#7N0HGCM[]MPPW.3])L?6C'0**Y6_6Z8L6@^(T*@ M*$1&Q%AK#_?-L%AVC`XNIQ8>$UCGSM+#Q*UU0_F]/NV` MDO;E\?R#D0PW7[JE[(=#/Z=!><*BDBQH%]#3)FNKH MXP+]L@B[D#I#E!LLI1`14DWXHX8)#C)I512=8+-EG\OA[DY.\%)<2'XVY8YJ MXZN/.'!NX(UZ6BP&C7&-%]MR.*:EW@2V#F6]D/B53LMSU^4#(+1&[Z9" MKV1'A_7EL8]2*O+\17@B3\B2DI1Z4?AO]L\P%@&+&QY)S$ES[QX(OMJ29\3UCO7+^97;;)WPGZ9/3(^P7WV>2I+N")1$M_3].T+ M"I6.%")%RL?H3<2`S\!0^E_9$XF*GB(-7@'EU>7=YOB#S3V=D<7=]^H\?KZ_.SF\77Y'S__Y\>?^5D,\WI%+0&$2D4=E96%;_7JGK%X?;@]82DUF[AVH-G^SQ!+ZBLC'GD!^-XMGF09A?="BXP9+_8> M`A'/\UI/I`H"\`T=;__I(.Z]&!-P?Z_%E'V0`>:89M>K4_;X0X,R(-+FH(%C MJ;K=('%,^35613OT\=Y&:\8-7[131;]@`[]J='2#O$IHP,'Y)_;CVS6OY/\I MR4TFN@H!0$@K56[#HVA87`BJ?'*UY0?21%MG]C`LU"\4=Q'O?="15N93X^:`ATRW,WDOOJ%5'9%>I::#23V:3? M@071*.:<[F?!6:V0`KZBBJ*]9\%?_RX[3K9<:K7&6RX-I_G>\FDPQR'OE]R$ M/'!&O8Q>[UY@_]C<(PAZHV2/"5U@"P$B)$A#!'VT'FQ*)$Q)FJ8X-'Z;@:Q[ M<9\!PL"W$QLU48VW$R4R\-N)4L75X7M@&-%-XO/1?M1'!H.*[.2$FLO9%,]+W[A@J[ MHQEVR=X2.1PR2@W0\K)Q>LVIO&XS2Y+XOKA+UCW@J[&DX8`22*#WX;57?F:U M4;1RL#?B:0TP"_EIX63))=/7R2VQ@@V=LKKT]V*&32"Z6> M73Y$%HC=%SZIN*N4*6.ZA52? M*,X=8"HSM+<;*4(-V`?PAIC#+P2KH@RHUPB;0DMS+9,.5TBSK3.ZS(WHH9/" MFG%UE)?/N42X2LSAN8`+A!AB1602=(.))DRF/MI<44X#[6Q1R@&4\+E9L!PI M-*X/A#L0\59N[J#3[$`ED0+P!N%V<+(,JBKD1ATAJRH[S<95V:!YGJ?AOCOAVT/%N<*_DI-WLW?O MQ'\D>_#X5I*WS1^2E%=Y_"OY>G9R\N?9-W_\<_5E*,P5)PN3;9[E7E$]U\O) M@@&9KI=L]O7^3S/"P2!:G5&__/0;\>F[-SCCVV'OUX&[E0\UP*&ZS(>:XD[) M9I5SZP2OY)X-,#TT"$(>+_.B&R\,+N,RFM;02^.7#80A$T9-3.EDCM9"A$N1 MRYB4WZZW(T3BCJ]`/];?"]0J#W@AG8$KWSK%"B%12 MY'5#CI2"XT_3C&^"&V!3TX"@:(5U$YRCVELX\"E1Y93_GM90=]RWN-GU:ZI/S[KW%4(9AM]F+ M=&JU@&*_.PN*08ZJ$X(?X*50TD/8X'"=,EKD-!";I#6E&F"NX4`F0GX0!?S(W("B,Z M:5B.,$,%)0TC%#A"9$*10F3#@E("DP&UTB;H=R@ET4S[?=B'TRAOFR-XP(-W MH%A%#^Q[&;N'>42V7N]23&THVQ3#Y.V^^F88:L@XPV`C._9IG$QHQK"DV5%> MB5.+X_&-MU8UP_`^;*BUJ18#:S-:LVI)``]F%II14G0NJD#1WPF M41X2\SV0:<-=CQ?`A!POHEEYF>J"IH^A3[-/5'O832$!F9JC5+J3B\!;[FZ] MK1K/"&N.EI%CK'W9".E0Z>%Z@J9OZ(''0HAARUISEUZL?DB00F\NE)HLD MTB]SE4*@,V:-ZMWY2Y;S2\A$+6BV`N3@OG)M`(AO2?$U%L-,--R(KPD'#DG8 M"JHH#H7#L/'TA628!*1M2G41"L@A&K.G%#$JSX-U&(=\LIN'C_2\N)E=QZL> M24BN]1K104LA(8:[?1E2"J&Q\B!;O'U;:"&$15@(4T"Y;$:6#K^-F`)8/*QP MC/PV*K[4O6+>1\-S66O(8F%293OUJ:I6U1TVKWE#M,-VMDJ'HAE2(;!1=`6M M^J7&;Z?:EQ*\<'3[E,3)OAHE\0V"E_VR@%0T,:1;;G@G4W.S%'OC0'1SB$U% M,;RP-*8V7 M?'Y3H.AR&L]O'-L?HGG2P#]N8%\'E6Y<7X,3>'R7/&O<8J$[&J:30D"Z7'DE M:,KFL[V[2-!.A@TT@HZ]+OQ0:!W3>_[[+U/K.Y,9YKBJ8W@8#5E5;D;-5`=F MGD-FG$[,-&UGF,Y-*R4&%*?EBT%U=+K:K`1'5MJ)";#UQ!&^^1=)^IQ:I],+-`P)^U*V-G!E9%D\V;%R=C.,L7\SC@$^UFM27R=.U MIG1DT$,!T[$5VV1INHF6M_DR:/8<8` M)R*C<#N*"EN=&>Y7X[R(5K2\'. M8I7F^SN4CM6D,]$?<[-RN'Z@JU$93#LK4`E&X9A459ZL#E-_]++0G\?!61AM M<^U)SCY)0+;U&]'&1UU-@K0-#0K6]@!F;#JA@]D\:WC^PGN8,A-X][9S@ZB?^H&Z@JIO9F]?& M7-4#*;NHJATT.L%W$6/;ZI6V=H^5XKL/7%N%:RF:CK\H#1)_RP.`(C`QG>EW M#[2V.MZ*:X+X88/2_I1LXS!7WCF4/W@YX7YWFU%QC8+O13ZO30.=VUX=O6&>#;(P=WD2\7IUZF4/%U'R)3.Z^4XC!EJL6ZM^MT1Q=7CT M>D6X`!$2#F2*#38D,30$MJ1R/ZBZQ95[$04:">!*B.A*0(./SY^9M[J,ZWS/ MN9^'CT5E6(,L2_O.8&,*]J;*9M8"A54WY.,S>7/HBSRM\CA@H%8EL04A@$9 M\L:T_]N6NZ!WR2WECRB,Z%XPY"X9C]J3_!SHK6R3/*[N[5GUS_`@9/U#I!NP M9%^_/$>"\!CSA!>[+1]CO`MLL,_YOWS^##?5,UP^DUT2DU?_%*I;FI*IW?O, M)J,IG&L[HQOVQD.QN&-_1Y3_P4]]K9,T#_\M7?0UGK>1.*#K,32GS8&FV(S4 M@L51RX8HEBL8P:SB?.*4MAC%5R$L@70X-OQI.Q`+\D`ZA!5-4^ZF;/,Z^B1! MW4"?$5V`%1*-)#=W$C[LS=G?P0\JX_`S0"9Z,PX4VC0D3M<)F+`&<*W3<#[7 MJXLP]MBT)K[G)51TV0M:,;X M,G-`9^8&N.K,L/M!!1C3+KG5-RLQMW8:H.&U[7X[@36=>"&(V4]SY%<:**AIE8,D*`] MZJMG==*[F+#8:FG%1X]?;;VL64V]`T?[YACSSG9Y`V:_V%:X8=0%;T,C6I4T&*"5:1ZNN8G(79 M)LG":DHZSS**Q^W!1G$APBP(A#7\W.6*34>?>/+&R`;9I?&#&01:Y,N*39U: M7S94`CU9E%(VPSBCQ?\;@?-3;Q/FV@M-!W0">_[(W#3)D20A1%Y7XF_(9=S8 MQ2J[<&`+ZR`[3Q_8O_@U,'%SGTEP382`H\;=S:^K7WK#ANCR\80QZE:4/7PE M)UCLL(O)S>XU@E:LE(BC\E%JCB$3)5=*ND-`(\/F4UY]:GWL;B(+<)V!FB_] M;D!)%DP'<$N9+PI]]DI%IEV22K:YK5R"48>H3L+09$.WL>NMS+UD:WQ9:HH[ MOF2@_0U#>4:).YYE&GMP_8P-+?L]CP4G,7W1V9;RR@J-0E:VSD?>`ZJW41EE MZ%Z8>%'^I5G0SBEW8FH@MT14%4E+2S;CEN8[U(V,:P>N^]`RJ=]?Z&B$&DG@ M1450WT3'#T#V4UC1FOV8;%6C*H9)ZWP!#1C>$W&%SGR7% MM^,7WC>M5XBM[J$N9Z#"N(Y&PL]^+],E)^I^J-BH_I%&P462\KP*N^W0CC3N M;JC$&-/-T&+#GLL>,>$C+NV.]S$QK+3@@342IVFR42TX>#=T)`N0=T-5;#'8 M#%50!7=^41=N'I@/(>\!>4A.B?3(T8U`WL:H*&1 MR81`S2$GTABO=AELAZ4RRCIR(YU1;J)U2F.C&[?3&FWM#6I[W4U7U,#4(F51 MC5$7TA9OO.?!.8N5K!,)BSM#;+,52TEW2-5O4JW[9B+=!T8)#M?3$%BO, M,Q/W*7%`*6#I3Z1;?EZ^N/"DYS+*`9U`E0&V-%OV<5'%BY?277,>\C-*R3(*[\L[OO*$+"D1.PSLS^(G=@^2C.US>>'QOT()3N MK>JW2F(4M?[V4AA)W?O.ZY7]D_(''/%[HSP9_A!$I3X'?>`H!@YTC<+OW=^G M(G*B\("T1DK;D;X`CSC!37)NZQRY=@R2'B6`@L]U9E?%ED0MQ&&L8LUJKO!3W]6 MF6>5"+WKI!EN=(=35I86)D5)?'_$W/>Z>5C:+:;UP],PYUB'3>0((U^$#.6= M1!P[SM@UQS(TX22]C`PK:.65=FA(A1AY'-$*]"BD@CE&@4@Y;5R\[D/C$"PZ M4J/R*-?O0O0M/@LS&NDQ(UQF^ MM]&;:NEUZL[#%&V>5'`IL%6@/6VI%T*L+:>A'0PLX^I4'& MJT<452D7#TF:W]%T73ASH;C.0YIU`%OLVCB5W)G.3Z-=_!EHI@H3YEMIZR(O&V*>F7EXM@[2TZW.2^PL[1[R\C0%U&D"OF\=8RXVG M/=:"QVB0ZH,]#FD-!RFE"!)E>]S\/F.=&*0LM&\"7CM$8;!U+-VQN&HRO/:@ M_8`#[G7/C/S%=8-7/+?^NCY-*^&@H2#4T703$Y1\%.-F>96F$",[.93CY$.L MN4G#V`\WS(1-`^U^:58DS&J63CP([G&S^8O;/WIK[1Q>WJ4;:IW=R> M'F=;VOV]:%WJ2)DY0E:U98ZFQ$QHEYM[ZX?OJ8-[%:[7/!:W1/(DXD9J3H@TA.4&-YEP-MY3RLB_F$ M<<%);KOX@^YZQ/$Q6-9!>IHA9&S[F@%,A/,VU^F]%X?_%A.H4S8I3*(P$/]@ M&M\49?'$/Z]7I6_TH@7[A(KII4$6WCC]`_JGL1Y(IW)`H]\9V>M9H+[9-U\_ MU[V37?<.).\Y\7@2Z\<#Z3-&I53;F8S)IQ?B9<["S(^2;)M2UGH1WL?A*O3Y M*:NB8BZ;K=VP_GPV5[NC3_E'9L9O4SFD(:J\%-\U[#%/XN9VJ@B9AC)DIPVI MU"&_<(6(T.AE^D6$1Z]RH2,^^A?C! MTGN'"3UB`&.-R7H=%L>+>80B$8,,C?D08^7D[?J!C#9:&M@)-^[DBZACLP>W MQ@H'3`6-S`V!;B. MIXN<_>I#$@4TS7B$/W_FZ60&PV:/("`/>TUH([$I0`H)D8'IP$!XD"U?&1H# M22(S?+5)8P0N;)+8C6/F?:!3Q\R?*UGDV,`UEHU?#3$2GVH60Y4M1.$(>.ZE M,1LV^<;SXL$S6M8I10#II5&[C;2J*<\$(:*Q`Z/15/I#LJ(/.FT2].`&#_,F M@XQ:!A'U.@'')&5'*P;(@1[U MVQCBS8EHWYA8N)`R,[4=D&PP@52;$`9XPN6$R:B@ET-FA(@W&C64,HB8U[K2+FI< M&!8FLP`3^?U^OP<]D%MZ9>;RPJ>QEX;)_"G4'767MP?=JI,KW-VR*MO-2-62 M^4G6%G$#;FS-87?5-$#I[J"I40*([?+'/\?9AOKA*J3!6;+V0EGIGGX92(QK M%.^@I6P[(XW6Y)>B/1[6)[,`%/-]`.K@7H^>PI0K)OD]^YO];^EEE'WQ_U!+ M`P04````"`!Z3K#GNDYU>`L``00E#@``!#D!``#M75ESXS82?M^J_0\N MY]FCT9'#4YFD-#X2UWK&*MN3W7U"020D84,1&H#TD5^_`$E)%$6`X"&!1/R4 M62T;[J^[G)\AWB(O]^0H1/^O<\^GBZ"8/6AUWM^?G[W,J7>.T+GO<'[]\/>^L/3^,L/ M+PSO?/T\7'_;[_WG\^V#LT!+>(9]%D#?V5*)8?+H^N?GY[WH_^6?,OR!1?2W MQ(%!A*"0KQ/I%^)_G:T_.Q,_G?4'9\/^NQ?FG@H94.*A>S0[B?[\A^!UA3Z> M,KQ<>8+MZ+<%1;./IS[Q*:?O]]^?#[X7U-]=$B=<(C\8^^Z5'^#@]<:?$;J, M>#X]$>-^O;_987[N(9\2AH1@:$3+WCEDV1/?]I3#]>JQ^A#``(G![V;7V.JGA:T*Y1-,JTHW(:O[I"[)]P;I"9;5Y#Z'".;(/JPX,M# M!:;VAJC)TC7$]`_HA>@S@BRDT?RKHLS\<>JJ$A; MR$>[>JHHH+TA2K&4=P3Q*(V']M&(Z>3G6SA%DKTL?9HY MWQDK)NK]^9=&@!M1&$F?GSWG"<2.T:,46OP#5X.,IYP:*@VH\D"?P1L,#;5KP M/E[%M7A,)!))>P;9-!)YR,[F$*YZ@O<>\@*V_B5"<_:^GWB3WR4_@\TA^1%. MMV:18C[_0]"/.4UKHRO'=<@PF8KSY;(2<*05R2)<2^2HLR&C!LAR:S M&I(H5`&CXTI="X)O;^B&_U-K3FX^!J-VJ%%W0J897RNN;U)S##GOYN2IYR(< M*XW_(ZLK_A.(-Y![-,=BW_"#+W"9MPG*/@7?MT-/._+?U96"=>D4.X;,+SC; M%'HW_*CW\B_TJA1ZYEOP0X>DOL^[?((<5NX7(17PKC%SH/=?!"GW<2\Y%(GH M99^#'SLA?07[:P4,C!C^-?80O>"NZ@A#T MWW="%7I(U@KZ_L@*6OO*CWQ8B2K2GX"^&;^^K-"S/*_%^\.1Q3OF3+B"D6L/ MRDQ]YQO0;XFK72#@/:;7$O[1D`%OHO**$TONMZ#?$I=8TZ3WF%]+_B=#DH]/ M4#%;U_RW/$]6^3WHM\2;U=1`+H"U%LZ-:D&<8_5UL/D:]+OAIRK8WSI-^0KH M97,*6;@-YQDT:XE,A9URN%(D*,J0O^4HRAJ]6IA_LS1%Q7AH2TY-Y>.A7<]. MC!E#`=-8.W8_;$L>8D<1^4K;8[PIA3TA.B7;=/QQ]28J'D45'/^/J#5[@I[8 MO\;!!:3TE3NE46V50IU:](;3%/N:R]>P+A8K%/^P(#1X1'1YXS\A%B3U=_*U M-N=SPUD-7;5*6&\L_V14C4F=+[M'#N(6R[>=+RA(8MJJ55A!9CAMHJO6`@CR MX'V7U/O5GV+/0U&5LA!'"JU"NPHJPUD97>6J$NBLQP\D=7NP40Y%F*+JE7[#8^'_N5+TL*=:8_,YQ5TE5?AF5YSJ)+ MZII0M(+8O7I9(9^AXFF8^[WI9)2N!J7,RQ,D7=+E7;!`=+MC,*TCD9S(=+9+ M5ZMJ!/+,3)=4&]\@?(0O2.\HE/N]Z>R:_D(K85Z>Z^F2+B\33CG`6"):\U1! M93J'IWW^44.0YY"ZI-T8V>_(QIXJ(S&=&=1V217\*Q)3);4:I"]$ MF="IKB(WZ+L1)]IC>J.R;H>()I2L$`U>)QZ,+\-\"_%*1,'4CHF*#/2[$2,J MPK#1L*DHD>0"6;(K$-^)K?'JQ?%"42,F!51TK:SZB*#?[I!1`_`V9M#M@-(] MXI"P$R`WR62D`MY;T2BFO-X`H&\FRM2$HO.7"7W<5J1^+M%*U!>PK"R5A^Y\ M$M`W$[(ZG"VHD-J1,EI['W&U";H@+(U3?2@HI`4#,Q&P0QJ$!F0[LDV_$>(^ M8R_O!D3V$S`P>+/[('I.(VLLP53)5VOL4-C<81`,S$3,FE=W#0$TEIW<8CC%'A;I4/&A\`C`P&Y!K M0-%R8-9,:1IR1K>2TIK5^31@8#8HU\S$EF.SPY^Z6JX\\HI04NA42O6%M&!@ MMMBK`1/0PFBZV$_FC<7F>^,'B,L_2-6ROSIU1`]DMW"\DUP;[T?%:JVXDA@ M:#9H5G?;KH;8CEK$"[C"(NR'($-W4P_/(^5I+/5J0C`T&V5K8!$H!FA)O>+Z MT+JIN=7VS_=IP-"&P)LK5.*CHP;$W43:(\272]")05V92,>ZJE;BD-&+8F M"E=*U4I`=N12(L?TEOCSQS7*Q"\I\M/S:,"H->&W4GI6`K(C@2+Q/;3F=2$M M&+4F'%=*[UK`3&=-&K\AF"LMC3RYC!2,6A.>*[>1:^"R([.RL[Z)-I):>E=0 M@5%KXG/5%_I]2(WE6-KABNMY9F#4^J/.A]'4X)JK M6C5[3ML^:U_X8&#F4S`RW:5%J1_)$2P'A!4.]-AU<K#L<*SO40"QC]QUN^>QXX3+,(H:\8,G=K#Z^F@1,1B9[DY3 M0?]ZL!ISN%NU>Y?:M<'(=%><"MK-AV'V`MAQ+I/H';1S2<'WK0F9-7#ZED+< MK.F-NU;';D/P"7KB\NK#`J%@$HEX@0+L<"!U"VZD(Q>]2%%(^-9!0.=RI(X8 MI4N?G;T#WEH<=U6#;RV.WUHZ-I=#8T=D:*]S MZ3@,%H3BO[8NB5K?6:H.](?60V%)J446XPUC83G=QA0=:$!=C,".\HF2#9=U MR#K0^%H3Q@&+)`PVF8S+]8_=3S+^JQLV-'*^$HJWF(_F1)#+[V\6[*GH578L MS'-K3:-(\2PZ2]YX>4#T"3M1HPJ5]O(IVA+?N2U^OTJ.P!*7D/&=1[R?&*52 M$H`/Q%.?'F5$;8GX:"A6":(QO\]@#O$W?N9@$TIFRL1_ZJOVA6^DRMOEV@XO M[C?D(PH];HQC=XE]+$X%`7Y"2:M@L>,UH?53 M&GR!BBK[$Y==Y2OG$1B.Q&CI*U_54CQ6G(;7Z!)QI!\_T]!Q#I7III(-:%J" MJOX)^3Q6N(_F8N!'<]NQ5$A5EF_3#2=K:%R)R88:V>T11+0P%OVIL1]RL,D9 MA?CL$YH1BE+OIER]<*%QZ-B']#7:!L4%+M'9FGA>ZFVEPG#I0?ZJZ6:890X) M!Q:#'6_8;<`G,^\3]X?4_KN$PG0[S?*6D0NA_DMU[=EE4*#E[NU\9[I[9BDO M(,MX8Z_+&=PRUA='UC4AGR###C_\7F(O#)0I]@)*TYTURVA6`TIC[\@UV77G MWPC/%YS!,5_3X1SM99*+E5EE&-,--G4T6Q77X=Z.,YAW%XT#KSWRS&XX;(J< MX-@I^#Q>M.Y>R\G>DO%E9TN^$-\R\F\9^18K3C2?YU8[H>0)\Z7PT^M7)I[] MW`3=QTZ`G^*+ M$AK@OZ+?%::G0VZXPN%0ZL\W-DV!6+',K5_,*Q\7+:`T7$%Q;(LIDH4=*TUZ M!MS-XJ;?7%11VV_5YJ8@,UR%<5P[*1"$'65VZP@FA"[`O)W?GB M5L#=;*?C_*;=O*I05VL`TR4DQ[4=?9G4+R'<308;2_%3\?SW)8K_FQ);\CJA MWA4\S4%,EX@( M2P@[G*,HST5HS@0K928Z`YJN7SF0X>A";[I(MBVV=!DB4<2WVY.HE/'DCF"Z M)N9`UB+%6M^A;J=Y1#<#MHMJ.3!K.]-M],>1+&O$%`*KOK: MN.X0H&\VC'L@VY"#K>](M]-")A2M(':+[UT4D8*^V8#M@2QB'Z2MSO"-_\3% M3&C9`T6*#O3-QF8/9`,9A/6=UW8:P)@Q%+#?D>?R<[4("97S7;/48&`V$'LH MUS4/9].W)=IB$JDK015#&KDC@('Q=Z`.LTY(L-:_C]%.\]A(+=T7H%8,-6<@ M,#`;1SV4&U(`N;%['2T-D1;WGBVD!8/6!D=E2BT;($TA-5Q6)+GID\LZ#44> M(;XB6G"5O_P@HCU)I[5>#;+I0B%M_>]2J"VX54C"6(1+F9-W0%5#`:&9@.L#5P"+4!GVN=IJ,@9OB95>&/G M6X@IVBFT'/NN3@&K_B!@:/@=M&JJSK>;4S26S M)DXIBL'`L%,/J55`9T=0[1ZMDKWV;G9!^'2@`9YZW.F;JNQ!006&K7QFH$B9 M^991@-.Z@X?HZ2::=-[-/B,7ATNQDWXA@7)'T:('0[/AU4:M0ANQ)8Y,"JY8 M3<5Y_NM)?2@&$K(Y[U3P5[*.VH&$]#U)SV,A(P,MR2X5"JSX(T72$N*=78L"P> MW(P*UVY%.N=NZN&Y["D./4(P:F7(L9QF]:$V70!N]FUT35@UR\1-Q]*$G#'?G3U5L3=GZ`G%L`)HIBXV2RQPE[*#`-&W7GIM"PN&SKJ MY6,>\YE!Z2N?!']`3UF/I44/1MV)(6H#:JR09A49&.>1!E;;0'?:-F@#:JQD M)K:!*S]]5CSVP_YW=`[]Y!$[T=@7SWT\PX[(T\;5[!SYA'C8$:>)8S?^3/%V M07S&V7#7C$Y2(MD\O@>]C<)U\B*-C&^@=4`MOB\QL3A_'G MH418@17#[0^:LAC)$F1`FH>[H'+LE2Q*>AW]P=UID))[\9*33V!@#=EE1&>J M2R@,STBI0"533(["GIEP099+'%?/B`--U#MPCGP36[B"E5+SIM0X!J:3%G\Z MLZS<0(8G7UFMR$[>93';,U4?`HYH03P.APFO(W@]?C>M+`693LR'GN.9?^^QNR2D1B85UE6=.:1E,;P MO%&(53)C5$CLF2'7$-,HP/490;$.Q.7J1S:T#1/;]4@GC*,B,S!=\MC1F3)* M.L/3ID#$DJE3A,B>Z?.`YN*72QC`HY_?XC]]CU:B&XD_USFY24A,G-DRK)0\ MK153FSZGR44M.Z%I8;)HZH13AKZ%_,>K)Q.;3O;OZ\P?"8F)^9-A16O6R&A, MSQ6Y6&5S18'DR#.D)QB<0H;X__@_4$L#!!0````(`%Q^:3^_1/VKL@8```$N M```1`!P`;F]N'ZLAE(;"-VUP[#4-`2;1.E M2(6DDGB_?H>49,L6K%#+MDCF.FKQOW,69T3DG0 M0&",J^O&4NOHTO,>'Q]/'L]/A%QX9Z>G+>_+[@W(*[_Q$N%:E978_7(#AO-&:8DRY4IC[F^"*`2=IMBZN+CP MK#13Y62!-0GV&K_PI&#$2]4R5*R:"XRC-6J.U/!2H<.;'TL) M)R!Q`"29[YUH;SV0;D8ADL1_9F)BZ=NY.<>^;I*GB&&.M9"K/OQ>,REN4,FZ9:$K?-O5YD&/:ZI7`[`K0^NG@2B,7ZG&.H*`S"FG-CHHPZB),IAI MCCJ?;GO#*6H/NPC^#Z9_H<&P/[J[;4\'H^&5MVLA,QHK$HSX>]N&":7`G'5K M:FN*2E5XGD(U=ZD;S/N6P`%#,QD+9D#L,*Y6N M>&84*NJZQ^,,!F%M`-J=T7`RNAETV]->%WULW[2'G1Z:_-'K32='.Q@?,3-+ M\&1)B!YC6%[TDF@*823\[Q>[*3^O3CGZ>\O@/T<[!+DY/H#]84@*4S_M=E/^ M:QGEDRG\,T5H@D9]-!KW[FSM.=[YGF.U@]6RS\2C&O"`PKJM"[P7-=Q#\*;Z M$'3:DS]0_V;T^7B'8"07F--_K4=872=TP:&*^QC66M]NC>$%:2P8]:G93YLA M.0CA'J*W9D&FRF="Q9+`C[Q-A'F`[7AUR2Q]-&S+S>]ON_P: MW>/EK"/"D&K;"1.V(^Q<@G>W]90N4W`S_&Z7X9P).X&WC!PO]1,M_&]+P0(B M5>\^AIU[5M<+_6ZB+W:)SB-_00GV>/GM8EB MC=/:D.MPDWI6*`H)!!G,$3,9SQ2YCZ&S]["9K85>-Z?G!4[7.)0`7SNQYH\Y M9K\C092K&XQ^J&P8GAV:#4`(^^$2 M@7E]:"([C\++IN-E1[S0VAS\@@`R$5(C[CR!WG>ME-RLW0C?FBF!F%_-#-_%^\4J[C>HI%DC@-W[RBKN,XQIU'&]>XM9R7<&LJW#O#]W^5ZE M&#$IMU"F(EV8(MAZ6R>"BJ4PYUW7]5Q^OULUFKR5WL;(8<&5?@E0959D&-.H M,2>*]\E5:-A%U1@8]YWY84$(/BR)(_UZQP92?GGNL!I;*2_2Q%'F1,*YB$[5$BOK131:BAXLD[`!/59;+YK&B?[NM68X22; M^YA&-K-BTG6,O&8J:E&PG7HHH%YAN7(E/\=,.;-/MKDZ$\V2&UY@A$'LJ;4:Q=H0:L;L M(X8-'#RU76=)J:#[_3*N M4P.]9%<)>\+_`%!+`0(>`Q0````(`%Q^:3^/GTAWZU(``,WS!``1`!@````` M``$```"D@0````!N;VYR+3(P,3$P.3(U+GAM;%54!0`#L.>Z3G5X"P`!!"4. M```$.0$``%!+`0(>`Q0````(`%Q^:3]9F$4P=0H``$^F```5`!@```````$` M``"D@393``!N;VYR+3(P,3$P.3(U7V-A;"YX;6Q55`4``[#GNDYU>`L``00E M#@``!#D!``!02P$"'@,4````"`!&UL550%``.PY[I.=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`7'YI/RK!R9_L(P``/1D"`!4`&``````` M`0```*2!,&X``&YO;G(M,C`Q,3`Y,C5?;&%B+GAM;%54!0`#L.>Z3G5X"P`! M!"4.```$.0$``%!+`0(>`Q0````(`%Q^:3\5+J.1'A,``,$S`0`5`!@````` M``$```"D@6N2``!N;VYR+3(P,3$P.3(U7W!R92YX;6Q55`4``[#GNDYU>`L` M`00E#@``!#D!``!02P$"'@,4````"`!`L``00E >#@``!#D!``!02P4&``````8`!@`:`@``U:P````` ` end XML 26 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONSOLIDATED BALANCE SHEETS (USD $)
Sep. 25, 2011
Dec. 26, 2010
ASSETS  
Cash and cash equivalents$ 15,653$ 1,669,868
Short-term investments12,30512,305
Accounts receivable (net of allowances of $24,320 and $26,120 for 2011 and 2010, respectively)5,336,7014,376,929
Unbilled contract receivables237,575370,887
Due from related party42,85842,858
Supply inventory70,78560,271
Prepaid expenses210,00997,450
Other receivables37,71458,464
Income tax receivable0161,356
Deferred tax asset484,167474,235
Assets held for sale1,047,3671,045,367
Total current assets7,495,1348,369,990
Property, plant and equipment, net1,510,1651,557,088
Other assets  
Restricted cash451,000450,000
Deposits53,06553,065
Deferred financing costs87,346104,499
Goodwill2,740,9132,740,913
Total other assets3,332,3243,348,477
TOTAL ASSETS12,337,62313,275,555
LIABILITIES AND STOCKHOLDERS' EQUITY  
Accounts payable1,181,159653,130
Deferred revenue426,8350
Accrued expenses296,229363,327
Accrued employee-related costs1,724,1501,972,581
Accrued interest, related party5,25448,750
Line of credit payable696,5700
Term note payable, current portion142,8570
Notes payable, current portion52,57813,978
Due to related party22,2868,002
Capital lease obligations, current portion11,61210,752
Income taxes payable351,97918,130
Total current liabilities4,911,5093,088,650
Long-term liabilities  
Convertible debentures due to related parties04,875,000
Term note payable, net of current portion857,1430
Notes payable, net of current portion36,99813,634
Capital lease obligations, net of current portion29,70738,527
Deferred tax liability394,599427,198
Other long-term liabilities27,025134,552
Total liabilities6,256,9818,577,561
Stockholders' equity  
Common stock ($0.01 par value; 10,000,000 shares authorized; 3,117,647 shares issued and outstanding at September 25, 2011 and December 26, 2010)31,17631,176
Additional paid-in-capital8,001,3387,972,098
Accumulated deficit(1,951,872)(3,305,280)
Total stockholders' equity6,080,6424,697,994
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$ 12,337,623$ 13,275,555
XML 27 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.15 Html 8 114 1 false 0 0 false 3 true false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.glenroseinstruments.com/role/DocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION false false R2.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.glenroseinstruments.com/role/StatementOfFinancialPositionClassified CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.glenroseinstruments.com/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.glenroseinstruments.com/role/StatementOfIncome CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.glenroseinstruments.com/role/StatementOfCashFlowsIndirect CONSOLIDATED STATEMENTS OF CASH FLOWS false false R6.htm 006 - Disclosure - Organization and Significant Accounting Policies: Sheet http://www.glenroseinstruments.com/role/OrganizationAndSignificantAccountingPolicies Organization and Significant Accounting Policies: false false R7.htm 007 - Disclosure - Debt: Sheet http://www.glenroseinstruments.com/role/Debt Debt: false false R8.htm 008 - Disclosure - Commitments and Contingencies: Sheet http://www.glenroseinstruments.com/role/CommitmentsAndContingencies Commitments and Contingencies: false false R9.htm 009 - Disclosure - Stockholders' Equity: Sheet http://www.glenroseinstruments.com/role/StockholdersEquity Stockholders' Equity: false false R10.htm 010 - Disclosure - Earnings per Share: Sheet http://www.glenroseinstruments.com/role/EarningsPerShare Earnings per Share: false false R11.htm 011 - Disclosure - Fair Value Measurements: Sheet http://www.glenroseinstruments.com/role/FairValueMeasurements Fair Value Measurements: false false R12.htm 012 - Disclosure - Segment Data: Sheet http://www.glenroseinstruments.com/role/SegmentData Segment Data: false false R13.htm 013 - Disclosure - Subsequent Events: Sheet http://www.glenroseinstruments.com/role/SubsequentEvents Subsequent Events: false false All Reports Book All Reports Process Flow-Through: 002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 26, 2010' Process Flow-Through: Removing column 'Dec. 27, 2009' Process Flow-Through: 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS nonr-20110925.xml nonr-20110925.xsd nonr-20110925_cal.xml nonr-20110925_def.xml nonr-20110925_lab.xml nonr-20110925_pre.xml true true EXCEL 28 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\S-#,U,C=D,%]B,#)C7S1E83E?.68T9E]E9F)F M9#,V,39C,&(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=OF%T M:6]N7V%N9%]3:6=N:69I8V%N=%]!/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D5A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9A:7)?5F%L=65?365A#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I3 M='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S-#,U,C=D,%]B,#)C M7S1E83E?.68T9E]E9F)F9#,V,39C,&(-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,S0S-3(W9#!?8C`R8U\T96$Y7SEF-&9?969B9F0S-C$V8S!B M+U=O'0O M:'1M;#L@8VAA"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA2!& M:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M4VUA;&QE3QS<&%N/CPO6UB;VP\+W1D M/@T*("`@("`@("`\=&0@8VQA2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^9F%L'0^4V5P(#(U+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E6%B;&4L(&YE="!O9B!C=7)R96YT M('!O3PO=&0^#0H@("`@("`@(#QT9"!C M;&%SF5D.R`S+#$Q M-RPV-#<@3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\S-#,U,C=D,%]B,#)C7S1E83E?.68T9E]E9F)F9#,V M,39C,&(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S0S-3(W9#!? M8C`R8U\T96$Y7SEF-&9?969B9F0S-C$V8S!B+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.#4L,S@X*3QS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S-#,U,C=D,%]B M,#)C7S1E83E?.68T9E]E9F)F9#,V,39C,&(-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,S0S-3(W9#!?8C`R8U\T96$Y7SEF-&9?969B9F0S-C$V M8S!B+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$&5S/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M/B@T,BPU,S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%SF%T:6]N(&]F(&1E9F5R M3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S"!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ-C$L,S4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!O<&5R871I M;F<@86-T:79I=&EE6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\S-#,U,C=D,%]B,#)C7S1E83E?.68T9E]E9F)F9#,V,39C,&(-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S0S-3(W9#!?8C`R8U\T96$Y M7SEF-&9?969B9F0S-C$V8S!B+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO M8VL[(&UA3H@8FQO8VL[)SXF(S$V,#L\ M+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!T:&4@1VQE M;E)O2!W87,@;W)G86YI>F5D('1O('-E2!T:&4@1VQE;E)O2!T:&4@1VQE;E)O&-H86YG960@9F]R(#,L,#`P+#`P,"!S:&%R97,@;V8@8V]M;6]N M('-T;V-K(&]F($=L96Y2;W-E($EN2P@86YD('1H92!C;VUP86YY(&]W;F5D(&%L;"!O9B!T:&4@;W5T3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY';&5N4F]S92!);G-TF%R9&]U&5D M('=A2P@96YV:7)O;FUE;G1A M;"P@71I8V%L M($-O6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY);B!-87)C:"`R,#$Q M('1H92!C;VUP86YY(')E=&%I;F5D('1H92!S97)V:6-E'1E6UO;F0@2F%M97,@)F%M<#L@07-S;V-I871E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\ M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,S9P=#L@ M9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY! M71I8V%L($QA8F]R871O2!T;R!T:&4@9F5D97)A;"!G;W9E71I8V%L($QA8F]R871O2!I;G-T3H@8FQO8VL[(&UA6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O M;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY03H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX] M,T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE28C.#(Q-SMS($9O3H@8FQO8VL[(&UA6QE/3-$)V1I3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY& M:7-C86P@665A3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD M:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE2!O9B!E86-H(&-A;&5N9&%R('EE87(N($5A8V@@<75A6QE/3-$)W=I9'1H.B`Q,#`E M.R<@:60],T1G;&9T3H@ M8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6EN9R!A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY#;VYC96YT6QE/3-$ M)V1I2!S=6)J96-T('1H92!C;VUP86YY('1O(&-O;F-E M;G1R871I;VYS(&]F(&-R961I="!R:7-K+"!C;VYS:7-T(&]F(&AI9VAL>2!L M:7%U:60@8V%S:"!E<75I=F%L96YT6QE/3-$)V1I M2!D;V5S(&YO="!R M97%U:7)E(&-O;&QA=&5R86PN(%1H92!C;VUP86YY('!R;W9I9&5S(&9O&EM871E;'D@-S,E(&%N9"`W,"4@;V8@2X@5&AE(&]T:&5R(&-U&EM871E;'D@.24@86YD(#0E(&]F(')E M=F5N=64@86YD(#(P)2!A;F0@-24@;V8@=')A9&4@86-C;W5N=',@2X\+V9O;G0^/"]D M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE.B!I=&%L:6,[(&1I3H@8FQO8VL[)SXF(S$V,#L\+V1I M=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE28C.#(Q-SMS(&-U2P@;W(@=&AE($1#04$L(&]R($QO2!R96-O2!T:&4@3&]S($%L86UO2!B92!S M=6)J96-T('1O(&%D:G5S=&UE;G0@9'5R:6YG('-U8G-E<75E;G0@875D:71S M(&1U65A6QE/3-$)V1I2!I;B!T:')E92!T>7!E6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY#;W-T(%)E:6UB=7)S86)L92!#;VYT2!N;W0@:&%V92!B965N(&)I;&QE9"P@87)E(&%L M;&]C871E9"!W:71H(&]P97)A=&EO;F%L(&9R:6YG92P@;W9E3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY&:7AE9"U0'!E;F1E9"!B96%R&-E960@=&AE(&-O;G1R86-T(&%M;W5N="P@=&AE(&5X M8V5S2!R96-O9VYI>F5D(&%S(&$@;&]S2!W:&5N(&-O2!R97-U;'0@:6X@F5D(&EN('1H92!P97)I M;V0@:6X@=VAI8V@@=&AE(')E=FES:6]N6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY$:7)E8W0@8V]S=',@;V8@8V]N=')A8W1S M(&EN8VQU9&4@9&ER96-T(&QA8F]R+"!S=6)C;VYT2!I&5M<'0@9G)O;2!F961EF4@6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O M;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T M>6QE.B!I=&%L:6,[(&1I2!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI M9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$ M)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4 M:&4@8V]M<&%N>2!U"!A"!R871E&%B M;&4@:6YC;VUE(&EN('1H92!C=7)R96YT(&%N9"!P&%B;&4@:6YC;VUE M+B!!9&1I=&EO;F%L;'DL(&UA;F%G96UE;G0@:7,@"!L M:6%B:6QI=&EE2X@5&AE"!P3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@8V]M M<&%N>2!C;VUP=71E2!T:&4@=V5I9VAT M960@879E&5R8VES92!P6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I'!E;G-E(&EN('1H92!S=&%T96UE;G0@;V8@;W!E2!R96-O9VYI>F5S(&-O;7!E;G-A=&EO;B!O M;B!A('-T2!V M97-T:6YG('!O65A&5R8VES960@=&AE(&-O;7!A;GD@;F]R;6%L;'D@:7-S=65S(&YE M=R!S:&%R97,N/"]F;VYT/CPO9&EV/@T*/&1I=CXF(S$V,#L\+V1I=CX-"CQD M:78@6QE/3-$)W=I9'1H.B`Q,#`E.R<@:60],T1A.60T8V4Y,S6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@8F]L9#LG/CPO9F]N M=#X\+V1I=CX-"CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA6%B;&4@86YD(&YO=&5S('!A>6%B;&4N)B,Q-C`[ M5&AE(')E8V]R9&5D('9A;'5E&EM871E(&9A:7(@=F%L=64@8F%S960@;VX@=&AE:7(@6%B;&4@:7,@97-T:6UA=&5D(&%T M(&ET6EN9R!V86QU92!B87-E9"!O;B!C=7)R96YT(')A=&5S+B8C M,38P.U1H92!C87)R>6EN9R!V86QU92!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS M(&QI;F4@;V8@8W)E9&ET(&%N9"!T97)M(&QO86X@87!P6QE/3-$)V1I6QE/3-$)V1I2!N;W0@8F4@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY4:&4@8V]M<&%N>2!O=VYS('!R;W!E2!E;G1E M65R('1O('-E;&P@=&AE('!R;W!E2!S=6)M:71T960@82!D971A:6QE M9"!S:71E(&%S2P@=VAI8V@@=V%S('-H:7!P960@9'5R:6YG('1H M92!Q=6%R=&5R+B!4:&4@8V]M<&%N>2!I2!B96QI979E2!B92!N965D960N(%1H92!C;VUP86YY(&5X<&5C=',@=&\@ M8V]M<&QE=&4@=&AE('-A;&4@:6X@,C`Q,2X\+V9O;G0^/"]D:78^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S-#,U,C=D,%]B M,#)C7S1E83E?.68T9E]E9F)F9#,V,39C,&(-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,S0S-3(W9#!?8C`R8U\T96$Y7SEF-&9?969B9F0S-C$V M8S!B+U=O'0O:'1M;#L@8VAA'0^/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F]T92`R M("8C.#(Q,3L@1&5B=#H\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY/;B!*=6QY(#(U+"`R,#`X+"!T:&4@8V]M<&%N>2!E;G1E28C.#(Q-SMS($-H86ER;6%N(&]F('1H92!B;V%R9"P@07)V:6X@2"X@4VUI M=&@L('1H92!C;VUP86YY)B,X,C$W.W,@4')E&5C=71I=F4@3V9F:6-E2!E>&-H M86YG:6YG(&5X:7-T:6YG('!R;VUI2!I;B!C87-H+"!A M;F0@;6%T=7)E9"!O;B!*=6QY(#(U+"`R,#$S+B!4:&4@9&5B96YT=7)E6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/;B!*=6QY(#(S M+"`R,#$P+"!T:&4@:&]L9&5R2!T:&4@ M;W!T:6]N('1O(')E9&5E;2!A;GD@<&]R=&EO;B!O9B!T:&4@9&5B96YT=7)E M2!W2!T:&4@ M8V]M<&%N>2!A;F0@8F4@7,@8G5T M(&YO="!M;W)E('1H86X@=&AI6QE/3-$)V1I6QE M/3-$)V1I2!R961E96UE9"!T:&4@;W5T6QE/3-$)V1I6QE/3-$ M)V1I2!E;G1EF%T M:6]N+"!A="!,:6)O6QE/3-$)W1E>'0M:6YD M96YT.B`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`R8U\T M96$Y7SEF-&9?969B9F0S-C$V8S!B+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F]T M92`S("8C.#(Q,3L@0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,Z/"]F M;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SLG/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE M9G0@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`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`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-#`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`],T1N;W=R87`^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`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`R<'@@'0M86QI9VXZ(&QE M9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE M/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`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`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`P/"]F M;VYT/CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`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`M3F]R=&AE&EC;RP@;W(@24%03DY-+"!T:&4@ M2!T:&4@8V]M<&%N>2!W97)E M('-U8G-E<75E;G1L>2!D965M960@=6YA;&QO=V%B;&4@;W(@;W1H97)W:7-E M(&YO="!R96EM8G5R2!R96EM8G5R2!W:6QL M('!R979A:6P@:6X@=&AI6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SY4:&4@8V]M<&%N>2!I7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA3H\8G(^/"]S=')O M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!.;W1E($1I'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H\+V9O;G0^/"]D:78^ M#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY3=&]C:RUB87-E9"!C;VUP96YS871I;VX@ M97AP96YS92!W87,@)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F]T92`U("8C.#(Q,3L@16%R M;FEN9W,@<&5R(%-H87)E.CPO9F]N=#X\+V1I=CX-"CQD:78@3H@8FQO8VL[)SXF(S$V,#L\+V1I M=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`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`R<'@@6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE M/3-$)V1I#LG('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX- M"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[)SXR,#$Q/"]F;VYT M/CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT-"B!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY796EG M:'1E9"!A=F5R86=E('-H87)E3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`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`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`],T1N;W=R87`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`],T1N;W=R87`^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXM/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#4R)3X-"CQD:78@86QI9VX],T1L969T('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R<'@@'0M86QI9VXZ(&QE9G0[)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V1I M6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`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`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXP+C`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`],T1N;W=R87`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`],T1N;W=R87`^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ#0H@;&5F=#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ-2PP,#`\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF M;VYT('-T>6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`],T1N;W=R M87`^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ-S,L,#`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`],T1N;W=R87`^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X- M"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`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`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE&-H86YG92!P&ET('!R:6-E*2!I;B!T:&4@<')I;F-I<&%L M(&]R(&UO2!I;B!A;B!O2!T M;R!M87AI;6EZ92!T:&4@=7-E(&]F(&]B6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[ M(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)V9O;G0M3H@:6YL:6YE.R<^ M3&5V96P@,R`\+V9O;G0^)B,X,C$R.R!5;F]B2!,979E;"`S(&9I;F%N8VEA;"!A6QE/3-$)V1I2!H860@)FYB'1087)T7S,T,S4R-V0P7V(P,F-?-&5A.5\Y9C1F7V5F8F9D,S8Q-F,P M8@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S-#,U,C=D,%]B,#)C M7S1E83E?.68T9E]E9F)F9#,V,39C,&(O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY4:&4@8V]M<&%N>28C.#(Q-SMS(&5X96-U=&EV92!O9F9I8V5R6QE/3-$)W=I M9'1H.B`Q,#`E.R<@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1I2!N971W;W)K(&%N9"!A(')A9&EO86-T:79E M(&-H96-K('-O=7)C92!M86YU9F%C='5R:6YG(&9A8VEL:71Y+B!4:&4@26YS M=')U;65N=',@3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W=I9'1H.B`Q,#`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`],T1N;W=R87`^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY397!T96UB97(F M(S$V,#LR-BP\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)V1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[)SXR,#$Q/"]F;VYT M/CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$ M)V1I6QE/3-$)W!A9&1I;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`R<'@@6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE M.R<^,C`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)V1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXH=6YA=61I=&5D*3PO9F]N=#X\+V1I=CX- M"CPO=&0^#0H\=&0@F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\ M='(@8F=C;VQO6QE/3-$)W1E>'0M M:6YD96YT.B`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`],T1N;W=R87`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`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`] M,T1N;W=R87`^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY);G-T#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`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`R<'@@'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`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`],T1N;W=R87`^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXY+#@Y."PV.30\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`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`],T1N;W=R87`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I M;F6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R<^ M+3PO9F]N=#X\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I M3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`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`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`],T1N;W=R87`^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`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`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`],T1N;W=R87`^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR+#4T-2PT,3$\+V9O;G0^ M/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T M>6QE/3-$)V1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY!;F%L>71I8V%L($QA M8F]R871O3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`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`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`R<'@@ M'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`],T1N;W=R87`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`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`R<'@@'0M86QI9VXZ(&QE M9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE M/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`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`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`],T1N;W=R87`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`],T1N;W=R87`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`],T1N;W=R87`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`],T1N;W=R87`^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD M96YT.B`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`],T1N;W=R87`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`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`R<'@@'0M86QI9VXZ(&QE9G0[ M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$ M)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@'0M M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V)O"!S M;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`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`],T1N;W=R87`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE.R<^/&9O;G0@ M3H@:6YL:6YE.R<^1&5P3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P M861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P M861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P M861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D M:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@<&%D M9&EN9RUB;W1T;VTZ(#)P>#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M M:6YD96YT.B`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`],T1N;W=R87`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`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`],T1N;W=R87`^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY);G-T#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R<-"B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXT-"PQ-3<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`T/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`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`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`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`R<'@@'0M86QI9VXZ(&-E M;G1E6QE/3-$)V1I3H@:6YL:6YE.R<^,C`Q,3PO9F]N=#X\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O M='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`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`],T1N;W=R M87`^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`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`R<'@@'0M86QI9VXZ(')I9VAT.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M)SXS-#`L,S8X/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`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`],T1N;W=R87`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`R8U\T M96$Y7SEF-&9?969B9F0S-C$V8S!B+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY4:&4@8V]M<&%N>2!H87,@979A;'5A=&5D('-U8G-E<75E;G0@979E M;G1S('1H3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\S-#,U,C=D,%]B,#)C7S1E83E?.68T9E]E9F)F M9#,V,39C,&(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S0S-3(W M9#!?8C`R8U\T96$Y7SEF-&9?969B9F0S-C$V8S!B+U=O&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U&UL/@T*+2TM+2TM/5].97AT4&%R=%\S-#,U D,C=D,%]B,#)C7S1E83E?.68T9E]E9F)F9#,V,39C,&(M+0T* ` end